<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="83cda613-b67b-45f7-81e0-f0d942d114a9" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;issue:issue:pii\:S0092867419X00045;article:article:pii\:S009286742030057X;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(20)30057-X">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/attachment/ae23c22a-bbf7-4982-8873-3ddb1654a990/fx1.jpg">
    


        <meta property="og:description" content="Broadly neutralizing antibodies targeting the HIV-1 envelope protein are a promising
option for prevention and treatment of HIV-1 infection. However, development of viral
resistance can limit clinical efficacy. Schommers et&nbsp;al. identify a highly broad and
potent antibody that targets the CD4 binding site of HIV-1. Compared with other potent
CD4 binding site antibodies, it restricts the development of viral escape and effectively
suppresses HIV-1 in&nbsp;vivo.">
    











        <meta name="twitter:title" content="Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/attachment/ae23c22a-bbf7-4982-8873-3ddb1654a990/fx1.jpg">
    


        <meta name="twitter:description" content="Broadly neutralizing antibodies targeting the HIV-1 envelope protein are a promising
option for prevention and treatment of HIV-1 infection. However, development of viral
resistance can limit clinical efficacy. Schommers et&nbsp;al. identify a highly broad and
potent antibody that targets the CD4 binding site of HIV-1. Compared with other potent
CD4 binding site antibodies, it restricts the development of viral escape and effectively
suppresses HIV-1 in&nbsp;vivo.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(20)30057-X">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody"> <meta name="citation_date" content="2020/02/06"> <meta name="citation_online_date" content="2020/01/30"> <meta name="citation_volume" content="180"> <meta name="citation_issue" content="3"> <meta name="citation_firstpage" content="471"> <meta name="citation_lastpage" content="489.e22"> <meta name="citation_pmid" content="32004464"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S009286742030057X"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S009286742030057X"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S009286742030057X"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2020.01.010"> <meta name="citation_pmid" content="32004464"> <meta name="citation_author" content="Philipp Schommers"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany"><meta name="citation_author_institution" content="German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Henning Gruell"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Morgan E. Abernathy"><meta name="citation_author_institution" content="Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA"><meta name="citation_author" content="My-Kim Tran"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Adam S. Dingens"><meta name="citation_author_institution" content="Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"><meta name="citation_author" content="Harry B. Gristick"><meta name="citation_author_institution" content="Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA"><meta name="citation_author" content="Christopher O. Barnes"><meta name="citation_author_institution" content="Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA"><meta name="citation_author" content="Till Schoofs"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Maike Schlotz"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Kanika Vanshylla"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Christoph Kreer"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Daniela Weiland"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Udo Holtick"><meta name="citation_author_institution" content="Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany"><meta name="citation_author" content="Christof Scheid"><meta name="citation_author_institution" content="Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany"><meta name="citation_author" content="Markus M. Valter"><meta name="citation_author_institution" content="Department of Gynecology and Obstetrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Marit J. van Gils"><meta name="citation_author_institution" content="Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands"><meta name="citation_author" content="Rogier W. Sanders"><meta name="citation_author_institution" content="Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA"><meta name="citation_author" content="Jörg J. Vehreschild"><meta name="citation_author_institution" content="Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany"><meta name="citation_author_institution" content="German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="Medical Department 2, University Hospital of Frankfurt, 60590 Frankfurt, Germany"><meta name="citation_author" content="Oliver A. Cornely"><meta name="citation_author_institution" content="Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany"><meta name="citation_author_institution" content="German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, 50935 Cologne, Germany"><meta name="citation_author_institution" content="Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Clara Lehmann"><meta name="citation_author_institution" content="Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany"><meta name="citation_author_institution" content="German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Gerd Fätkenheuer"><meta name="citation_author_institution" content="Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany"><meta name="citation_author_institution" content="German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany"><meta name="citation_author" content="Michael S. Seaman"><meta name="citation_author_institution" content="Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Jesse D. Bloom"><meta name="citation_author_institution" content="Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA"><meta name="citation_author_institution" content="Howard Hughes Medical Institute, Seattle, WA 98109, USA"><meta name="citation_author" content="Pamela J. Bjorkman"><meta name="citation_author_institution" content="Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA"><meta name="citation_author" content="Florian Klein"><meta name="citation_author_email" content="florian.klein@uk-koeln.de"><meta name="citation_author_institution" content="Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany"><meta name="citation_author_institution" content="Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany"><meta name="citation_keywords" content="HIV-1; broadly neutralizing antibodies; CD4 binding site; escape mutations; immunotherapy; cryogenic electron microscopy; deep mutational scanning; mutational antigenic profiling; HIV-1 escape restriction; humanized mice"><meta name="citation_reference" content="citation_title=PHENIX: a comprehensive Python-based system for macromolecular structure solution; citation_author=P.D. Adams; citation_author=P.V. Afonine; citation_author=G. Bunkóczi; citation_author=V.B. Chen; citation_author=I.W. Davis; citation_author=N. Echols; citation_author=J.J. Headd; citation_author=L.W. Hung; citation_author=G.J. Kapral; citation_author=R.W. Grosse-Kunstleve; citation_author=et al.; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=213; citation_lastpage=221; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E; citation_author=J.P. Anderson; citation_author=A.G. Rodrigo; citation_author=G.H. Learn; citation_author=A. Madan; citation_author=C. Delahunty; citation_author=M. Coon; citation_author=M. Girard; citation_author=S. Osmanov; citation_author=L. Hood; citation_author=J.I. Mullins; citation_journal_title=J.&nbsp;Virol.; citation_volume=74; citation_firstpage=10752; citation_lastpage=10765; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Antibody-based protection against HIV infection by vectored immunoprophylaxis; citation_author=A.B. Balazs; citation_author=J. Chen; citation_author=C.M. Hong; citation_author=D.S. Rao; citation_author=L. Yang; citation_author=D. Baltimore; citation_journal_title=Nature; citation_volume=481; citation_firstpage=81; citation_lastpage=84; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption; citation_author=K.J. Bar; citation_author=M.C. Sneller; citation_author=L.J. Harrison; citation_author=J.S. Justement; citation_author=E.T. Overton; citation_author=M.E. Petrone; citation_author=D.B. Salantes; citation_author=C.A. Seamon; citation_author=B. Scheinfeld; citation_author=R.W. Kwan; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=375; citation_firstpage=2037; citation_lastpage=2050; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals; citation_author=Y. Bar-On; citation_author=H. Gruell; citation_author=T. Schoofs; citation_author=J.A. Pai; citation_author=L. Nogueira; citation_author=A.L. Butler; citation_author=K. Millard; citation_author=C. Lehmann; citation_author=I. Suárez; citation_author=T.Y. Oliveira; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=1701; citation_lastpage=1707; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys; citation_author=D.H. Barouch; citation_author=J.B. Whitney; citation_author=B. Moldt; citation_author=F. Klein; citation_author=T.Y. Oliveira; citation_author=J. Liu; citation_author=K.E. Stephenson; citation_author=H.W. Chang; citation_author=K. Shekhar; citation_author=S. Gupta; citation_author=et al.; citation_journal_title=Nature; citation_volume=503; citation_firstpage=224; citation_lastpage=228; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Software for the analysis and visualization of deep mutational scanning data; citation_author=J.D. Bloom; citation_journal_title=BMC Bioinformatics; citation_volume=16; citation_firstpage=168; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody; citation_author=M. Bonsignori; citation_author=T. Zhou; citation_author=Z. Sheng; citation_author=L. Chen; citation_author=F. Gao; citation_author=M.G. Joyce; citation_author=G. Ozorowski; citation_author=G.Y. Chuang; citation_author=C.A. Schramm; citation_author=K. Wiehe; citation_author=NISC Comparative Sequencing Program; citation_author=et al.; citation_journal_title=Cell; citation_volume=165; citation_firstpage=449; citation_lastpage=463; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117; citation_author=M. Caskey; citation_author=F. Klein; citation_author=J.C. Lorenzi; citation_author=M.S. Seaman; citation_author=A.P. West; citation_author=N. Buckley; citation_author=G. Kremer; citation_author=L. Nogueira; citation_author=M. Braunschweig; citation_author=J.F. Scheid; citation_author=et al.; citation_journal_title=Nature; citation_volume=522; citation_firstpage=487; citation_lastpage=491; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Antibody 10-1074 suppresses viremia in HIV-1-infected individuals; citation_author=M. Caskey; citation_author=T. Schoofs; citation_author=H. Gruell; citation_author=A. Settler; citation_author=T. Karagounis; citation_author=E.F. Kreider; citation_author=B. Murrell; citation_author=N. Pfeifer; citation_author=L. Nogueira; citation_author=T.Y. Oliveira; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=23; citation_firstpage=185; citation_lastpage=191; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic; citation_author=M. Caskey; citation_author=F. Klein; citation_author=M.C. Nussenzweig; citation_journal_title=Nat. Med.; citation_volume=25; citation_firstpage=547; citation_lastpage=553; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=MolProbity: all-atom structure validation for macromolecular crystallography; citation_author=V.B. Chen; citation_author=W.B. Arendall; citation_author=J.J. Headd; citation_author=D.A. Keedy; citation_author=R.M. Immormino; citation_author=G.J. Kapral; citation_author=L.W. Murray; citation_author=J.S. Richardson; citation_author=D.C. Richardson; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=12; citation_lastpage=21; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition; citation_author=G.Y. Chuang; citation_author=J. Zhou; citation_author=P. Acharya; citation_author=R. Rawi; citation_author=C.H. Shen; citation_author=Z. Sheng; citation_author=B. Zhang; citation_author=T. Zhou; citation_author=R.T. Bailer; citation_author=V.P. Dandey; citation_author=et al.; citation_journal_title=Structure; citation_volume=27; citation_firstpage=196; citation_lastpage=206.e6; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Stable 293&nbsp;T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies; citation_author=N.P. Chung; citation_author=K. Matthews; citation_author=H.J. Kim; citation_author=T.J. Ketas; citation_author=M. Golabek; citation_author=K. de Los Reyes; citation_author=J. Korzun; citation_author=A. Yasmeen; citation_author=R.W. Sanders; citation_author=P.J. Klasse; citation_author=et al.; citation_journal_title=Retrovirology; citation_volume=11; citation_firstpage=33; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117; citation_author=Y.Z. Cohen; citation_author=J.C.C. Lorenzi; citation_author=L. Krassnig; citation_author=J.P. Barton; citation_author=L. Burke; citation_author=J. Pai; citation_author=C.L. Lu; citation_author=P. Mendoza; citation_author=T.Y. Oliveira; citation_author=C. Sleckman; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=215; citation_firstpage=2311; citation_lastpage=2324; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells; citation_author=Y.Z. Cohen; citation_author=J.C.C. Lorenzi; citation_author=M.S. Seaman; citation_author=L. Nogueira; citation_author=T. Schoofs; citation_author=L. Krassnig; citation_author=A. Butler; citation_author=K. Millard; citation_author=T. Fitzsimons; citation_author=X. Daniell; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=92; citation_firstpage=e01883-17; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial; citation_author=T.A. Crowell; citation_author=D.J. Colby; citation_author=S. Pinyakorn; citation_author=C. Sacdalan; citation_author=A. Pagliuzza; citation_author=J. Intasan; citation_author=K. Benjapornpong; citation_author=K. Tangnaree; citation_author=N. Chomchey; citation_author=E. Kroon; citation_author=RV397 Study Group; citation_author=et al.; citation_journal_title=Lancet HIV; citation_volume=6; citation_firstpage=e297; citation_lastpage=e306; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes; citation_author=S.W. de Taeye; citation_author=G. Ozorowski; citation_author=A. Torrents de la Peña; citation_author=M. Guttman; citation_author=J.P. Julien; citation_author=T.L. van den Kerkhof; citation_author=J.A. Burger; citation_author=L.K. Pritchard; citation_author=P. Pugach; citation_author=A. Yasmeen; citation_author=et al.; citation_journal_title=Cell; citation_volume=163; citation_firstpage=1702; citation_lastpage=1715; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies; citation_author=A. deCamp; citation_author=P. Hraber; citation_author=R.T. Bailer; citation_author=M.S. Seaman; citation_author=C. Ochsenbauer; citation_author=J. Kappes; citation_author=R. Gottardo; citation_author=P. Edlefsen; citation_author=S. Self; citation_author=H. Tang; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=88; citation_firstpage=2489; citation_lastpage=2507; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T&nbsp;cells from HIV-1 infection; citation_author=C.A. Didigu; citation_author=C.B. Wilen; citation_author=J. Wang; citation_author=J. Duong; citation_author=A.J. Secreto; citation_author=G.A. Danet-Desnoyers; citation_author=J.L. Riley; citation_author=P.D. Gregory; citation_author=C.H. June; citation_author=M.C. Holmes; citation_author=R.W. Doms; citation_journal_title=Blood; citation_volume=123; citation_firstpage=61; citation_lastpage=69; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody; citation_author=A.S. Dingens; citation_author=H.K. Haddox; citation_author=J. Overbaugh; citation_author=J.D. Bloom; citation_journal_title=Cell Host Microbe; citation_volume=21; citation_firstpage=777; citation_lastpage=787.e4; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes; citation_author=A.S. Dingens; citation_author=D. Arenz; citation_author=H. Weight; citation_author=J. Overbaugh; citation_author=J.D. Bloom; citation_journal_title=Immunity; citation_volume=50; citation_firstpage=520; citation_lastpage=532.e3; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Increasing the potency and breadth of an HIV antibody by using structure-based rational design; citation_author=R. Diskin; citation_author=J.F. Scheid; citation_author=P.M. Marcovecchio; citation_author=A.P. West; citation_author=F. Klein; citation_author=H. Gao; citation_author=P.N. Gnanapragasam; citation_author=A. Abadir; citation_author=M.S. Seaman; citation_author=M.C. Nussenzweig; citation_author=P.J. Bjorkman; citation_journal_title=Science; citation_volume=334; citation_firstpage=1289; citation_lastpage=1293; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies; citation_author=R. Diskin; citation_author=F. Klein; citation_author=J.A. Horwitz; citation_author=A. Halper-Stromberg; citation_author=D.N. Sather; citation_author=P.M. Marcovecchio; citation_author=T. Lee; citation_author=A.P. West; citation_author=H. Gao; citation_author=M.S. Seaman; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=210; citation_firstpage=1235; citation_lastpage=1249; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting; citation_author=N.A. Doria-Rose; citation_author=H.R. Altae-Tran; citation_author=R.S. Roark; citation_author=S.D. Schmidt; citation_author=M.S. Sutton; citation_author=M.K. Louder; citation_author=G.Y. Chuang; citation_author=R.T. Bailer; citation_author=V. Cortez; citation_author=R. Kong; citation_author=et al.; citation_journal_title=PLoS Pathog.; citation_volume=13; citation_firstpage=e1006148; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses; citation_author=P. Dosenovic; citation_author=A.K. Pettersson; citation_author=A. Wall; citation_author=E.S. Thientosapol; citation_author=J. Feng; citation_author=C. Weidle; citation_author=K. Bhullar; citation_author=E.E. Kara; citation_author=H. Hartweger; citation_author=J.A. Pai; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=216; citation_firstpage=2316; citation_lastpage=2330; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin; citation_author=M.B. Doud; citation_author=J.M. Lee; citation_author=J.D. Bloom; citation_journal_title=Nat. Commun.; citation_volume=9; citation_firstpage=1386; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV; citation_author=S.A. Ehrhardt; citation_author=M. Zehner; citation_author=V. Krähling; citation_author=H. Cohen-Dvashi; citation_author=C. Kreer; citation_author=N. Elad; citation_author=H. Gruell; citation_author=M.S. Ercanoglu; citation_author=P. Schommers; citation_author=L. Gieselmann; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=25; citation_firstpage=1589; citation_lastpage=1600; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Features and development of Coot; citation_author=P. Emsley; citation_author=B. Lohkamp; citation_author=W.G. Scott; citation_author=K. Cowtan; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=486; citation_lastpage=501; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques; citation_author=A. Escolano; citation_author=H.B. Gristick; citation_author=M.E. Abernathy; citation_author=J. Merkenschlager; citation_author=R. Gautam; citation_author=T.Y. Oliveira; citation_author=J. Pai; citation_author=A.P. West; citation_author=C.O. Barnes; citation_author=A.A. Cohen; citation_author=et al.; citation_journal_title=Nature; citation_volume=570; citation_firstpage=468; citation_lastpage=473; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir; citation_author=C. Gaebler; citation_author=J.C.C. Lorenzi; citation_author=T.Y. Oliveira; citation_author=L. Nogueira; citation_author=V. Ramos; citation_author=C.L. Lu; citation_author=J.A. Pai; citation_author=P. Mendoza; citation_author=M. Jankovic; citation_author=M. Caskey; citation_author=M.C. Nussenzweig; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=216; citation_firstpage=2253; citation_lastpage=2264; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment; citation_author=L. Gama; citation_author=R.A. Koup; citation_journal_title=Annu. Rev. Med.; citation_volume=69; citation_firstpage=409; citation_lastpage=419; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies; citation_author=F. Gao; citation_author=M. Bonsignori; citation_author=H.X. Liao; citation_author=A. Kumar; citation_author=S.M. Xia; citation_author=X. Lu; citation_author=F. Cai; citation_author=K.K. Hwang; citation_author=H. Song; citation_author=T. Zhou; citation_author=et al.; citation_journal_title=Cell; citation_volume=158; citation_firstpage=481; citation_lastpage=491; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults; citation_author=M.R. Gaudinski; citation_author=E.E. Coates; citation_author=K.V. Houser; citation_author=G.L. Chen; citation_author=G. Yamshchikov; citation_author=J.G. Saunders; citation_author=L.A. Holman; citation_author=I. Gordon; citation_author=S. Plummer; citation_author=C.S. Hendel; citation_author=VRC 606 Study Team; citation_author=et al.; citation_journal_title=PLoS Med.; citation_volume=15; citation_firstpage=e1002493; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial; citation_author=M.R. Gaudinski; citation_author=K.V. Houser; citation_author=N.A. Doria-Rose; citation_author=G.L. Chen; citation_author=R.S.S. Rothwell; citation_author=N. Berkowitz; citation_author=P. Costner; citation_author=L.A. Holman; citation_author=I.J. Gordon; citation_author=C.S. Hendel; citation_author=VRC 605 study team; citation_author=et al.; citation_journal_title=Lancet HIV; citation_volume=6; citation_firstpage=e667; citation_lastpage=e679; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges; citation_author=R. Gautam; citation_author=Y. Nishimura; citation_author=A. Pegu; citation_author=M.C. Nason; citation_author=F. Klein; citation_author=A. Gazumyan; citation_author=J. Golijanin; citation_author=A. Buckler-White; citation_author=R. Sadjadpour; citation_author=K. Wang; citation_author=et al.; citation_journal_title=Nature; citation_volume=533; citation_firstpage=105; citation_lastpage=109; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Visualizing density maps with UCSF Chimera; citation_author=T.D. Goddard; citation_author=C.C. Huang; citation_author=T.E. Ferrin; citation_journal_title=J.&nbsp;Struct. Biol.; citation_volume=157; citation_firstpage=281; citation_lastpage=287; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Progress in HIV-1 antibody research using humanized mice; citation_author=H. Gruell; citation_author=F. Klein; citation_journal_title=Curr. Opin. HIV AIDS; citation_volume=12; citation_firstpage=285; citation_lastpage=293; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Antibody-mediated prevention and treatment of HIV-1 infection; citation_author=H. Gruell; citation_author=F. Klein; citation_journal_title=Retrovirology; citation_volume=15; citation_firstpage=73; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0; citation_author=S. Guindon; citation_author=J.F. Dufayard; citation_author=V. Lefort; citation_author=M. Anisimova; citation_author=W. Hordijk; citation_author=O. Gascuel; citation_journal_title=Syst. Biol.; citation_volume=59; citation_firstpage=307; citation_lastpage=321; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV’s Envelope Protein on Viral Replication in Cell Culture; citation_author=H.K. Haddox; citation_author=A.S. Dingens; citation_author=J.D. Bloom; citation_journal_title=PLoS Pathog.; citation_volume=12; citation_firstpage=e1006114; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Mapping mutational effects along the evolutionary landscape of HIV envelope; citation_author=H.K. Haddox; citation_author=A.S. Dingens; citation_author=S.K. Hilton; citation_author=J. Overbaugh; citation_author=J.D. Bloom; citation_journal_title=eLife; citation_volume=7; citation_firstpage=e34420; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies; citation_author=B.F. Haynes; citation_author=J. Fleming; citation_author=E.W. St Clair; citation_author=H. Katinger; citation_author=G. Stiegler; citation_author=R. Kunert; citation_author=J. Robinson; citation_author=R.M. Scearce; citation_author=K. Plonk; citation_author=H.F. Staats; citation_author=et al.; citation_journal_title=Science; citation_volume=308; citation_firstpage=1906; citation_lastpage=1908; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice; citation_author=J.A. Horwitz; citation_author=A. Halper-Stromberg; citation_author=H. Mouquet; citation_author=A.D. Gitlin; citation_author=A. Tretiakova; citation_author=T.R. Eisenreich; citation_author=M. Malbec; citation_author=S. Gravemann; citation_author=E. Billerbeck; citation_author=M. Dorner; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=110; citation_firstpage=16538; citation_lastpage=16543; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In&nbsp;Vivo; citation_author=J.A. Horwitz; citation_author=Y. Bar-On; citation_author=C.L. Lu; citation_author=D. Fera; citation_author=A.A.K. Lockhart; citation_author=J.C.C. Lorenzi; citation_author=L. Nogueira; citation_author=J. Golijanin; citation_author=J.F. Scheid; citation_author=M.S. Seaman; citation_author=et al.; citation_journal_title=Cell; citation_volume=170; citation_firstpage=637; citation_lastpage=648.e10; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments; citation_author=P. Hraber; citation_author=C. Rademeyer; citation_author=C. Williamson; citation_author=M.S. Seaman; citation_author=R. Gottardo; citation_author=H. Tang; citation_author=K. Greene; citation_author=H. Gao; citation_author=C. LaBranche; citation_author=J.R. Mascola; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=91; citation_firstpage=e00991-17; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth; citation_author=J. Huang; citation_author=B.H. Kang; citation_author=E. Ishida; citation_author=T. Zhou; citation_author=T. Griesman; citation_author=Z. Sheng; citation_author=F. Wu; citation_author=N.A. Doria-Rose; citation_author=B. Zhang; citation_author=K. McKee; citation_author=et al.; citation_journal_title=Immunity; citation_volume=45; citation_firstpage=1108; citation_lastpage=1121; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity; citation_author=Y. Huang; citation_author=J. Yu; citation_author=A. Lanzi; citation_author=X. Yao; citation_author=C.D. Andrews; citation_author=L. Tsai; citation_author=M.R. Gajjar; citation_author=M. Sun; citation_author=M.S. Seaman; citation_author=N.N. Padte; citation_author=D.D. Ho; citation_journal_title=Cell; citation_volume=165; citation_firstpage=1621; citation_lastpage=1631; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model; citation_author=W.L. Ince; citation_author=L. Zhang; citation_author=Q. Jiang; citation_author=K. Arrildt; citation_author=L. Su; citation_author=R. Swanstrom; citation_journal_title=J.&nbsp;Virol.; citation_volume=84; citation_firstpage=2740; citation_lastpage=2752; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Neutralizing antibodies for HIV-1 prevention; citation_author=B. Julg; citation_author=D.H. Barouch; citation_journal_title=Curr. Opin. HIV AIDS; citation_volume=14; citation_firstpage=318; citation_lastpage=324; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys; citation_author=B. Julg; citation_author=A. Pegu; citation_author=P. Abbink; citation_author=J. Liu; citation_author=A. Brinkman; citation_author=K. Molloy; citation_author=S. Mojta; citation_author=A. Chandrashekar; citation_author=K. Callow; citation_author=K. Wang; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=91; citation_firstpage=e00498-17; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=High throughput functional analysis of HIV-1 env genes without cloning; citation_author=J.L. Kirchherr; citation_author=X. Lu; citation_author=W. Kasongo; citation_author=V. Chalwe; citation_author=L. Mwananyanda; citation_author=R.M. Musonda; citation_author=S.M. Xia; citation_author=R.M. Scearce; citation_author=H.X. Liao; citation_author=D.C. Montefiori; citation_author=et al.; citation_journal_title=J.&nbsp;Virol. Methods; citation_volume=143; citation_firstpage=104; citation_lastpage=111; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=HIV therapy by a combination of broadly neutralizing antibodies in humanized mice; citation_author=F. Klein; citation_author=A. Halper-Stromberg; citation_author=J.A. Horwitz; citation_author=H. Gruell; citation_author=J.F. Scheid; citation_author=S. Bournazos; citation_author=H. Mouquet; citation_author=L.A. Spatz; citation_author=R. Diskin; citation_author=A. Abadir; citation_author=et al.; citation_journal_title=Nature; citation_volume=492; citation_firstpage=118; citation_lastpage=122; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=openPrimeR for multiplex amplification of highly diverse templates; citation_author=C. Kreer; citation_author=M. Döring; citation_author=N. Lehnen; citation_author=M.S. Ercanoglu; citation_author=L. Gieselmann; citation_author=D. Luca; citation_author=K. Jain; citation_author=P. Schommers; citation_author=N. Pfeifer; citation_author=F. Klein; citation_journal_title=bioRxiv; citation_doi=10.1101/847574; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Inference of macromolecular assemblies from crystalline state; citation_author=E. Krissinel; citation_author=K. Henrick; citation_journal_title=J.&nbsp;Mol. Biol.; citation_volume=372; citation_firstpage=774; citation_lastpage=797; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Microbial evolution. Global epistasis makes adaptation predictable despite sequence-level stochasticity; citation_author=S. Kryazhimskiy; citation_author=D.P. Rice; citation_author=E.R. Jerison; citation_author=M.M. Desai; citation_journal_title=Science; citation_volume=344; citation_firstpage=1519; citation_lastpage=1522; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Quantifying the local resolution of cryo-EM density maps; citation_author=A. Kucukelbir; citation_author=F.J. Sigworth; citation_author=H.D. Tagare; citation_journal_title=Nat. Methods; citation_volume=11; citation_firstpage=63; citation_lastpage=65; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody; citation_author=P.D. Kwong; citation_author=R. Wyatt; citation_author=J. Robinson; citation_author=R.W. Sweet; citation_author=J. Sodroski; citation_author=W.A. Hendrickson; citation_journal_title=Nature; citation_volume=393; citation_firstpage=648; citation_lastpage=659; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults; citation_author=J.E. Ledgerwood; citation_author=E.E. Coates; citation_author=G. Yamshchikov; citation_author=J.G. Saunders; citation_author=L. Holman; citation_author=M.E. Enama; citation_author=A. DeZure; citation_author=R.M. Lynch; citation_author=I. Gordon; citation_author=S. Plummer; citation_author=VRC 602 Study Team; citation_author=et al.; citation_journal_title=Clin. Exp. Immunol.; citation_volume=182; citation_firstpage=289; citation_lastpage=301; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure; citation_author=J.H. Lee; citation_author=R. Andrabi; citation_author=C.Y. Su; citation_author=A. Yasmeen; citation_author=J.P. Julien; citation_author=L. Kong; citation_author=N.C. Wu; citation_author=R. McBride; citation_author=D. Sok; citation_author=M. Pauthner; citation_author=et al.; citation_journal_title=Immunity; citation_volume=46; citation_firstpage=690; citation_lastpage=702; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells; citation_author=C.K. Leonard; citation_author=M.W. Spellman; citation_author=L. Riddle; citation_author=R.J. Harris; citation_author=J.N. Thomas; citation_author=T.J. Gregory; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=265; citation_firstpage=10373; citation_lastpage=10382; citation_publication_date=1990; "><meta name="citation_reference" content="citation_title=Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer; citation_author=Q. Liu; citation_author=P. Acharya; citation_author=M.A. Dolan; citation_author=P. Zhang; citation_author=C. Guzzo; citation_author=J. Lu; citation_author=A. Kwon; citation_author=D. Gururani; citation_author=H. Miao; citation_author=T. Bylund; citation_author=et al.; citation_journal_title=Nat. Struct. Mol. Biol.; citation_volume=24; citation_firstpage=370; citation_lastpage=378; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Improvement of antibody functionality by structure-guided paratope engraftment; citation_author=Q. Liu; citation_author=Y.T. Lai; citation_author=P. Zhang; citation_author=M.K. Louder; citation_author=A. Pegu; citation_author=R. Rawi; citation_author=M. Asokan; citation_author=X. Chen; citation_author=C.H. Shen; citation_author=G.Y. Chuang; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=10; citation_firstpage=721; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection; citation_author=R.M. Lynch; citation_author=E. Boritz; citation_author=E.E. Coates; citation_author=A. DeZure; citation_author=P. Madden; citation_author=P. Costner; citation_author=M.E. Enama; citation_author=S. Plummer; citation_author=L. Holman; citation_author=C.S. Hendel; citation_author=VRC 601 Study Team; citation_author=et al.; citation_journal_title=Sci. Transl. Med.; citation_volume=7; citation_firstpage=319ra206; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies; citation_author=R.M. Lynch; citation_author=P. Wong; citation_author=L. Tran; citation_author=S. O’Dell; citation_author=M.C. Nason; citation_author=Y. Li; citation_author=X. Wu; citation_author=J.R. Mascola; citation_journal_title=J.&nbsp;Virol.; citation_volume=89; citation_firstpage=4201; citation_lastpage=4213; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer; citation_author=D. Lyumkis; citation_author=J.P. Julien; citation_author=N. de Val; citation_author=A. Cupo; citation_author=C.S. Potter; citation_author=P.J. Klasse; citation_author=D.R. Burton; citation_author=R.W. Sanders; citation_author=J.P. Moore; citation_author=B. Carragher; citation_author=et al.; citation_journal_title=Science; citation_volume=342; citation_firstpage=1484; citation_lastpage=1490; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain; citation_author=P.J. Maddon; citation_author=A.G. Dalgleish; citation_author=J.S. McDougal; citation_author=P.R. Clapham; citation_author=R.A. Weiss; citation_author=R. Axel; citation_journal_title=Cell; citation_volume=47; citation_firstpage=333; citation_lastpage=348; citation_publication_date=1986; "><meta name="citation_reference" content="citation_title=Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial; citation_author=K.H. Mayer; citation_author=K.E. Seaton; citation_author=Y. Huang; citation_author=N. Grunenberg; citation_author=A. Isaacs; citation_author=M. Allen; citation_author=J.E. Ledgerwood; citation_author=I. Frank; citation_author=M.E. Sobieszczyk; citation_author=L.R. Baden; citation_author=HVTN 104 Protocol Team; citation_author=and the NIAID HIV Vaccine Trials Network; citation_author=et al.; citation_journal_title=PLoS Med.; citation_volume=14; citation_firstpage=e1002435; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Combination therapy with anti-HIV-1 antibodies maintains viral suppression; citation_author=P. Mendoza; citation_author=H. Gruell; citation_author=L. Nogueira; citation_author=J.A. Pai; citation_author=A.L. Butler; citation_author=K. Millard; citation_author=C. Lehmann; citation_author=I. Suárez; citation_author=T.Y. Oliveira; citation_author=J.C.C. Lorenzi; citation_author=et al.; citation_journal_title=Nature; citation_volume=561; citation_firstpage=479; citation_lastpage=484; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Highly potent HIV-specific antibody neutralization in&nbsp;vitro translates into effective protection against mucosal SHIV challenge in&nbsp;vivo; citation_author=B. Moldt; citation_author=E.G. Rakasz; citation_author=N. Schultz; citation_author=P.Y. Chan-Hui; citation_author=K. Swiderek; citation_author=K.L. Weisgrau; citation_author=S.M. Piaskowski; citation_author=Z. Bergman; citation_author=D.I. Watkins; citation_author=P. Poignard; citation_author=D.R. Burton; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=109; citation_firstpage=18921; citation_lastpage=18925; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies; citation_author=H. Mouquet; citation_author=L. Scharf; citation_author=Z. Euler; citation_author=Y. Liu; citation_author=C. Eden; citation_author=J.F. Scheid; citation_author=A. Halper-Stromberg; citation_author=P.N. Gnanapragasam; citation_author=D.I. Spencer; citation_author=M.S. Seaman; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=109; citation_firstpage=E3268; citation_lastpage=E3277; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies; citation_author=Y. Otsuka; citation_author=K. Schmitt; citation_author=B.D. Quinlan; citation_author=M.R. Gardner; citation_author=B. Alfant; citation_author=A. Reich; citation_author=M. Farzan; citation_author=H. Choe; citation_journal_title=PLoS Pathog.; citation_volume=14; citation_firstpage=e1007238; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Amplification and analysis of cDNA generated from a single cell by 5′-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells; citation_author=T. Ozawa; citation_author=H. Kishi; citation_author=A. Muraguchi; citation_journal_title=Biotechniques; citation_volume=40; citation_firstpage=469; citation_lastpage=470, 472, 474 passim; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield; citation_author=R. Pejchal; citation_author=K.J. Doores; citation_author=L.M. Walker; citation_author=R. Khayat; citation_author=P.S. Huang; citation_author=S.K. Wang; citation_author=R.L. Stanfield; citation_author=J.P. Julien; citation_author=A. Ramos; citation_author=M. Crispin; citation_author=et al.; citation_journal_title=Science; citation_volume=334; citation_firstpage=1097; citation_lastpage=1103; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness; citation_author=J. Pietzsch; citation_author=J.F. Scheid; citation_author=H. Mouquet; citation_author=F. Klein; citation_author=M.S. Seaman; citation_author=M. Jankovic; citation_author=D. Corti; citation_author=A. Lanzavecchia; citation_author=M.C. Nussenzweig; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=207; citation_firstpage=1995; citation_lastpage=2002; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1; citation_author=E.J. Platt; citation_author=K. Wehrly; citation_author=S.E. Kuhmann; citation_author=B. Chesebro; citation_author=D. Kabat; citation_journal_title=J.&nbsp;Virol.; citation_volume=72; citation_firstpage=2855; citation_lastpage=2864; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination; citation_author=A. Punjani; citation_author=J.L. Rubinstein; citation_author=D.J. Fleet; citation_author=M.A. Brubaker; citation_journal_title=Nat. Methods; citation_volume=14; citation_firstpage=290; citation_lastpage=296; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART; citation_author=S.A. Riddler; citation_author=L. Zheng; citation_author=C.M. Durand; citation_author=J. Ritz; citation_author=R.A. Koup; citation_author=J. Ledgerwood; citation_author=R.T. Bailer; citation_author=S.L. Koletar; citation_author=J.J. Eron; citation_author=M.C. Keefer; citation_author=AIDS Clinical Trials Group A5342 Protocol Team; citation_author=et al.; citation_journal_title=Open Forum Infect. Dis.; citation_volume=5; citation_firstpage=ofy242; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding; citation_author=C.D. Rizzuto; citation_author=R. Wyatt; citation_author=N. Hernández-Ramos; citation_author=Y. Sun; citation_author=P.D. Kwong; citation_author=W.A. Hendrickson; citation_author=J. Sodroski; citation_journal_title=Science; citation_volume=280; citation_firstpage=1949; citation_lastpage=1953; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Enhanced potency of a broadly neutralizing HIV-1 antibody in&nbsp;vitro improves protection against lentiviral infection in&nbsp;vivo; citation_author=R.S. Rudicell; citation_author=Y.D. Kwon; citation_author=S.Y. Ko; citation_author=A. Pegu; citation_author=M.K. Louder; citation_author=I.S. Georgiev; citation_author=X. Wu; citation_author=J. Zhu; citation_author=J.C. Boyington; citation_author=X. Chen; citation_author=NISC Comparative Sequencing Program; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=88; citation_firstpage=12669; citation_lastpage=12682; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses; citation_author=M.M. Sajadi; citation_author=A. Dashti; citation_author=Z. Rikhtegaran Tehrani; citation_author=W.D. Tolbert; citation_author=M.S. Seaman; citation_author=X. Ouyang; citation_author=N. Gohain; citation_author=M. Pazgier; citation_author=D. Kim; citation_author=G. Cavet; citation_author=et al.; citation_journal_title=Cell; citation_volume=173; citation_firstpage=1783; citation_lastpage=1795.e14; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing; citation_author=J.F. Salazar-Gonzalez; citation_author=E. Bailes; citation_author=K.T. Pham; citation_author=M.G. Salazar; citation_author=M.B. Guffey; citation_author=B.F. Keele; citation_author=C.A. Derdeyn; citation_author=P. Farmer; citation_author=E. Hunter; citation_author=S. Allen; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=82; citation_firstpage=3952; citation_lastpage=3970; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies; citation_author=R.W. Sanders; citation_author=R. Derking; citation_author=A. Cupo; citation_author=J.P. Julien; citation_author=A. Yasmeen; citation_author=N. de Val; citation_author=H.J. Kim; citation_author=C. Blattner; citation_author=A.T. de la Peña; citation_author=J. Korzun; citation_author=et al.; citation_journal_title=PLoS Pathog.; citation_volume=9; citation_firstpage=e1003618; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1; citation_author=M. Sarzotti-Kelsoe; citation_author=R.T. Bailer; citation_author=E. Turk; citation_author=C.L. Lin; citation_author=M. Bilska; citation_author=K.M. Greene; citation_author=H. Gao; citation_author=C.A. Todd; citation_author=D.A. Ozaki; citation_author=M.S. Seaman; citation_author=et al.; citation_journal_title=J.&nbsp;Immunol. Methods; citation_volume=409; citation_firstpage=131; citation_lastpage=146; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus; citation_author=D.N. Sather; citation_author=S. Carbonetti; citation_author=J. Kehayia; citation_author=Z. Kraft; citation_author=I. Mikell; citation_author=J.F. Scheid; citation_author=F. Klein; citation_author=L. Stamatatos; citation_journal_title=J.&nbsp;Virol.; citation_volume=86; citation_firstpage=12676; citation_lastpage=12685; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike; citation_author=L. Scharf; citation_author=J.F. Scheid; citation_author=J.H. Lee; citation_author=A.P. West; citation_author=C. Chen; citation_author=H. Gao; citation_author=P.N. Gnanapragasam; citation_author=R. Mares; citation_author=M.S. Seaman; citation_author=A.B. Ward; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=7; citation_firstpage=785; citation_lastpage=795; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=A method for identification of HIV gp140 binding memory B cells in human blood; citation_author=J.F. Scheid; citation_author=H. Mouquet; citation_author=N. Feldhahn; citation_author=B.D. Walker; citation_author=F. Pereyra; citation_author=E. Cutrell; citation_author=M.S. Seaman; citation_author=J.R. Mascola; citation_author=R.T. Wyatt; citation_author=H. Wardemann; citation_author=M.C. Nussenzweig; citation_journal_title=J.&nbsp;Immunol. Methods; citation_volume=343; citation_firstpage=65; citation_lastpage=67; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding; citation_author=J.F. Scheid; citation_author=H. Mouquet; citation_author=B. Ueberheide; citation_author=R. Diskin; citation_author=F. Klein; citation_author=T.Y. Oliveira; citation_author=J. Pietzsch; citation_author=D. Fenyo; citation_author=A. Abadir; citation_author=K. Velinzon; citation_author=et al.; citation_journal_title=Science; citation_volume=333; citation_firstpage=1633; citation_lastpage=1637; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption; citation_author=J.F. Scheid; citation_author=J.A. Horwitz; citation_author=Y. Bar-On; citation_author=E.F. Kreider; citation_author=C.L. Lu; citation_author=J.C. Lorenzi; citation_author=A. Feldmann; citation_author=M. Braunschweig; citation_author=L. Nogueira; citation_author=T. Oliveira; citation_author=et al.; citation_journal_title=Nature; citation_volume=535; citation_firstpage=556; citation_lastpage=560; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Prevention of overfitting in cryo-EM structure determination; citation_author=S.H. Scheres; citation_author=S. Chen; citation_journal_title=Nat. Methods; citation_volume=9; citation_firstpage=853; citation_lastpage=854; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1; citation_author=T. Schoofs; citation_author=F. Klein; citation_author=M. Braunschweig; citation_author=E.F. Kreider; citation_author=A. Feldmann; citation_author=L. Nogueira; citation_author=T. Oliveira; citation_author=J.C. Lorenzi; citation_author=E.H. Parrish; citation_author=G.H. Learn; citation_author=et al.; citation_journal_title=Science; citation_volume=352; citation_firstpage=997; citation_lastpage=1001; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression; citation_author=M. Schreiber; citation_author=C. Wachsmuth; citation_author=H. Müller; citation_author=C. Hagen; citation_author=H. Schmitz; citation_author=J. van Lunzen; citation_journal_title=J.&nbsp;Gen. Virol.; citation_volume=77; citation_firstpage=2403; citation_lastpage=2414; citation_publication_date=1996; "><meta name="citation_reference" content="citation_title=Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies; citation_author=M.S. Seaman; citation_author=H. Janes; citation_author=N. Hawkins; citation_author=L.E. Grandpre; citation_author=C. Devoy; citation_author=A. Giri; citation_author=R.T. Coffey; citation_author=L. Harris; citation_author=B. Wood; citation_author=M.G. Daniels; citation_author=et al.; citation_journal_title=J.&nbsp;Virol.; citation_volume=84; citation_firstpage=1439; citation_lastpage=1452; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Structural basis of coreceptor recognition by HIV-1 envelope spike; citation_author=M.M. Shaik; citation_author=H. Peng; citation_author=J. Lu; citation_author=S. Rits-Volloch; citation_author=C. Xu; citation_author=M. Liao; citation_author=B. Chen; citation_journal_title=Nature; citation_volume=565; citation_firstpage=318; citation_lastpage=323; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia; citation_author=M. Shingai; citation_author=Y. Nishimura; citation_author=F. Klein; citation_author=H. Mouquet; citation_author=O.K. Donau; citation_author=R. Plishka; citation_author=A. Buckler-White; citation_author=M. Seaman; citation_author=M. Piatak; citation_author=J.D. Lifson; citation_author=et al.; citation_journal_title=Nature; citation_volume=503; citation_firstpage=277; citation_lastpage=280; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques; citation_author=M. Shingai; citation_author=O.K. Donau; citation_author=R.J. Plishka; citation_author=A. Buckler-White; citation_author=J.R. Mascola; citation_author=G.J. Nabel; citation_author=M.C. Nason; citation_author=D. Montefiori; citation_author=B. Moldt; citation_author=P. Poignard; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=211; citation_firstpage=2061; citation_lastpage=2074; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer; citation_author=K. Sliepen; citation_author=T. van Montfort; citation_author=G. Ozorowski; citation_author=L.K. Pritchard; citation_author=M. Crispin; citation_author=A.B. Ward; citation_author=R.W. Sanders; citation_journal_title=Biomolecules; citation_volume=5; citation_firstpage=2919; citation_lastpage=2934; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Recent progress in broadly neutralizing antibodies to HIV; citation_author=D. Sok; citation_author=D.R. Burton; citation_journal_title=Nat. Immunol.; citation_volume=19; citation_firstpage=1179; citation_lastpage=1188; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex; citation_author=D. Sok; citation_author=M.J. van Gils; citation_author=M. Pauthner; citation_author=J.P. Julien; citation_author=K.L. Saye-Francisco; citation_author=J. Hsueh; citation_author=B. Briney; citation_author=J.H. Lee; citation_author=K.M. Le; citation_author=P.S. Lee; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=111; citation_firstpage=17624; citation_lastpage=17629; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G; citation_author=G.B. Stewart-Jones; citation_author=C. Soto; citation_author=T. Lemmin; citation_author=G.Y. Chuang; citation_author=A. Druz; citation_author=R. Kong; citation_author=P.V. Thomas; citation_author=K. Wagh; citation_author=T. Zhou; citation_author=A.J. Behrens; citation_author=et al.; citation_journal_title=Cell; citation_volume=165; citation_firstpage=813; citation_lastpage=826; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Automated map sharpening by maximization of detail and connectivity; citation_author=T.C. Terwilliger; citation_author=O.V. Sobolev; citation_author=P.V. Afonine; citation_author=P.D. Adams; citation_journal_title=Acta Crystallogr. D Struct. Biol.; citation_volume=74; citation_firstpage=545; citation_lastpage=559; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning; citation_author=T. Tiller; citation_author=E. Meffre; citation_author=S. Yurasov; citation_author=M. Tsuiji; citation_author=M.C. Nussenzweig; citation_author=H. Wardemann; citation_journal_title=J.&nbsp;Immunol. Methods; citation_volume=329; citation_firstpage=112; citation_lastpage=124; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Web servers and services for electrostatics calculations with APBS and PDB2PQR; citation_author=S. Unni; citation_author=Y. Huang; citation_author=R.M. Hanson; citation_author=M. Tobias; citation_author=S. Krishnan; citation_author=W.W. Li; citation_author=J.E. Nielsen; citation_author=N.A. Baker; citation_journal_title=J.&nbsp;Comput. Chem.; citation_volume=32; citation_firstpage=1488; citation_lastpage=1491; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Only five of 10 strictly conserved disulfide bonds are essential for folding and eight for function of the HIV-1 envelope glycoprotein; citation_author=E. van Anken; citation_author=R.W. Sanders; citation_author=I.M. Liscaljet; citation_author=A. Land; citation_author=I. Bontjer; citation_author=S. Tillemans; citation_author=A.A. Nabatov; citation_author=W.A. Paxton; citation_author=B. Berkhout; citation_author=I. Braakman; citation_journal_title=Mol. Biol. Cell; citation_volume=19; citation_firstpage=4298; citation_lastpage=4309; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Sequencing and cloning of antigen-specific antibodies from mouse memory B cells; citation_author=L. von Boehmer; citation_author=C. Liu; citation_author=S. Ackerman; citation_author=A.D. Gitlin; citation_author=Q. Wang; citation_author=A. Gazumyan; citation_author=M.C. Nussenzweig; citation_journal_title=Nat. Protoc.; citation_volume=11; citation_firstpage=1908; citation_lastpage=1923; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Passive immunotherapy of viral infections: ‘super-antibodies’ enter the fray; citation_author=L.M. Walker; citation_author=D.R. Burton; citation_journal_title=Nat. Rev. Immunol.; citation_volume=18; citation_firstpage=297; citation_lastpage=308; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Unravelling the mechanisms of durable control of HIV-1; citation_author=B.D. Walker; citation_author=X.G. Yu; citation_journal_title=Nat. Rev. Immunol.; citation_volume=13; citation_firstpage=487; citation_lastpage=498; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target; citation_author=L.M. Walker; citation_author=S.K. Phogat; citation_author=P.Y. Chan-Hui; citation_author=D. Wagner; citation_author=P. Phung; citation_author=J.L. Goss; citation_author=T. Wrin; citation_author=M.D. Simek; citation_author=S. Fling; citation_author=J.L. Mitcham; citation_author=Protocol G Principal Investigators; citation_author=et al.; citation_journal_title=Science; citation_volume=326; citation_firstpage=285; citation_lastpage=289; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Broad neutralization coverage of HIV by multiple highly potent antibodies; citation_author=L.M. Walker; citation_author=M. Huber; citation_author=K.J. Doores; citation_author=E. Falkowska; citation_author=R. Pejchal; citation_author=J.P. Julien; citation_author=S.K. Wang; citation_author=A. Ramos; citation_author=P.Y. Chan-Hui; citation_author=M. Moyle; citation_author=Protocol G Principal Investigators; citation_author=et al.; citation_journal_title=Nature; citation_volume=477; citation_firstpage=466; citation_lastpage=470; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120; citation_author=A.P. West; citation_author=R. Diskin; citation_author=M.C. Nussenzweig; citation_author=P.J. Bjorkman; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=109; citation_firstpage=E2083; citation_lastpage=E2090; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues; citation_author=A.P. West; citation_author=L. Scharf; citation_author=J. Horwitz; citation_author=F. Klein; citation_author=M.C. Nussenzweig; citation_author=P.J. Bjorkman; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=110; citation_firstpage=10598; citation_lastpage=10603; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Potent and broad HIV-neutralizing antibodies in memory B cells and plasma; citation_author=L.D. Williams; citation_author=G. Ofek; citation_author=S. Schätzle; citation_author=J.R. McDaniel; citation_author=X. Lu; citation_author=N.I. Nicely; citation_author=L. Wu; citation_author=C.S. Lougheed; citation_author=T. Bradley; citation_author=M.K. Louder; citation_author=et al.; citation_journal_title=Sci. Immunol.; citation_volume=2; citation_firstpage=eaal2200; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1; citation_author=X. Wu; citation_author=Z.Y. Yang; citation_author=Y. Li; citation_author=C.M. Hogerkorp; citation_author=W.R. Schief; citation_author=M.S. Seaman; citation_author=T. Zhou; citation_author=S.D. Schmidt; citation_author=L. Wu; citation_author=L. Xu; citation_author=et al.; citation_journal_title=Science; citation_volume=329; citation_firstpage=856; citation_lastpage=861; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques; citation_author=L. Xu; citation_author=A. Pegu; citation_author=E. Rao; citation_author=N. Doria-Rose; citation_author=J. Beninga; citation_author=K. McKee; citation_author=D.M. Lord; citation_author=R.R. Wei; citation_author=G. Deng; citation_author=M. Louder; citation_author=et al.; citation_journal_title=Science; citation_volume=358; citation_firstpage=85; citation_lastpage=90; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1; citation_author=K. Xu; citation_author=P. Acharya; citation_author=R. Kong; citation_author=C. Cheng; citation_author=G.Y. Chuang; citation_author=K. Liu; citation_author=M.K. Louder; citation_author=S. O’Dell; citation_author=R. Rawi; citation_author=M. Sastry; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=857; citation_lastpage=867; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins; citation_author=X. Yang; citation_author=M. Farzan; citation_author=R. Wyatt; citation_author=J. Sodroski; citation_journal_title=J.&nbsp;Virol.; citation_volume=74; citation_firstpage=5716; citation_lastpage=5725; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=IgBLAST: an immunoglobulin variable domain sequence analysis tool; citation_author=J. Ye; citation_author=N. Ma; citation_author=T.L. Madden; citation_author=J.M. Ostell; citation_journal_title=Nucleic Acids Res.; citation_volume=41; citation_firstpage=W34-40; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=CATNAP: a tool to compile, analyze and tally neutralizing antibody panels; citation_author=H. Yoon; citation_author=J. Macke; citation_author=A.P. West; citation_author=B. Foley; citation_author=P.J. Bjorkman; citation_author=B. Korber; citation_author=K. Yusim; citation_journal_title=Nucleic Acids Res.; citation_volume=43; citation_number=W1; citation_firstpage=W213-9; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Gctf: Real-time CTF determination and correction; citation_author=K. Zhang; citation_journal_title=J.&nbsp;Struct. Biol.; citation_volume=193; citation_firstpage=1; citation_lastpage=12; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection; citation_author=Y.J. Zhang; citation_author=T. Hatziioannou; citation_author=T. Zang; citation_author=D. Braaten; citation_author=J. Luban; citation_author=S.P. Goff; citation_author=P.D. Bieniasz; citation_journal_title=J.&nbsp;Virol.; citation_volume=76; citation_firstpage=6332; citation_lastpage=6343; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy; citation_author=S.Q. Zheng; citation_author=E. Palovcak; citation_author=J.P. Armache; citation_author=K.A. Verba; citation_author=Y. Cheng; citation_author=D.A. Agard; citation_journal_title=Nat. Methods; citation_volume=14; citation_firstpage=331; citation_lastpage=332; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Structural definition of a conserved neutralization epitope on HIV-1 gp120; citation_author=T. Zhou; citation_author=L. Xu; citation_author=B. Dey; citation_author=A.J. Hessell; citation_author=D. Van Ryk; citation_author=S.H. Xiang; citation_author=X. Yang; citation_author=M.Y. Zhang; citation_author=M.B. Zwick; citation_author=J. Arthos; citation_author=et al.; citation_journal_title=Nature; citation_volume=445; citation_firstpage=732; citation_lastpage=737; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01; citation_author=T. Zhou; citation_author=I. Georgiev; citation_author=X. Wu; citation_author=Z.Y. Yang; citation_author=K. Dai; citation_author=A. Finzi; citation_author=Y.D. Kwon; citation_author=J.F. Scheid; citation_author=W. Shi; citation_author=L. Xu; citation_author=et al.; citation_journal_title=Science; citation_volume=329; citation_firstpage=811; citation_lastpage=817; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies; citation_author=T. Zhou; citation_author=J. Zhu; citation_author=X. Wu; citation_author=S. Moquin; citation_author=B. Zhang; citation_author=P. Acharya; citation_author=I.S. Georgiev; citation_author=H.R. Altae-Tran; citation_author=G.Y. Chuang; citation_author=M.G. Joyce; citation_author=NISC Comparative Sequencing Program; citation_author=et al.; citation_journal_title=Immunity; citation_volume=39; citation_firstpage=245; citation_lastpage=258; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors; citation_author=T. Zhou; citation_author=R.M. Lynch; citation_author=L. Chen; citation_author=P. Acharya; citation_author=X. Wu; citation_author=N.A. Doria-Rose; citation_author=M.G. Joyce; citation_author=D. Lingwood; citation_author=C. Soto; citation_author=R.T. Bailer; citation_author=NISC Comparative Sequencing Program; citation_author=et al.; citation_journal_title=Cell; citation_volume=161; citation_firstpage=1280; citation_lastpage=1292; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=New tools for automated high-resolution cryo-EM structure determination in RELION-3; citation_author=J. Zivanov; citation_author=T. Nakane; citation_author=B.O. Forsberg; citation_author=D. Kimanius; citation_author=W.J.H. Hagen; citation_author=E. Lindahl; citation_author=S.H.W. Scheres; citation_journal_title=eLife; citation_volume=7; citation_firstpage=e42166; citation_publication_date=2018; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Broadly neutralizing antibodies (bNAbs) represent a promising approach to prevent and treat HIV-1 infection. However, viral escape through mutation of the HIV-1 envelope glycoprotein (Env) limits clinical applications. Here we describe 1-18, a new V<sub>H</sub>1-46-encoded CD4 binding site (CD4bs) bNAb with outstanding breadth (97%) and potency (GeoMean IC<sub>50</sub>&nbsp;= 0.048&nbsp;μg/mL). Notably, 1-18 is not susceptible to typical CD4bs escape mutations and effectively overcomes HIV-1 resistance to other CD4bs bNAbs. Moreover, mutational antigenic profiling uncovered restricted pathways of HIV-1 escape. Of most promise for therapeutic use, even 1-18 alone fully suppressed viremia in HIV-1-infected humanized mice without selecting for resistant viral variants. A 2.5-Å cryo-EM structure of a 1-18-BG505<sub>SOSIP.664</sub> Env complex revealed that these characteristics are likely facilitated by a heavy-chain insertion and increased inter-protomer contacts. The ability of 1-18 to effectively restrict HIV-1 escape pathways provides a new option to successfully prevent and treat HIV-1 infection.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=4944&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(20)30057-X&amp;be=3368&amp;fe=4799&amp;dc=4665&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749585422688,%22n%22:0,%22f%22:2805,%22dn%22:2806,%22dne%22:2806,%22c%22:2806,%22s%22:2806,%22ce%22:2806,%22rq%22:2807,%22rp%22:3341,%22rpe%22:4332,%22dl%22:3347,%22di%22:4608,%22ds%22:4665,%22de%22:4686,%22dc%22:4799,%22l%22:4799,%22le%22:4834%7D,%22navigation%22:%7B%7D%7D&amp;fp=3916&amp;fcp=3916&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(20)30057-X"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(20)30057-X"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-389908" aria-expanded="false" aria-controls="login-links-389908" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-389908" id="login-links--389908" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-389908" data-opens="#links-dialog-389908" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-389908" aria-modal="true"><button data-closes="#links-dialog-389908" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930057-X" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2020.01.010">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(20)30057-X" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="full" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(19)X0004-5"><span>Volume 180</span>, <span>Issue 3</span></a></span><span class="meta-panel__pages"><span>p471-489.e22</span></span><span class="meta-panel__onlineDate">February 06, 2020</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--open"><span>Open access</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=180&amp;issue=3&amp;pii=S0092-8674%2819%29X0004-5" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Philipp</span> <span property="familyName">Schommers</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Philipp</span> <span property="familyName">Schommers</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">15</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Schommers/Philipp" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">15</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Henning</span> <span property="familyName">Gruell</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Henning</span> <span property="familyName">Gruell</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">15</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Gruell/Henning" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">15</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Morgan E.</span> <span property="familyName">Abernathy</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Morgan E.</span> <span property="familyName">Abernathy</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">15</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Abernathy/Morgan+E" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a role="doc-noteref">15</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">My-Kim</span> <span property="familyName">Tran</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">My-Kim</span> <span property="familyName">Tran</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Tran/My-Kim" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Adam S.</span> <span property="familyName">Dingens</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Adam S.</span> <span property="familyName">Dingens</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Dingens/Adam+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Harry B.</span> <span property="familyName">Gristick</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Harry B.</span> <span property="familyName">Gristick</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Gristick/Harry+B" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Christopher O.</span> <span property="familyName">Barnes</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Christopher O.</span> <span property="familyName">Barnes</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Barnes/Christopher+O" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Till</span> <span property="familyName">Schoofs</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Till</span> <span property="familyName">Schoofs</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Schoofs/Till" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Maike</span> <span property="familyName">Schlotz</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Maike</span> <span property="familyName">Schlotz</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Schlotz/Maike" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Kanika</span> <span property="familyName">Vanshylla</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kanika</span> <span property="familyName">Vanshylla</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Vanshylla/Kanika" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Christoph</span> <span property="familyName">Kreer</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Christoph</span> <span property="familyName">Kreer</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Kreer/Christoph" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Daniela</span> <span property="familyName">Weiland</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Daniela</span> <span property="familyName">Weiland</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Weiland/Daniela" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Udo</span> <span property="familyName">Holtick</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Udo</span> <span property="familyName">Holtick</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Holtick/Udo" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Christof</span> <span property="familyName">Scheid</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Christof</span> <span property="familyName">Scheid</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Scheid/Christof" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Markus M.</span> <span property="familyName">Valter</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Markus M.</span> <span property="familyName">Valter</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Gynecology and Obstetrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Valter/Markus+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Marit J.</span> <span property="familyName">van Gils</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Marit J.</span> <span property="familyName">van Gils</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands</span></div></div><div class="core-author-link"><a href="/authored-by/van+Gils/Marit+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Rogier W.</span> <span property="familyName">Sanders</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Rogier W.</span> <span property="familyName">Sanders</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Sanders/Rogier+W" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">8</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Jörg J.</span> <span property="familyName">Vehreschild</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jörg J.</span> <span property="familyName">Vehreschild</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">Medical Department 2, University Hospital of Frankfurt, 60590 Frankfurt, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Vehreschild/J%C3%B6rg+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Oliver A.</span> <span property="familyName">Cornely</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Oliver A.</span> <span property="familyName">Cornely</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, 50935 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Cornely/Oliver+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">10</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">11</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Clara</span> <span property="familyName">Lehmann</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Clara</span> <span property="familyName">Lehmann</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Lehmann/Clara" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Gerd</span> <span property="familyName">Fätkenheuer</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Gerd</span> <span property="familyName">Fätkenheuer</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/F%C3%A4tkenheuer/Gerd" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Michael S.</span> <span property="familyName">Seaman</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Michael S.</span> <span property="familyName">Seaman</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Seaman/Michael+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">13</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">Jesse D.</span> <span property="familyName">Bloom</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jesse D.</span> <span property="familyName">Bloom</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Howard Hughes Medical Institute, Seattle, WA 98109, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Bloom/Jesse+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">14</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Pamela J.</span> <span property="familyName">Bjorkman</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Pamela J.</span> <span property="familyName">Bjorkman</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Bjorkman/Pamela+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Florian</span> <span property="familyName">Klein</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Florian</span> <span property="familyName">Klein</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:florian.klein@uk-koeln.de" property="email" title="Send email to Florian Klein">florian.klein@uk-koeln.de</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">16</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span property="name">Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Klein/Florian" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a>,<a role="doc-noteref">16</a></sup> <a id="eadd0010" href="mailto:florian.klein@uk-koeln.de" property="email" title="Send email to Florian Klein">florian.klein@uk-koeln.de</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">German Center for Infection Research (DZIF), partner site Bonn-Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Department of Gynecology and Obstetrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">Medical Department 2, University Hospital of Frankfurt, 60590 Frankfurt, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, 50935 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">12</span><span id="aff12" property="name">Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">13</span><span id="aff13" property="name">Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">14</span><span id="aff14" property="name">Howard Hughes Medical Institute, Seattle, WA 98109, USA</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">15</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">16</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received September 30, 2019</span>; <span>Revised December 5, 2019</span>; <span>Accepted January 6, 2020</span>; <span>Published online January 30, 2020</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2020.01.010" property="sameAs" target="_blank">10.1016/j.cell.2020.01.010 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S009286742030057X" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2020 The Authors. Published by Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution (CC BY 4.0)</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2020.01.010" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(19)X0004-5"><img src="/cms/asset/625c1d51-4245-4cb2-8066-7e93c7c4b35f/cov200h.gif" alt="Cover Image - Cell, Volume 180, Issue 3"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2820%2930057-X" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical Abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental Information (7)</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930057-X" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.01.010">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2820%2930057-X" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2020.01.010&amp;pii=S0092-8674%2820%2930057-X" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930057-X" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.01.010">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2020.01.010" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S009286742030057X&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S009286742030057X&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=180&amp;issue=3&amp;pii=S0092-8674%2819%29X0004-5" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(20)30053-2" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(19)31392-3" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract" aria-current="true">Highlights</a></li><li><a href="#author-abstract" aria-current="false">Summary</a></li><li><a href="#graphical-abstract" aria-current="false">Graphical Abstract</a></li><li><a href="#keywords" aria-current="false">Keywords</a></li><li><a href="#sec-1" aria-current="false">Introduction</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li><a href="#sec-4" aria-current="false">STAR★Methods</a></li><li><a href="#acknowledgments" aria-current="false">Acknowledgments</a></li><li><a href="#supplementary-material" aria-current="false">Supplemental Information (7)</a></li><li><a href="#references" aria-current="false">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Identification of 1-18, a highly broad and potent V<sub>H</sub>1-46-derived CD4bs antibody</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">2.5-Å cryo-EM structure of 1-18-Env complex reveals inter-protomer contacts</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">1-18 overcomes VRC01-class resistance and restricts development of HIV-1 escape</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Monotherapy with 1-18 maintains viral suppression in HIV-1<sub>YU2</sub>-infected humanized mice</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Broadly neutralizing antibodies (bNAbs) represent a promising approach to prevent and treat HIV-1 infection. However, viral escape through mutation of the HIV-1 envelope glycoprotein (Env) limits clinical applications. Here we describe 1-18, a new V<sub>H</sub>1-46-encoded CD4 binding site (CD4bs) bNAb with outstanding breadth (97%) and potency (GeoMean IC<sub>50</sub>&nbsp;= 0.048&nbsp;μg/mL). Notably, 1-18 is not susceptible to typical CD4bs escape mutations and effectively overcomes HIV-1 resistance to other CD4bs bNAbs. Moreover, mutational antigenic profiling uncovered restricted pathways of HIV-1 escape. Of most promise for therapeutic use, even 1-18 alone fully suppressed viremia in HIV-1-infected humanized mice without selecting for resistant viral variants. A 2.5-Å cryo-EM structure of a 1-18-BG505<sub>SOSIP.664</sub> Env complex revealed that these characteristics are likely facilitated by a heavy-chain insertion and increased inter-protomer contacts. The ability of 1-18 to effectively restrict HIV-1 escape pathways provides a new option to successfully prevent and treat HIV-1 infection.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical Abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/560f4464-4bd2-4ab1-8539-782ccfa98639/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2020.01.010/asset/ae23c22a-bbf7-4982-8873-3ddb1654a990/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/560f4464-4bd2-4ab1-8539-782ccfa98639/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;HIV-1&quot;" alt="Search on this keyword" rel="nofollow">HIV-1</a></li><li><a href="/action/doSearch?AllField=&quot;broadly+neutralizing+antibodies&quot;" alt="Search on this keyword" rel="nofollow">broadly neutralizing antibodies</a></li><li><a href="/action/doSearch?AllField=&quot;CD4+binding+site&quot;" alt="Search on this keyword" rel="nofollow">CD4 binding site</a></li><li><a href="/action/doSearch?AllField=&quot;escape+mutations&quot;" alt="Search on this keyword" rel="nofollow">escape mutations</a></li><li><a href="/action/doSearch?AllField=&quot;immunotherapy&quot;" alt="Search on this keyword" rel="nofollow">immunotherapy</a></li><li><a href="/action/doSearch?AllField=&quot;cryogenic+electron+microscopy&quot;" alt="Search on this keyword" rel="nofollow">cryogenic electron microscopy</a></li><li><a href="/action/doSearch?AllField=&quot;deep+mutational+scanning&quot;" alt="Search on this keyword" rel="nofollow">deep mutational scanning</a></li><li><a href="/action/doSearch?AllField=&quot;mutational+antigenic+profiling&quot;" alt="Search on this keyword" rel="nofollow">mutational antigenic profiling</a></li><li><a href="/action/doSearch?AllField=&quot;HIV-1+escape+restriction&quot;" alt="Search on this keyword" rel="nofollow">HIV-1 escape restriction</a></li><li><a href="/action/doSearch?AllField=&quot;humanized+mice&quot;" alt="Search on this keyword" rel="nofollow">humanized mice</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0030" role="paragraph">Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope protein (Env) can prevent infection in animal models and are under investigation for passive immunization in clinical trials (<span class="dropBlock reference-citations"><a id="body-ref-sref96" href="#" role="doc-biblioref" data-xml-rid="bib3 bib36 bib50 bib70 bib96" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref96" aria-controls="sref96">Balazs et&nbsp;al., 2011; Gautam et&nbsp;al., 2016; Julg and Barouch, 2019; Moldt et&nbsp;al., 2012; Shingai et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref96"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Balazs, A.B. ∙ Chen, J. ∙ Hong, C.M. ...</div><div><strong>Antibody-based protection against HIV infection by vectored immunoprophylaxis</strong></div><div><em>Nature.</em> 2011; <strong>481</strong>:81-84</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10660" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84855466746" target="_blank" aria-label="Open Scopus in new tab">Scopus (340)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22139420/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10660&amp;pmid=22139420" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Gautam, R. ∙ Nishimura, Y. ∙ Pegu, A. ...</div><div><strong>A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges</strong></div><div><em>Nature.</em> 2016; <strong>533</strong>:105-109</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature17677" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84966389751" target="_blank" aria-label="Open Scopus in new tab">Scopus (247)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27120156/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature17677&amp;pmid=27120156" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Julg, B. ∙ Barouch, D.H.</div><div><strong>Neutralizing antibodies for HIV-1 prevention</strong></div><div><em>Curr. Opin. HIV AIDS.</em> 2019; <strong>14</strong>:318-324</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/COH.0000000000000556" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85067266618" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31082819/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FCOH.0000000000000556&amp;pmid=31082819" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Moldt, B. ∙ Rakasz, E.G. ∙ Schultz, N. ...</div><div><strong>Highly potent HIV-specific antibody neutralization in&nbsp;vitro translates into effective protection against mucosal SHIV challenge in&nbsp;vivo</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:18921-18925</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1214785109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84869232528" target="_blank" aria-label="Open Scopus in new tab">Scopus (297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23100539/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1214785109&amp;pmid=23100539" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Shingai, M. ∙ Donau, O.K. ∙ Plishka, R.J. ...</div><div><strong>Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2014; <strong>211</strong>:2061-2074</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20132494" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84907212727" target="_blank" aria-label="Open Scopus in new tab">Scopus (182)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25155019/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20132494&amp;pmid=25155019" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Moreover, bNAbs have been demonstrated to suppress viremia and delay viral rebound after interruption of antiretroviral therapy (ART) in HIV-1-infected individuals (<span class="dropBlock reference-citations"><a id="body-ref-sref89-1" href="#" role="doc-biblioref" data-xml-rid="bib4 bib5 bib9 bib10 bib64 bib69 bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89-1" aria-controls="sref89-1">Bar et&nbsp;al., 2016; Bar-On et&nbsp;al., 2018; Caskey et&nbsp;al., 2015, 2017; Lynch et&nbsp;al., 2015a; Mendoza et&nbsp;al., 2018; Scheid et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref89-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bar, K.J. ∙ Sneller, M.C. ∙ Harrison, L.J. ...</div><div><strong>Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2037-2050</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1608243" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84997817411" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1608243&amp;pmid=27959728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bar-On, Y. ∙ Gruell, H. ∙ Schoofs, T. ...</div><div><strong>Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1701-1707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0186-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054012075" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0186-4&amp;pmid=30258217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Caskey, M. ∙ Schoofs, T. ∙ Gruell, H. ...</div><div><strong>Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</strong></div><div><em>Nat. Med.</em> 2017; <strong>23</strong>:185-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4268" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85009820387" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28092665/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4268&amp;pmid=28092665" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Scheid, J.F. ∙ Horwitz, J.A. ∙ Bar-On, Y. ...</div><div><strong>HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption</strong></div><div><em>Nature.</em> 2016; <strong>535</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18929" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84976406858" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338952/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18929&amp;pmid=27338952" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although these results highlight the significant clinical potential of bNAbs, pre-existing or <i>de novo</i> HIV-1 resistance cause treatment failure and can strongly limit bNAb applications in humans (<span class="dropBlock reference-citations"><a id="body-ref-sref89-2" href="#" role="doc-biblioref" data-xml-rid="bib4 bib5 bib9 bib10 bib64 bib69 bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89-2" aria-controls="sref89-2">Bar et&nbsp;al., 2016; Bar-On et&nbsp;al., 2018; Caskey et&nbsp;al., 2015, 2017; Lynch et&nbsp;al., 2015a; Mendoza et&nbsp;al., 2018; Scheid et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref89-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bar, K.J. ∙ Sneller, M.C. ∙ Harrison, L.J. ...</div><div><strong>Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2037-2050</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1608243" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84997817411" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1608243&amp;pmid=27959728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bar-On, Y. ∙ Gruell, H. ∙ Schoofs, T. ...</div><div><strong>Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1701-1707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0186-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054012075" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0186-4&amp;pmid=30258217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Caskey, M. ∙ Schoofs, T. ∙ Gruell, H. ...</div><div><strong>Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</strong></div><div><em>Nat. Med.</em> 2017; <strong>23</strong>:185-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4268" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85009820387" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28092665/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4268&amp;pmid=28092665" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Scheid, J.F. ∙ Horwitz, J.A. ∙ Bar-On, Y. ...</div><div><strong>HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption</strong></div><div><em>Nature.</em> 2016; <strong>535</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18929" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84976406858" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338952/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18929&amp;pmid=27338952" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Strategies to prevent and overcome viral escape are therefore critical to effectively implement bNAb-mediated approaches for HIV-1 prevention and therapy (<span class="dropBlock reference-citations"><a id="body-ref-sref39-1" href="#" role="doc-biblioref" data-xml-rid="bib11 bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-1" aria-controls="sref39-1">Caskey et&nbsp;al., 2019; Gruell and Klein, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Caskey, M. ∙ Klein, F. ∙ Nussenzweig, M.C.</div><div><strong>Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:547-553</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0412-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85063768243" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936546/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0412-8&amp;pmid=30936546" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Gruell, H. ∙ Klein, F.</div><div><strong>Antibody-mediated prevention and treatment of HIV-1 infection</strong></div><div><em>Retrovirology.</em> 2018; <strong>15</strong>:73</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12977-018-0455-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85056710424" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30445968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12977-018-0455-9&amp;pmid=30445968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0035" role="paragraph">In recent years, potent bNAbs have been isolated from HIV-1-infected donors that target distinct vulnerable epitopes on the Env trimer. These epitopes include the CD4 binding site (CD4bs), the V1/V2 loop, the V3 loop glycan patch, the membrane-proximal external region (MPER), and the interface between the gp120 and gp41 subunits (<span class="dropBlock reference-citations"><a id="body-ref-sref106" href="#" role="doc-biblioref" data-xml-rid="bib32 bib98 bib106" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref106" aria-controls="sref106">Gama and Koup, 2018; Sok and Burton, 2018; Walker and Burton, 2018</a><div class="dropBlock__holder" data-db-target-of="sref106"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Gama, L. ∙ Koup, R.A.</div><div><strong>New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment</strong></div><div><em>Annu. Rev. Med.</em> 2018; <strong>69</strong>:409-419</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-med-061016-041032" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85041720660" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29029583/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-med-061016-041032&amp;pmid=29029583" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">98.</div><div>Sok, D. ∙ Burton, D.R.</div><div><strong>Recent progress in broadly neutralizing antibodies to HIV</strong></div><div><em>Nat. Immunol.</em> 2018; <strong>19</strong>:1179-1188</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41590-018-0235-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85055080189" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30333615/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41590-018-0235-7&amp;pmid=30333615" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">106.</div><div>Walker, L.M. ∙ Burton, D.R.</div><div><strong>Passive immunotherapy of viral infections: ‘super-antibodies’ enter the fray</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:297-308</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85045850427" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29379211/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.148&amp;pmid=29379211" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Among these sites, the CD4bs is of particular interest because CD4 serves as the primary receptor for viral entry (<span class="dropBlock reference-citations"><a id="body-ref-sref122" href="#" role="doc-biblioref" data-xml-rid="bib58 bib67 bib122" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref122" aria-controls="sref122">Kwong et&nbsp;al., 1998; Maddon et&nbsp;al., 1986; Zhou et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref122"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Kwong, P.D. ∙ Wyatt, R. ∙ Robinson, J. ...</div><div><strong>Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody</strong></div><div><em>Nature.</em> 1998; <strong>393</strong>:648-659</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/31405" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0032543307" target="_blank" aria-label="Open Scopus in new tab">Scopus (2341)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9641677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F31405&amp;pmid=9641677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Maddon, P.J. ∙ Dalgleish, A.G. ∙ McDougal, J.S. ...</div><div><strong>The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain</strong></div><div><em>Cell.</em> 1986; <strong>47</strong>:333-348</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2F0092-8674%2886%2990590-8&amp;cf=abstract&amp;site=cell-site">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2F0092-8674%2886%2990590-8&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0023028190" target="_blank" aria-label="Open Scopus in new tab">Scopus (1429)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3094962/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0092-8674%2886%2990590-8&amp;pmid=3094962" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">122.</div><div>Zhou, T. ∙ Xu, L. ∙ Dey, B. ...</div><div><strong>Structural definition of a conserved neutralization epitope on HIV-1 gp120</strong></div><div><em>Nature.</em> 2007; <strong>445</strong>:732-737</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature05580" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_122_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33847101745" target="_blank" aria-label="Open Scopus in new tab">Scopus (619)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17301785/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature05580&amp;pmid=17301785" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0040" role="paragraph">Most potent CD4bs bNAbs are characterized by use of the immunoglobulin heavy-chain gene segment IGVH1-2<sup>∗</sup>02, high levels of somatic hypermutation, a five-residue complementarity-determining region 3 of the light chain (CDRL3), and mimicry of the CD4-Env interaction (<span class="dropBlock reference-citations"><a id="body-ref-sref125-1" href="#" role="doc-biblioref" data-xml-rid="bib110 bib123 bib124 bib125" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref125-1" aria-controls="sref125-1">West et&nbsp;al., 2012; Zhou et&nbsp;al., 2010, 2013, 2015</a><div class="dropBlock__holder" data-db-target-of="sref125-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">110.</div><div>West, Jr., A.P. ∙ Diskin, R. ∙ Nussenzweig, M.C. ...</div><div><strong>Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:E2083-E2090</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1208984109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_110_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84864363185" target="_blank" aria-label="Open Scopus in new tab">Scopus (130)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22745174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1208984109&amp;pmid=22745174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">123.</div><div>Zhou, T. ∙ Georgiev, I. ∙ Wu, X. ...</div><div><strong>Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01</strong></div><div><em>Science.</em> 2010; <strong>329</strong>:811-817</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1192819" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_123_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77954943648" target="_blank" aria-label="Open Scopus in new tab">Scopus (754)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20616231/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1192819&amp;pmid=20616231" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">124.</div><div>Zhou, T. ∙ Zhu, J. ∙ Wu, X. ..., NISC Comparative Sequencing Program</div><div><strong>Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:245-258</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_124_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2013.04.012&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_124_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2013.04.012&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_124_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84882589754" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23911655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2013.04.012&amp;pmid=23911655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">125.</div><div>Zhou, T. ∙ Lynch, R.M. ∙ Chen, L. ..., NISC Comparative Sequencing Program</div><div><strong>Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors</strong></div><div><em>Cell.</em> 2015; <strong>161</strong>:1280-1292</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.05.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.05.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84930418589" target="_blank" aria-label="Open Scopus in new tab">Scopus (154)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26004070/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.05.007&amp;pmid=26004070" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Named after the prototypical antibody, these antibodies are referred to as VRC01-class bNAbs (<span class="dropBlock reference-citations"><a id="body-ref-sref113-1" href="#" role="doc-biblioref" data-xml-rid="bib113" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref113-1" aria-controls="sref113-1">Wu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref113-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">113.</div><div>Wu, X. ∙ Yang, Z.Y. ∙ Li, Y. ...</div><div><strong>Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1</strong></div><div><em>Science.</em> 2010; <strong>329</strong>:856-861</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1187659" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_113_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77954920017" target="_blank" aria-label="Open Scopus in new tab">Scopus (1099)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20616233/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1187659&amp;pmid=20616233" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Additional members of this class include 3BNC117, NIH45-46, N49-P7, N6, and VRC07-523 (<span class="dropBlock reference-citations"><a id="body-ref-sref88-1" href="#" role="doc-biblioref" data-xml-rid="bib47 bib80 bib81 bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-1" aria-controls="sref88-1">Huang et&nbsp;al., 2016a; Rudicell et&nbsp;al., 2014; Sajadi et&nbsp;al., 2018; Scheid et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref88-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Huang, J. ∙ Kang, B.H. ∙ Ishida, E. ...</div><div><strong>Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth</strong></div><div><em>Immunity.</em> 2016; <strong>45</strong>:1108-1121</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84999836139" target="_blank" aria-label="Open Scopus in new tab">Scopus (116)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27851912/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.10.027&amp;pmid=27851912" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Rudicell, R.S. ∙ Kwon, Y.D. ∙ Ko, S.Y. ..., NISC Comparative Sequencing Program</div><div><strong>Enhanced potency of a broadly neutralizing HIV-1 antibody in&nbsp;vitro improves protection against lentiviral infection in&nbsp;vivo</strong></div><div><em>J.&nbsp;Virol.</em> 2014; <strong>88</strong>:12669-12682</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02213-14" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84907971356" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25142607/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02213-14&amp;pmid=25142607" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Sajadi, M.M. ∙ Dashti, A. ∙ Rikhtegaran Tehrani, Z. ...</div><div><strong>Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses</strong></div><div><em>Cell.</em> 2018; <strong>173</strong>:1783-1795.e14</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2018.03.061&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2018.03.061&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85046157216" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29731169/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.03.061&amp;pmid=29731169" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Scheid, J.F. ∙ Mouquet, H. ∙ Ueberheide, B. ...</div><div><strong>Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding</strong></div><div><em>Science.</em> 2011; <strong>333</strong>:1633-1637</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1207227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-80052925616" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21764753/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1207227&amp;pmid=21764753" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Other bNAbs that mimic CD4 binding are derived from the V<sub>H</sub>1-46 gene segment. However, compared with V<sub>H</sub>1-2-derived bNAbs, the V<sub>H</sub>1-46 bNAbs reported to date have lower potencies and breadth, which limits their potential for clinical use (<span class="dropBlock reference-citations"><a id="body-ref-sref88-2" href="#" role="doc-biblioref" data-xml-rid="bib8 bib33 bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-2" aria-controls="sref88-2">Bonsignori et&nbsp;al., 2016; Gao et&nbsp;al., 2014; Scheid et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref88-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bonsignori, M. ∙ Zhou, T. ∙ Sheng, Z. ..., NISC Comparative Sequencing Program</div><div><strong>Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:449-463</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84959296091" target="_blank" aria-label="Open Scopus in new tab">Scopus (138)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26949186/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.02.022&amp;pmid=26949186" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Gao, F. ∙ Bonsignori, M. ∙ Liao, H.X. ...</div><div><strong>Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies</strong></div><div><em>Cell.</em> 2014; <strong>158</strong>:481-491</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2014.06.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2014.06.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25065977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.06.022&amp;pmid=25065977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Scheid, J.F. ∙ Mouquet, H. ∙ Ueberheide, B. ...</div><div><strong>Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding</strong></div><div><em>Science.</em> 2011; <strong>333</strong>:1633-1637</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1207227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-80052925616" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21764753/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1207227&amp;pmid=21764753" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For example, CH235.12, one of the best V<sub>H</sub>1-46-derived CD4bs antibodies, is less broad and more than 10-fold less potent than the VRC01-class bNAb N6 when tested against a large panel of HIV-1 strains (<span class="dropBlock reference-citations"><a id="body-ref-sref8-2" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-2" aria-controls="sref8-2">Bonsignori et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref8-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bonsignori, M. ∙ Zhou, T. ∙ Sheng, Z. ..., NISC Comparative Sequencing Program</div><div><strong>Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:449-463</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84959296091" target="_blank" aria-label="Open Scopus in new tab">Scopus (138)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26949186/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.02.022&amp;pmid=26949186" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0045" role="paragraph">Accordingly, all CD4bs bNAbs that have advanced into clinical testing are members of the VRC01 class (3BNC117, N6, VRC01, and VRC07-523) (<span class="dropBlock reference-citations"><a id="body-ref-sref89-3" href="#" role="doc-biblioref" data-xml-rid="bib4 bib5 bib9 bib11 bib15 bib17 bib34 bib35 bib39 bib59 bib64 bib68 bib69 bib78 bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89-3" aria-controls="sref89-3">Bar et&nbsp;al., 2016; Bar-On et&nbsp;al., 2018; Caskey et&nbsp;al., 2015, 2019; Cohen et&nbsp;al., 2018a; Crowell et&nbsp;al., 2019; Gaudinski et&nbsp;al., 2018, 2019; Gruell and Klein, 2018; Ledgerwood et&nbsp;al., 2015; Lynch et&nbsp;al., 2015a; Mayer et&nbsp;al., 2017; Mendoza et&nbsp;al., 2018; Riddler et&nbsp;al., 2018; Scheid et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref89-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bar, K.J. ∙ Sneller, M.C. ∙ Harrison, L.J. ...</div><div><strong>Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2037-2050</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1608243" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84997817411" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1608243&amp;pmid=27959728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bar-On, Y. ∙ Gruell, H. ∙ Schoofs, T. ...</div><div><strong>Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1701-1707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0186-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054012075" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0186-4&amp;pmid=30258217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Caskey, M. ∙ Klein, F. ∙ Nussenzweig, M.C.</div><div><strong>Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:547-553</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0412-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85063768243" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936546/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0412-8&amp;pmid=30936546" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Cohen, Y.Z. ∙ Lorenzi, J.C.C. ∙ Krassnig, L. ...</div><div><strong>Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2018; <strong>215</strong>:2311-2324</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20180936" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054152954" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30072495/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20180936&amp;pmid=30072495" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Crowell, T.A. ∙ Colby, D.J. ∙ Pinyakorn, S. ..., RV397 Study Group</div><div><strong>Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial</strong></div><div><em>Lancet HIV.</em> 2019; <strong>6</strong>:e297-e306</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930053-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930053-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85064867914" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31000477/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS2352-3018%2819%2930053-0&amp;pmid=31000477" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gaudinski, M.R. ∙ Coates, E.E. ∙ Houser, K.V. ..., VRC 606 Study Team</div><div><strong>Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults</strong></div><div><em>PLoS Med.</em> 2018; <strong>15</strong>:e1002493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85041696060" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29364886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1002493&amp;pmid=29364886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Gaudinski, M.R. ∙ Houser, K.V. ∙ Doria-Rose, N.A. ..., VRC 605 study team</div><div><strong>Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial</strong></div><div><em>Lancet HIV.</em> 2019; <strong>6</strong>:e667-e679</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930181-X&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930181-X&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072659478" target="_blank" aria-label="Open Scopus in new tab">Scopus (3)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31473167/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS2352-3018%2819%2930181-X&amp;pmid=31473167" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Gruell, H. ∙ Klein, F.</div><div><strong>Antibody-mediated prevention and treatment of HIV-1 infection</strong></div><div><em>Retrovirology.</em> 2018; <strong>15</strong>:73</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12977-018-0455-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85056710424" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30445968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12977-018-0455-9&amp;pmid=30445968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Ledgerwood, J.E. ∙ Coates, E.E. ∙ Yamshchikov, G. ..., VRC 602 Study Team</div><div><strong>Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults</strong></div><div><em>Clin. Exp. Immunol.</em> 2015; <strong>182</strong>:289-301</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cei.12692" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84946480939" target="_blank" aria-label="Open Scopus in new tab">Scopus (118)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26332605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcei.12692&amp;pmid=26332605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Mayer, K.H. ∙ Seaton, K.E. ∙ Huang, Y. ..., HVTN 104 Protocol Team, and the NIAID HIV Vaccine Trials Network</div><div><strong>Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial</strong></div><div><em>PLoS Med.</em> 2017; <strong>14</strong>:e1002435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85036569550" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29136037/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1002435&amp;pmid=29136037" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Riddler, S.A. ∙ Zheng, L. ∙ Durand, C.M. ..., AIDS Clinical Trials Group A5342 Protocol Team</div><div><strong>Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART</strong></div><div><em>Open Forum Infect. Dis.</em> 2018; <strong>5</strong>:ofy242</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/ofid/ofy242" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85063978638" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30364428/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fofid%2Fofy242&amp;pmid=30364428" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Scheid, J.F. ∙ Horwitz, J.A. ∙ Bar-On, Y. ...</div><div><strong>HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption</strong></div><div><em>Nature.</em> 2016; <strong>535</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18929" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84976406858" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338952/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18929&amp;pmid=27338952" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, although escape from VRC01 has been associated with a reduction in viral fitness (<span class="dropBlock reference-citations"><a id="body-ref-sref65-1" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-1" aria-controls="sref65-1">Lynch et&nbsp;al., 2015b</a><div class="dropBlock__holder" data-db-target-of="sref65-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Lynch, R.M. ∙ Wong, P. ∙ Tran, L. ...</div><div><strong>HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2015; <strong>89</strong>:4201-4213</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.03608-14" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84925431182" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25631091/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.03608-14&amp;pmid=25631091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the effects of VRC01-class monotherapy are only transient and associated with emergence of viral escape variants (<span class="dropBlock reference-citations"><a id="body-ref-sref89-4" href="#" role="doc-biblioref" data-xml-rid="bib4 bib9 bib44 bib53 bib64 bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89-4" aria-controls="sref89-4">Bar et&nbsp;al., 2016; Caskey et&nbsp;al., 2015; Horwitz et&nbsp;al., 2013; Klein et&nbsp;al., 2012; Lynch et&nbsp;al., 2015a; Scheid et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref89-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bar, K.J. ∙ Sneller, M.C. ∙ Harrison, L.J. ...</div><div><strong>Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2037-2050</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1608243" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84997817411" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1608243&amp;pmid=27959728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Horwitz, J.A. ∙ Halper-Stromberg, A. ∙ Mouquet, H. ...</div><div><strong>HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:16538-16543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1315295110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84885338257" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24043801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1315295110&amp;pmid=24043801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Scheid, J.F. ∙ Horwitz, J.A. ∙ Bar-On, Y. ...</div><div><strong>HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption</strong></div><div><em>Nature.</em> 2016; <strong>535</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18929" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84976406858" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338952/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18929&amp;pmid=27338952" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0050" role="paragraph">Here we describe bNAb 1-18, a V<sub>H</sub>1-46-derived CD4bs antibody that exceeds the potency and breadth of most classical V<sub>H</sub>1-46- and V<sub>H</sub>1-2-derived bNAbs. The structural basis of its high activity was revealed by a single-particle cryoelectron microscopy (cryo-EM) structure of a 1-18 Fab-BG505<sub>SOSIP.664</sub> Env trimer complex solved at 2.5-Å resolution. Of particular interest, compared with 3BNC117 and VRC01, the two most clinically advanced CD4bs bNAbs, 1-18 effectively restricts viral escape and maintains both neutralizing activity against VRC01-class escape variants and full viral suppression when tested in HIV-1<sub>YU2</sub>-infected humanized mice. Therefore, 1-18 is a highly promising candidate for antibody-mediated strategies to effectively treat and prevent HIV-1 infection.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>Identification of Potent V<sub>H</sub>1-46-Derived bNAbs</h3><div id="p0055" role="paragraph">To identify individuals with elite HIV-1-neutralizing activity, we screened HIV-1-infected subjects. From each individual, purified serum or plasma immunoglobulin G (IgG) was tested for neutralizing activity in a TZM-bl cell assay against a multiclade screening panel of 12 HIV-1 pseudoviruses (<span class="dropBlock reference-citations"><a id="body-ref-sref84-1" href="#" role="doc-biblioref" data-xml-rid="bib19 bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-1" aria-controls="sref84-1">deCamp et&nbsp;al., 2014; Sarzotti-Kelsoe et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref84-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>deCamp, A. ∙ Hraber, P. ∙ Bailer, R.T. ...</div><div><strong>Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2014; <strong>88</strong>:2489-2507</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02853-13" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84896739535" target="_blank" aria-label="Open Scopus in new tab">Scopus (122)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24352443/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02853-13&amp;pmid=24352443" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Sarzotti-Kelsoe, M. ∙ Bailer, R.T. ∙ Turk, E. ...</div><div><strong>Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2014; <strong>409</strong>:131-146</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2013.11.022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84906084946" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24291345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2013.11.022&amp;pmid=24291345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0255" href="#fig1">Figure&nbsp;1</a>A). We identified IDC561, a clade B-infected long-term non-progressor (<span class="dropBlock reference-citations"><a id="body-ref-sref107" href="#" role="doc-biblioref" data-xml-rid="bib107" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref107" aria-controls="sref107">Walker and Yu, 2013</a><div class="dropBlock__holder" data-db-target-of="sref107"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">107.</div><div>Walker, B.D. ∙ Yu, X.G.</div><div><strong>Unravelling the mechanisms of durable control of HIV-1</strong></div><div><em>Nat. Rev. Immunol.</em> 2013; <strong>13</strong>:487-498</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri3478" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_107_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879614980" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23797064/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri3478&amp;pmid=23797064" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), as ranking among the top 1% of a cohort of 2,274 individuals (HIV-1-neutralizing activity at a geometric mean IC<sub>50</sub> [50% inhibitory concentration] of 41.7&nbsp;μg IgG/mL; <a id="crosref0265" href="#fig1">Figures 1</a>A and <a id="crosref0270" href="#figs1">S1</a>A–S1C). To characterize the epitope specificity of the IgG response, we performed neutralization fingerprinting and detected VRC01-like activity (<span class="dropBlock reference-citations"><a id="body-ref-sref25-1" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-1" aria-controls="sref25-1">Doria-Rose et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref25-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Doria-Rose, N.A. ∙ Altae-Tran, H.R. ∙ Roark, R.S. ...</div><div><strong>Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting</strong></div><div><em>PLoS Pathog.</em> 2017; <strong>13</strong>:e1006148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011002666" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28052137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006148&amp;pmid=28052137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0280" href="#figs1">Figure&nbsp;S1</a>D). However, virus obtained from IDC561 was sensitive to 3BNC117 and N6, suggesting that the HIV-1-neutralizing antibodies in IDC561 differ from VRC01-class antibodies (<a id="crosref0285" href="#figs1">Figure&nbsp;S1</a>E).</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/e4a3145f-1a67-4183-8334-b8b990a792d8/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2020.01.010/asset/408e84d8-5627-4671-943e-bf890587b871/main.assets/gr1.jpg" height="833" width="753" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/e4a3145f-1a67-4183-8334-b8b990a792d8/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Identification of Broad and Potent Antibodies in Donor IDC561</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) Identification of the elite neutralizer IDC561.</div><div id="fspara0020" role="paragraph">(B) Single BG505<sub>SOSIP</sub>.<sub>664</sub>- (top) or YU2<sub>gp140</sub>-reactive (bottom) B cells were sorted, and antibody sequences were amplified using OPT5/oPR primers. Left pie charts showing the numbers of heavy-chain sequences identified, with clonal sequences indicated in light blue; right pie charts showing the numbers of clonal heavy-chain sequences, with individual clones represented by slices. Antibodies of members of clones in dark blue and green were tested. A black line indicates clones identified by both HIV-1 Env-sorting strategies.</div><div id="fspara0025" role="paragraph">(C) Monoclonal antibodies were produced from members of 33 clones (clone 4 comprised subclones 4.1–4.4) (left). Boxes in the middle and on the right correspond to the left panel and show antibodies binding to YU2<sub>gp140</sub> or BG505<sub>SOSIP.664</sub> or neutralizing more than 90% of the global panel HIV-1 strains, respectively.</div><div id="fspara0030" role="paragraph">(D) Phylogenetic tree of clone 4 members. Boxes indicate GeoMean IC<sub>50</sub> and breadth against the global panel. aa, amino acids. Black, gray, and green asterisks indicate antibodies 1-18, 1-55, and 2-12, respectively.</div><div id="fspara0035" role="paragraph">See also <a id="crosref0211" href="#figs1">Figures S1</a> and <a id="crosref0212" href="#figs2">S2</a> and <a id="crosref1305" href="#mmc1">Tables S1</a>, <a id="crosref1310" href="#mmc2">S2</a>, <a id="crosref1315" href="#mmc3">S3</a>, and <a id="crosref1320" href="#mmc4">S4</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/7523f523-4c24-4f46-b81c-2dcc3376af06/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2020.01.010/asset/8779a263-3725-402a-a4d0-423201fc175a/main.assets/figs1.jpg" height="790" width="659" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/7523f523-4c24-4f46-b81c-2dcc3376af06/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Clinical Characteristics, Neutralizing IgG Activity, and B Cell Repertoire of Individual IDC561, Related to <a id="crosref1410" href="#fig1">Figure 1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0220" role="paragraph">(A) Clinical characteristics of IDC561 at the time of leukapheresis from which monoclonal antibodies were isolated.</div><div id="fspara0225" role="paragraph">(B) Plasma HIV-1 RNA copies (left y axis) and CD4<sup>+</sup> T&nbsp;cell counts (right y axis). Arrows indicate sample collections. Monoclonal antibodies were isolated from the last indicated sampling time point. Dashed line indicates HIV-1 RNA quantification limit.</div><div id="fspara0230" role="paragraph">(C) Neutralizing activity of IDC561 serum IgG against global panel.</div><div id="fspara0235" role="paragraph">(D) Neutralizing activity of IDC561 serum IgG against f61 fingerprinting panel and BG505<sub>T332N</sub> (left, colors as in C). Right panels show delineation scores of f61 panel-based computational epitope mapping.</div><div id="fspara0240" role="paragraph">(E) Neutralizing activity of IDC561 serum IgG and monoclonal bNAbs against outgrowth culture-derived viruses from bulk CD4<sup>+</sup> T&nbsp;cells obtained at indicated time points (colors as in C).</div><div id="fspara0245" role="paragraph">(F–H) Comparison of total B cell repertoire of IDC561 and Env-reactive B cells, indicating (F) CDRH3 lengths, (G) V<sub>H</sub> gene germline identity, and (H) V<sub>H</sub> allele distribution. Dashed lines indicate medians.</div></div></div></div></figcaption></figure></div><div id="p0060" role="paragraph">To identify antibodies that accounted for the potent neutralizing activity of IDC561, we performed single-cell sorting of Env-reactive B cells that bound to native-like BG505<sub>SOSIP.664</sub> (<span class="dropBlock reference-citations"><a id="body-ref-sref97-1" href="#" role="doc-biblioref" data-xml-rid="bib83 bib97" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref97-1" aria-controls="sref97-1">Sanders et&nbsp;al., 2013; Sliepen et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref97-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Sanders, R.W. ∙ Derking, R. ∙ Cupo, A. ...</div><div><strong>A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies</strong></div><div><em>PLoS Pathog.</em> 2013; <strong>9</strong>:e1003618</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1003618" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84884678235" target="_blank" aria-label="Open Scopus in new tab">Scopus (436)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24068931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1003618&amp;pmid=24068931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Sliepen, K. ∙ van Montfort, T. ∙ Ozorowski, G. ...</div><div><strong>Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer</strong></div><div><em>Biomolecules.</em> 2015; <strong>5</strong>:2919-2934</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/biom5042919" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85012065361" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26512709/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3390%2Fbiom5042919&amp;pmid=26512709" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (0.08% of IgG<sup>+</sup> B cells) or to YU2<sub>gp140</sub> (<span class="dropBlock reference-citations"><a id="body-ref-sref116-1" href="#" role="doc-biblioref" data-xml-rid="bib87 bib116" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref116-1" aria-controls="sref116-1">Scheid et&nbsp;al., 2009; Yang et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref116-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Scheid, J.F. ∙ Mouquet, H. ∙ Feldhahn, N. ...</div><div><strong>A method for identification of HIV gp140 binding memory B cells in human blood</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2009; <strong>343</strong>:65-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2008.11.012" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-63749100579" target="_blank" aria-label="Open Scopus in new tab">Scopus (141)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19100741/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2008.11.012&amp;pmid=19100741" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">116.</div><div>Yang, X. ∙ Farzan, M. ∙ Wyatt, R. ...</div><div><strong>Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins</strong></div><div><em>J.&nbsp;Virol.</em> 2000; <strong>74</strong>:5716-5725</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.74.12.5716-5725.2000" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_116_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0034087050" target="_blank" aria-label="Open Scopus in new tab">Scopus (149)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10823881/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.74.12.5716-5725.2000&amp;pmid=10823881" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (0.72% of IgG<sup>+</sup> B cells) (<a id="crosref0290" href="#fig1">Figure&nbsp;1</a>B). Using a new amplification strategy with primer sets optimized for precise detection of highly mutated IgG gene segments (OPT5/oPR; <span class="dropBlock reference-citations"><a id="body-ref-sref54-1" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-1" aria-controls="sref54-1">Kreer et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref54-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Kreer, C. ∙ Döring, M. ∙ Lehnen, N. ...</div><div><strong>openPrimeR for multiplex amplification of highly diverse templates</strong></div><div><em>bioRxiv.</em> 2019;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/847574" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2F847574" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), we obtained and analyzed 812 IgG heavy-chain sequences (BG505<sub>SOSIP.664</sub>, n&nbsp;= 445; YU2<sub>gp140</sub>, n&nbsp;= 367) (<a id="crosref0300" href="#fig1">Figure&nbsp;1</a>B). Compared with the total IgG<sup>+</sup> B cell reservoir of IDC561, Env-reactive B cells carried slightly longer CDRH3s (median length of 17 versus 16 amino acids, p&nbsp;&lt; 0.001), had higher levels of somatic mutation (median V<sub>H</sub> gene nucleotide germline identity of 88.4% versus 95.3%, p&nbsp;&lt; 0.001), and were enriched for the V<sub>H</sub> gene segments 1-46, 1-69, and 4-4 (<a id="crosref0305" href="#figs1">Figures S1</a>F–S1H). Among Env-reactive B cells, we identified 80 B cell clones with two or more members (<a id="crosref0310" href="#fig1">Figure&nbsp;1</a>B).</div><div id="p0065" role="paragraph">Following production of monoclonal antibodies (<a id="crosref0315" href="#mmc1">Table S1</a>), binding of both BG505<sub>SOSIP.664</sub> and YU2<sub>gp140</sub> was detected by ELISA for 70% of the tested antibody clones (<a id="crosref0320" href="#fig1">Figure&nbsp;1</a>C; <a id="crosref0325" href="#mmc2">Table S2</a>). The antibodies of most clones showed no or minimal neutralizing activity when analyzed against the 12-strain global panel, suggesting that they play a limited role in the serum activity of IDC561 (<a id="crosref0330" href="#fig1">Figure&nbsp;1</a>C; <a id="crosref0335" href="#mmc3">Table S3</a>A). In contrast, all tested members (23 antibodies) of B cell clone 4 (comprising subclones 4.1–4.4) neutralized 92%–100% of viruses in the screening panel with remarkable potency (GeoMean IC<sub>50</sub> of 0.032–0.198&nbsp;μg/mL; <a id="crosref0340" href="#fig1">Figure&nbsp;1</a>D; <a id="crosref0345" href="#mmc3">Table S3</a>A). B cell clone 4, derived from the V<sub>H</sub>1-46 and V<sub>Κ</sub>3-20 gene segments, included members with different CDRH3 lengths of 18 (subclones 4.1 and 4.2), 20 (subclone 4.4), or 21 (subclone 4.3) amino acids (<a id="crosref0350" href="#mmc1">Table S1</a>). Subclone 4.1 showed the highest breadth and potency and was characterized by a six-amino-acid CDRH1 insertion that lengthened the CDRH1 from 8 to 14 amino acids (<a id="crosref0355" href="#fig1">Figure&nbsp;1</a>D; <a id="crosref0360" href="#mmc1">Tables S1</a> and <a id="crosref0365" href="#mmc4">S4</a>). We conclude that antibodies of the V<sub>H</sub>1-46-derived B cell clone 4 are highly potent, broadly active, and likely mediate the neutralizing serum activity of the elite neutralizer IDC561.</div></section><section id="sec-2-2"><h3>1-18: A CD4bs bNAb with Near-Universal Breadth and Outstanding Potency</h3><div id="p0070" role="paragraph">We selected antibodies 561_01_18 and 561_01_55 (hereafter referred to as 1-18 and 1-55), two representative members of clone 4.1, for further analyses (<a id="crosref0370" href="#fig2">Figure&nbsp;2</a>A). Both antibodies are highly mutated, with heavy and light chain V gene germline nucleotide sequence identities of 68% and 78%–79%, respectively (<a id="crosref0375" href="#fig2">Figure&nbsp;2</a>A; <a id="crosref0380" href="#mmc4">Table S4</a>). Notably, the neutralizing activities of 1-18 and serum IgG of IDC561 against 42 pseudoviruses strongly correlated, suggesting that members of clone 4.1 are main contributors to the serum activity of IDC561 (<a id="crosref0385" href="#figs2">Figure&nbsp;S2</a>A). To determine binding of 1-18 and 1-55 to the BG505<sub>SOSIP.664</sub> trimer in the presence of other HIV-1 bNAbs, we performed competition ELISAs and detected interference with 3BNC117, N6, and VRC01 (<a id="crosref0390" href="#fig2">Figures 2</a>A; <a id="crosref0395" href="#figs2">S2</a>B). However, compared with these VRC01-class CD4bs antibodies, a different binding pattern was detected for 1-18 and 1-55 when tested by ELISA against several Env proteins. For example, whereas 3BNC117, N6, and VRC01 bound similarly to YU2<sub>gp120</sub>, YU2<sub>gp140</sub>, and BAL<sub>gp140</sub> and were reactive to the V<sub>1</sub>-V<sub>3</sub> loop-deficient gp120 variant RSC3 (<span class="dropBlock reference-citations"><a id="body-ref-sref113-2" href="#" role="doc-biblioref" data-xml-rid="bib113" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref113-2" aria-controls="sref113-2">Wu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref113-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">113.</div><div>Wu, X. ∙ Yang, Z.Y. ∙ Li, Y. ...</div><div><strong>Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1</strong></div><div><em>Science.</em> 2010; <strong>329</strong>:856-861</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1187659" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_113_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77954920017" target="_blank" aria-label="Open Scopus in new tab">Scopus (1099)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20616233/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1187659&amp;pmid=20616233" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), bNAbs 1-18 and 1-55 showed lower (YU2<sub>gp120,</sub> YU2<sub>gp140</sub>, and BAL<sub>gp140</sub>) or no (RSC3) binding to these proteins (<a id="crosref0405" href="#figs2">Figure&nbsp;S2</a>C). Therefore, 1-18 and 1-55 target the CD4bs but recognize this epitope differently than VRC01-class antibodies.</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/8b51611a-1731-403a-9db3-950a62a7206c/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2020.01.010/asset/a9bfc220-369e-46c5-93f2-4d7b6e69f40b/main.assets/gr2.jpg" height="935" width="704" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/8b51611a-1731-403a-9db3-950a62a7206c/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">bNAb 1-18 Demonstrates Highly Potent and Near-Pan HIV-1-Neutralizing Activity</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0045" role="paragraph">(A) Characteristics of antibodies 1-18 and 1-55.</div><div id="fspara0050" role="paragraph">(B) Activity of 1-18 against the global panel compared with bNAbs in advanced stages of clinical testing, individually sorted by increasing IC<sub>50</sub> values for each bNAb. Data for 3BNC117, VRC01, 10-1074, and PGT121 were derived from CATNAP (<span class="dropBlock reference-citations"><a id="body-ref-sref118-1" href="#" role="doc-biblioref" data-xml-rid="bib118" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref118-1" aria-controls="sref118-1">Yoon et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref118-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">118.</div><div>Yoon, H. ∙ Macke, J. ∙ West, Jr., A.P. ...</div><div><strong>CATNAP: a tool to compile, analyze and tally neutralizing antibody panels</strong></div><div><em>Nucleic Acids Res.</em> 2015; <strong>43</strong>:W213-9</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkv404" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_118_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84979866871" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26044712/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkv404&amp;pmid=26044712" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="fspara0055" role="paragraph">(C) Activity of 1-18 compared with a selection of bNAbs against an identical set of 109 pseudovirus strains (<span class="dropBlock reference-citations"><a id="body-ref-sref118-2" href="#" role="doc-biblioref" data-xml-rid="bib118" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref118-2" aria-controls="sref118-2">Yoon et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref118-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">118.</div><div>Yoon, H. ∙ Macke, J. ∙ West, Jr., A.P. ...</div><div><strong>CATNAP: a tool to compile, analyze and tally neutralizing antibody panels</strong></div><div><em>Nucleic Acids Res.</em> 2015; <strong>43</strong>:W213-9</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkv404" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_118_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84979866871" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26044712/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkv404&amp;pmid=26044712" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For N6, neutralization data were determined in the same laboratory as for 1-18.</div><div id="fspara0060" role="paragraph">(D) Activity against the 119-pseudovirus multiclade panel. Data for 3BNC117, VRC01, 10-1074, and PGT121 were derived from CATNAP (<span class="dropBlock reference-citations"><a id="body-ref-sref118-3" href="#" role="doc-biblioref" data-xml-rid="bib118" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref118-3" aria-controls="sref118-3">Yoon et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref118-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">118.</div><div>Yoon, H. ∙ Macke, J. ∙ West, Jr., A.P. ...</div><div><strong>CATNAP: a tool to compile, analyze and tally neutralizing antibody panels</strong></div><div><em>Nucleic Acids Res.</em> 2015; <strong>43</strong>:W213-9</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkv404" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_118_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84979866871" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26044712/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkv404&amp;pmid=26044712" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="fspara0065" role="paragraph">(E) Activity against patient-derived bulk culture outgrowth virus.</div><div id="fspara0070" role="paragraph">(F) Activity of 1-18 compared with N6 against the 119-pseudovirus multiclade panel and patient-derived bulk culture outgrowth viruses.</div><div id="fspara0075" role="paragraph">In (D)–(F), IC<sub>50</sub> values are shown at the top and IC<sub>80</sub> values at the bottom. See also <a id="crosref1340" href="#figs2">Figure&nbsp;S2</a> and <a id="crosref1345" href="#mmc3">Tables S3</a> and <a id="crosref1350" href="#mmc5">S5</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/8c002e8b-1058-4f2c-96dd-e2e6e1e0b459/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2020.01.010/asset/16de7a06-1339-4deb-a23a-d13412607a01/main.assets/figs2.jpg" height="823" width="659" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/8c002e8b-1058-4f2c-96dd-e2e6e1e0b459/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Neutralization and ELISA Binding Profiles, Related to <a id="crosref1420" href="#fig1">Figures 1</a> and <a id="crosref1425" href="#fig2">2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0255" role="paragraph">(A) Left panel indicates neutralizing activity of 1-18 (left y axis) compared to serum IgG of donor IDC561 (right y axis) against the global pseudovirus panel (left x axis) and a 30-strain YU2 pseudovirus mutant panel (right x axis), with pseudoviruses indicated on the x axis. Right panel indicates correlation and calculated Spearman’s rho.</div><div id="fspara0260" role="paragraph">(B) Competition ELISAs indicating binding of 1-18 (left) and 1-55 (right) to BG505<sub>SOSIP.664</sub> following an incubation with increasing concentrations of the indicated competing antibodies.</div><div id="fspara0265" role="paragraph">(C) ELISAs of 1-18, 1-55, and additional CD4bs antibodies against the indicated HIV-1 Env antigens. Circles show means and error bars indicate standard deviation.</div><div id="fspara0270" role="paragraph">(D) Neutralizing activity of 1-18, 3BNC117, and the combination of both (mixed at a 1:1 ratio) against the global pseudovirus panel and YU2. Single antibodies were tested up to a concentration of 1&nbsp;μg/ml, the combination up to a concentration of 2&nbsp;μg/ml (total IgG amount).</div></div></div></div></figcaption></figure></div><div id="p0075" role="paragraph">We next evaluated the neutralizing activity of 1-18 in detail. In comparison with four bNAbs in advanced stages of clinical investigation (3BNC117, VRC01, 10-1074, and PGT121), 1-18 demonstrated superior activity with high potency (GeoMean IC<sub>50</sub> of 0.035&nbsp;μg/mL, GeoMean IC<sub>80</sub> [80% inhibitory concentration] of 0.155&nbsp;μg/mL) against all viruses of the 12-strain global screening panel (<span class="dropBlock reference-citations"><a id="body-ref-sref19-2" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-2" aria-controls="sref19-2">deCamp et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref19-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>deCamp, A. ∙ Hraber, P. ∙ Bailer, R.T. ...</div><div><strong>Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2014; <strong>88</strong>:2489-2507</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02853-13" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84896739535" target="_blank" aria-label="Open Scopus in new tab">Scopus (122)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24352443/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02853-13&amp;pmid=24352443" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0415" href="#fig2">Figure&nbsp;2</a>B; <a id="crosref0420" href="#mmc3">Table S3</a>A). Although 1-18 competed with other CD4bs bNAbs for binding to BG505<sub>SOSIP.664</sub> by ELISA, no reduction in neutralizing activity was detected when 1-18 and 3BNC117 were combined (<a id="crosref0425" href="#figs2">Figure&nbsp;S2</a>D). To confirm the results of the screening panel, we evaluated the activity of 1-18 on extended pseudovirus panels. Overall, 1-18 ranked among the best bNAbs that are currently available (<a id="crosref0430" href="#fig2">Figure&nbsp;2</a>C). When tested against a 119-strain multiclade panel, 1-18 showed highly potent&nbsp;activity (GeoMean IC<sub>50</sub> of 0.048&nbsp;μg/mL, GeoMean IC<sub>80</sub> of 0.183&nbsp;μg/mL) with a breadth of 97% (<a id="crosref0435" href="#fig2">Figure&nbsp;2</a>D; <a id="crosref0440" href="#mmc5">Table S5</a>A). In addition, 1-18 demonstrated high potency (GeoMean IC<sub>50</sub> of 0.074&nbsp;μg/mL, GeoMean IC<sub>80</sub> of 0.279&nbsp;μg/mL) and breadth (90%) when tested against a 100-strain clade C panel (<a id="crosref0445" href="#mmc5">Table S5</a>B). Finally, we determined the activity of 1-18 against culture-derived primary HIV-1 strains that are generally more difficult to neutralize than pseudoviruses (<span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Cohen et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Cohen, Y.Z. ∙ Lorenzi, J.C.C. ∙ Seaman, M.S. ...</div><div><strong>Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells</strong></div><div><em>J.&nbsp;Virol.</em> 2018; <strong>92</strong>:e01883-17</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.01883-17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85042032314" target="_blank" aria-label="Open Scopus in new tab">Scopus (13)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29237833/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.01883-17&amp;pmid=29237833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Against viruses obtained from 51 HIV-1-infected individuals, 1-18 demonstrated higher breadth and/or potency (GeoMean IC<sub>50</sub> of 0.56&nbsp;μg/mL, GeoMean IC<sub>80</sub> of 1.57&nbsp;μg/mL, 96% breadth) than 3BNC117, VRC01, 10-1074, and PGDM1400 (<a id="crosref0455" href="#fig2">Figure&nbsp;2</a>E; <a id="crosref0460" href="#mmc5">Table S5</a>C) and was superior to the near-pan-neutralizing V<sub>H</sub>1-2-derived CD4bs bNAb N6 (<span class="dropBlock reference-citations"><a id="body-ref-sref47-2" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-2" aria-controls="sref47-2">Huang et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref47-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Huang, J. ∙ Kang, B.H. ∙ Ishida, E. ...</div><div><strong>Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth</strong></div><div><em>Immunity.</em> 2016; <strong>45</strong>:1108-1121</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84999836139" target="_blank" aria-label="Open Scopus in new tab">Scopus (116)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27851912/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.10.027&amp;pmid=27851912" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0470" href="#fig2">Figure&nbsp;2</a>F; <a id="crosref0475" href="#mmc5">Table S5</a>C).</div><div id="p0080" role="paragraph">We conclude that 1-18 is a highly broad and potent V<sub>H</sub>1-46-derived antibody that rivals or exceeds the activity of CD4bs bNAbs described to date.</div></section><section id="sec-2-3"><h3>1-18 Targets the CD4bs and Regions of the Adjacent gp120 Protomer</h3><div id="p0085" role="paragraph">To characterize Env recognition by the 1-18 family of bNAbs, we solved cryo-EM structures of 1-18 and 1-55 Fabs in complex with&nbsp;soluble native-like Env trimers and the V3-targeting bNAb 10-1074 at resolutions of 2.5&nbsp;Å (1-18 complexed with BG505<sub>SOSIP.664</sub>) and 3.9&nbsp;Å (1-55 complexed with RC1, a designed immunogen that is a derivative of BG505<sub>SOSIP.664</sub>; <span class="dropBlock reference-citations"><a id="body-ref-sref30-1" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-1" aria-controls="sref30-1">Escolano et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref30-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Escolano, A. ∙ Gristick, H.B. ∙ Abernathy, M.E. ...</div><div><strong>Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques</strong></div><div><em>Nature.</em> 2019; <strong>570</strong>:468-473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1250-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85066803291" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31142836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1250-z&amp;pmid=31142836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="crosref0485" href="#fig3">Figures 3</a>A and <a id="crosref0490" href="#figs3">S3</a>; <a id="crosref0495" href="#mmc6">Table S6</a>). Notably, at 2.5-Å resolution, the 1-18 complex is the highest resolution view yet obtained of an HIV-1 Env trimer (<a id="crosref0500" href="#figs3">Figure S3</a>A; <a id="crosref0505" href="#mmc6">Table S6</a>). Both complexes contained three 1-18 family Fabs and three 10-1074 Fabs interacting with three-fold symmetry with a SOSIP-Env trimer. 1-18 and 1-55 recognized the CD4bs similarly to other V<sub>H</sub>1-46-derived bNAbs, including 8ANC131 and CH235.12 (<span class="dropBlock reference-citations"><a id="body-ref-sref125-2" href="#" role="doc-biblioref" data-xml-rid="bib8 bib125" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref125-2" aria-controls="sref125-2">Bonsignori et&nbsp;al., 2016; Zhou et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref125-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bonsignori, M. ∙ Zhou, T. ∙ Sheng, Z. ..., NISC Comparative Sequencing Program</div><div><strong>Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:449-463</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84959296091" target="_blank" aria-label="Open Scopus in new tab">Scopus (138)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26949186/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.02.022&amp;pmid=26949186" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">125.</div><div>Zhou, T. ∙ Lynch, R.M. ∙ Chen, L. ..., NISC Comparative Sequencing Program</div><div><strong>Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors</strong></div><div><em>Cell.</em> 2015; <strong>161</strong>:1280-1292</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.05.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.05.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84930418589" target="_blank" aria-label="Open Scopus in new tab">Scopus (154)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26004070/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.05.007&amp;pmid=26004070" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), with interactions encompassing contacts with the N276<sub>gp120</sub> and N197<sub>gp120</sub> glycans, the CD4bs loop via the CDRH2, the V5 loop via the CDRH2, and loop D via the CDRL3 (<a id="crosref0510" href="#fig3">Figures 3</a>A, 3B, <a id="crosref0515" href="#figs4">S4</a>A, and S4B). However, in addition, 1-18 contacts Env by residue F54<sub>HC</sub>, which is buried in the gp120 ‘Phe43 pocket’, and by residue R64<sub>HC</sub>, which makes a salt bridge with V5 residue D457<sub>gp120</sub> (<a id="crosref0520" href="#figs4">Figure&nbsp;S4</a>B). These interactions mimic analogous gp120 contacts made by CD4 residues F43<sub>CD4</sub> and K35<sub>CD4</sub>, respectively, and the V<sub>H</sub>1-2-derived bNAb N6 also buries an aromatic residue (Y54<sub>HC</sub>) in the ‘Phe43 pocket’ (<span class="dropBlock reference-citations"><a id="body-ref-sref58-2" href="#" role="doc-biblioref" data-xml-rid="bib47 bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58-2" aria-controls="sref58-2">Huang et&nbsp;al., 2016a; Kwong et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref58-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Huang, J. ∙ Kang, B.H. ∙ Ishida, E. ...</div><div><strong>Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth</strong></div><div><em>Immunity.</em> 2016; <strong>45</strong>:1108-1121</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84999836139" target="_blank" aria-label="Open Scopus in new tab">Scopus (116)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27851912/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.10.027&amp;pmid=27851912" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Kwong, P.D. ∙ Wyatt, R. ∙ Robinson, J. ...</div><div><strong>Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody</strong></div><div><em>Nature.</em> 1998; <strong>393</strong>:648-659</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/31405" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0032543307" target="_blank" aria-label="Open Scopus in new tab">Scopus (2341)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9641677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F31405&amp;pmid=9641677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0525" href="#figs4">Figure&nbsp;S4</a>B).</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/be33c7da-8052-459d-aa94-8b003d7a554f/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2020.01.010/asset/a9e70290-e70b-4af6-8c6b-771b04370e6d/main.assets/gr3.jpg" height="848" width="659" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/be33c7da-8052-459d-aa94-8b003d7a554f/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Cryo-EM Structures of 1-18 and 1-55 Fab Complexes with Env Trimers</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0085" role="paragraph">(A) EM densities for side views of Env trimers complexed with 1-18 or 1-55 Fabs and 10-1074 bNAb Fabs. 1-55 Fabs were based on sequence variants that contained primer-induced mutations at the start and end of the V genes (total of 2 aa [V<sub>H</sub>] and 4 aa [V<sub>κ</sub>] mutations).</div><div id="fspara0090" role="paragraph">(B) Top view of 1-18-BG505-10-1074 complex density. The inset shows a close up of the interactions between the 1-18 V<sub>H</sub>-V<sub>L</sub> domains (cartoon representation) and Env, with primary gp120 shown in light gray and secondary gp120 (gp120<sub>2</sub>) shown in dark gray. Protein regions that are contacted by 1-18 are shown as colored surfaces, and glycans are shown as sticks.</div><div id="fspara0095" role="paragraph">(C) Close up of interactions of 1-18 CDRH1 residues with residues on secondary gp120. Hydrogen bonds and electrostatic contacts are shown as dotted lines. The percent conservation among Env sequences of gp120<sub>2</sub> residues contacted by CDRH1 is indicated in parentheses (<span class="dropBlock reference-citations"><a id="body-ref-sref111-1" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111-1" aria-controls="sref111-1">West et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref111-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>West, Jr., A.P. ∙ Scharf, L. ∙ Horwitz, J. ...</div><div><strong>Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:10598-10603</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1309215110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879538530" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23754383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1309215110&amp;pmid=23754383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). <sup>∗</sup> denotes the conservation percentage in the 500 viruses that have residue 308.</div><div id="fspara0100" role="paragraph">(D) Electrostatic surface representation of the Env region contacted by the 1-18 CDRH1.</div><div id="fspara0105" role="paragraph">(E) Buried surface areas from CD4bs bNAb contacts on the primary (gp120<sub>1</sub>) and secondary (gp120<sub>2</sub>) protomers. Env trimer structures are SOSIP.664 versions of the indicated Env strains.</div><div id="fspara0110" role="paragraph">See also <a id="crosref1360" href="#figs3">Figures S3</a> and <a id="crosref1365" href="#figs4">S4</a> and <a id="crosref1370" href="#mmc6">Table S6</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/b2698f80-7b0f-4b1e-867f-9d08c5e200d9/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2020.01.010/asset/e1b65a53-3efa-420a-a860-42896e19a666/main.assets/figs3.jpg" height="941" width="693" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/b2698f80-7b0f-4b1e-867f-9d08c5e200d9/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Cryo-EM Data Collection and Processing, Related to <a id="crosref1430" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0280" role="paragraph">(A–B) A micrograph with examples of picked particles, selected two-dimensional class averages, an orientation distribution image, a local resolution graphic, a GSFSC resolution plot, and representative densities for protein and <i>N</i>-linked glycan regions are shown for the (A) 1-18–BG505–10-1074 and (B) 1-55–RC1–10-1074 complexes.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/4f47e248-5707-4364-91b5-fbafc1710dc5/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2020.01.010/asset/b1465c96-a1f8-47b9-8bea-1ac19f44cbf8/main.assets/figs4.jpg" height="903" width="751" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/4f47e248-5707-4364-91b5-fbafc1710dc5/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Structural Interaction Details of 1-18- and 1-55-Env Complexes, Related to <a id="crosref1435" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0290" role="paragraph">(A) Alignment of 1-18 heavy (top) and light (bottom) chain sequences to germline. Residues interacting with BG505<sub>SOSIP.664</sub> are indicated by circles. Interacting residues mutated from the germline sequences are indicated in red.</div><div id="fspara0295" role="paragraph">(B) Comparison of Env-interactions of 1-18, the CD4bs bNAbs N6 and 8ANC131, and CD4 at four sites: D368<sub>gp120</sub>, Loop D, the ‘Phe43 pocket’, and the V5 loop. Heavy chains are shown in darker colors than light chains. PDB codes are indicated on the left.</div><div id="fspara0300" role="paragraph">(C) Comparison of Env-interactions of bNAbs with Asp-rich insertions in CDRH1 or FWRH3 contacting the adjacent gp120 protomer. Each SOSIP.664 trimer is shown as semi-transparent surface with the primary gp120 protomer in white and the adjacent gp120 in gray. V<sub>H</sub>V<sub>L</sub> regions are shown in teal with insertions in red. PDB code, insertion location, and insertion sequence are listed.</div><div id="fspara0305" role="paragraph">(D) Differences between Fabs of 1-18 and 1-55. One 1-18 V<sub>H</sub>V<sub>L</sub> (dark green surface) is shown bound to one gp120 (gray cartoon). Locations of residues varying between 1-18 and 1-55 are highlighted in magenta. Glycans at positions N197<sub>gp120</sub> and N276<sub>gp120</sub> are shown as red sticks. 1-55 Fabs were based on earlier sequence variants and contained primer-induced mutations at the start and end of the V genes (for a total of 2 aa [V<sub>H</sub><sub>]</sub> and 4 aa [V<sub>Κ</sub><sub>]</sub> mutations).</div></div></div></div></figcaption></figure></div><div id="p0090" role="paragraph">In addition to the canonical V<sub>H</sub>1-46 contacts, 1-18 contains a six-residue insertion in its CDRH1, resulting in a negatively charged <sup>25</sup>DDDPYTDDD<sup>33</sup> motif that interacts with the adjacent gp120 protomer (<a id="crosref0530" href="#fig3">Figures 3</a>B–3D). At the adjacent protomer, four Asp residues in the 1-18 CDRH1 (D25<sub>HC</sub>, D27<sub>HC</sub>, D31<sub>HC</sub>, and D32<sub>HC</sub>) plus T30<sub>HC</sub> form coordinated interactions around the highly conserved Env residue K207<sub>gp120</sub> (<a id="crosref0535" href="#fig3">Figure&nbsp;3</a>C). In addition, the increased length of the 1-18 CDRH1 places Y29<sub>HC</sub> in a position to interact with residues in the V3 loop on the adjacent protomer (S306<sub>gp120</sub>, R308<sub>gp120</sub>, A316<sub>gp120</sub>, and Y318<sub>gp120</sub>) (<a id="crosref0540" href="#fig3">Figure&nbsp;3</a>C). Although not all of the Asp residues in the 1-18 CDRH1 contact positively charged residues on gp120, the Asp-rich insertion may have been selected to carry an overall negative charge that is electrostatically attracted to the positively charged patch within the V3 loop on the adjacent protomer (<a id="crosref0545" href="#fig3">Figure&nbsp;3</a>D), which could drive formation of an initial Env-antibody complex (<span class="dropBlock reference-citations"><a id="body-ref-sref92" href="#" role="doc-biblioref" data-xml-rid="bib92" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref92" aria-controls="sref92">Schreiber et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref92"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">92.</div><div>Schreiber, M. ∙ Wachsmuth, C. ∙ Müller, H. ...</div><div><strong>Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression</strong></div><div><em>J.&nbsp;Gen. Virol.</em> 1996; <strong>77</strong>:2403-2414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1099/0022-1317-77-10-2403" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8887471/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1099%2F0022-1317-77-10-2403&amp;pmid=8887471" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although other CD4bs bNAbs include Asp-containing insertions in either the CDRH1 or heavy-chain framework region 3 (FWRH3) that interact with the positively charged gp120 patch (<span class="dropBlock reference-citations"><a id="body-ref-sref115" href="#" role="doc-biblioref" data-xml-rid="bib60 bib63 bib115" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref115" aria-controls="sref115">Lee et&nbsp;al., 2017; Liu et&nbsp;al., 2019; Xu et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref115"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Lee, J.H. ∙ Andrabi, R. ∙ Su, C.Y. ...</div><div><strong>A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure</strong></div><div><em>Immunity.</em> 2017; <strong>46</strong>:690-702</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85019040760" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28423342/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2017.03.017&amp;pmid=28423342" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Liu, Q. ∙ Lai, Y.T. ∙ Zhang, P. ...</div><div><strong>Improvement of antibody functionality by structure-guided paratope engraftment</strong></div><div><em>Nat. Commun.</em> 2019; <strong>10</strong>:721</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-08658-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061489670" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30760721/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-08658-4&amp;pmid=30760721" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">115.</div><div>Xu, K. ∙ Acharya, P. ∙ Kong, R. ...</div><div><strong>Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:857-867</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0042-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85047980123" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867235/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0042-6&amp;pmid=29867235" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0555" href="#figs4">Figure&nbsp;S4</a>C), the number of Asp in the CDRH1 of 1-18 and the extent of their interaction to Env have not been described before. Notably, gp120 residues contacted by the 1-18 CDRH1 contribute to the CD4 and/or co-receptor binding sites (<span class="dropBlock reference-citations"><a id="body-ref-sref94" href="#" role="doc-biblioref" data-xml-rid="bib62 bib79 bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94" aria-controls="sref94">Liu et&nbsp;al., 2017; Rizzuto et&nbsp;al., 1998; Shaik et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref94"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Liu, Q. ∙ Acharya, P. ∙ Dolan, M.A. ...</div><div><strong>Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2017; <strong>24</strong>:370-378</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsmb.3382" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85013157801" target="_blank" aria-label="Open Scopus in new tab">Scopus (42)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28218750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsmb.3382&amp;pmid=28218750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Rizzuto, C.D. ∙ Wyatt, R. ∙ Hernández-Ramos, N. ...</div><div><strong>A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding</strong></div><div><em>Science.</em> 1998; <strong>280</strong>:1949-1953</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.280.5371.1949" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0032546952" target="_blank" aria-label="Open Scopus in new tab">Scopus (730)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9632396/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.280.5371.1949&amp;pmid=9632396" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">94.</div><div>Shaik, M.M. ∙ Peng, H. ∙ Lu, J. ...</div><div><strong>Structural basis of coreceptor recognition by HIV-1 envelope spike</strong></div><div><em>Nature.</em> 2019; <strong>565</strong>:318-323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0804-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85060134274" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30542158/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0804-9&amp;pmid=30542158" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and most residues are highly conserved (<a id="crosref0560" href="#fig3">Figure&nbsp;3</a>C). Demonstrating their importance for viral function, mutations in some of these residues have been shown to substantially reduce infectivity (<span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib18 bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">de Taeye et&nbsp;al., 2015; Liu et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>de Taeye, S.W. ∙ Ozorowski, G. ∙ Torrents de la Peña, A. ...</div><div><strong>Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes</strong></div><div><em>Cell.</em> 2015; <strong>163</strong>:1702-1715</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.11.056&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.11.056&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84950267324" target="_blank" aria-label="Open Scopus in new tab">Scopus (157)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26687358/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.11.056&amp;pmid=26687358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Liu, Q. ∙ Acharya, P. ∙ Dolan, M.A. ...</div><div><strong>Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2017; <strong>24</strong>:370-378</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsmb.3382" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85013157801" target="_blank" aria-label="Open Scopus in new tab">Scopus (42)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28218750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsmb.3382&amp;pmid=28218750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0095" role="paragraph">To evaluate the relevance of the CDRH1 insertion for the neutralizing activity of 1-18, we engineered 1-18Δins, a 1-18 variant lacking the insertion. When tested against the 12-strain global panel, 1-18Δins showed significantly reduced potency compared with 1-18 (GeoMean IC<sub>50</sub> values of 0.114&nbsp;μg/mL [1-18Δins] and 0.035&nbsp;μg/mL [1-18], respectively; p&nbsp;= 0.012; <a id="crosref0565" href="#mmc3">Table S3</a>B). In addition, we investigated antibody 561_02_12 (referred to as 2-12), a member of clone 4 that developed in individual IDC561 but does not have a CDRH1 insertion. Compared with 1-18, antibody 2-12 showed lower breadth on extended pseudovirus panels (119-strain multiclade panel: 1-18, 97% breadth; 2-12, 87% breadth; 100-strain clade C panel: 1-18, 90% breadth; 2-12, 74% breadth; <a id="crosref0570" href="#mmc5">Tables S5</a>A and S5B). Analysis of the neutralization panel data (<span class="dropBlock reference-citations"><a id="body-ref-sref111-2" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111-2" aria-controls="sref111-2">West et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref111-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>West, Jr., A.P. ∙ Scharf, L. ∙ Horwitz, J. ...</div><div><strong>Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:10598-10603</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1309215110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879538530" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23754383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1309215110&amp;pmid=23754383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) indicated reduced potency of 2-12 against viruses carrying H364<sub>gp120</sub> in the CD4 binding loop. In contrast, 1-18 is less affected by this variation, suggesting a higher tolerance for structural variations in this site.</div><div id="p0100" role="paragraph">Compared with the epitopes of the CD4bs bNAbs 3BNC117 and VRC01 (<span class="dropBlock reference-citations"><a id="body-ref-sref100" href="#" role="doc-biblioref" data-xml-rid="bib60 bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100" aria-controls="sref100">Lee et&nbsp;al., 2017; Stewart-Jones et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref100"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Lee, J.H. ∙ Andrabi, R. ∙ Su, C.Y. ...</div><div><strong>A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure</strong></div><div><em>Immunity.</em> 2017; <strong>46</strong>:690-702</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85019040760" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28423342/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2017.03.017&amp;pmid=28423342" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">100.</div><div>Stewart-Jones, G.B. ∙ Soto, C. ∙ Lemmin, T. ...</div><div><strong>Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:813-826</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.04.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.04.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27114034/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.04.010&amp;pmid=27114034" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), 1-18 and 1-55 bury more surface area on both the primary gp120 epitope and the adjacent protomer, another potential mechanism for their increased breadth and potency (<span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Chuang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Chuang, G.Y. ∙ Zhou, J. ∙ Acharya, P. ...</div><div><strong>Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition</strong></div><div><em>Structure.</em> 2019; <strong>27</strong>:196-206.e6</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.str.2018.10.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.str.2018.10.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85059495283" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30471922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.str.2018.10.007&amp;pmid=30471922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0585" href="#fig3">Figure&nbsp;3</a>E). Finally, the slightly higher neutralizing activity of 1-18 compared with 1-55 might be explained by variations in glycan accommodation (<a id="crosref0590" href="#figs4">Figure&nbsp;S4</a>D). We conclude that 1-18 mediates exceptional HIV-1-neutralizing activity by an increase in buried surface on gp120, primarily through increased inter-protomer contacts mediated by its unique CDRH1.</div></section><section id="sec-2-4"><h3>1-18 Is Not Affected by Typical VRC01-Class Escape Mutations</h3><div id="p0105" role="paragraph">To determine how known Env escape mutations affect the neutralizing activity of 1-18, we evaluated the sensitivity of HIV-1<sub>YU2</sub> pseudovirus variants. As expected, removal of potential <i>N</i>-linked glycosylation sites (PNGSs) in the V2 (N160<sub>gp120</sub>) and V3 (N301<sub>gp120</sub>, N332<sub>gp120</sub>) loops mediated resistance to the V1/V2-directed bNAbs PG16 and PDGM1400 and the V3-directed bNAbs 10-1074 and PGT128, respectively (<span class="dropBlock reference-citations"><a id="body-ref-sref109" href="#" role="doc-biblioref" data-xml-rid="bib71 bib74 bib99 bib108 bib109" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref109" aria-controls="sref109">Mouquet et&nbsp;al., 2012; Pejchal et&nbsp;al., 2011; Sok et&nbsp;al., 2014; Walker et&nbsp;al., 2009, 2011</a><div class="dropBlock__holder" data-db-target-of="sref109"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Mouquet, H. ∙ Scharf, L. ∙ Euler, Z. ...</div><div><strong>Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:E3268-E3277</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1217207109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84869831194" target="_blank" aria-label="Open Scopus in new tab">Scopus (296)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23115339/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1217207109&amp;pmid=23115339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Pejchal, R. ∙ Doores, K.J. ∙ Walker, L.M. ...</div><div><strong>A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield</strong></div><div><em>Science.</em> 2011; <strong>334</strong>:1097-1103</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1213256" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-82255179322" target="_blank" aria-label="Open Scopus in new tab">Scopus (483)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21998254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1213256&amp;pmid=21998254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Sok, D. ∙ van Gils, M.J. ∙ Pauthner, M. ...</div><div><strong>Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2014; <strong>111</strong>:17624-17629</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1415789111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_99_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84917705974" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25422458/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1415789111&amp;pmid=25422458" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">108.</div><div>Walker, L.M. ∙ Phogat, S.K. ∙ Chan-Hui, P.Y. ..., Protocol G Principal Investigators</div><div><strong>Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target</strong></div><div><em>Science.</em> 2009; <strong>326</strong>:285-289</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1178746" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_108_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-70349887757" target="_blank" aria-label="Open Scopus in new tab">Scopus (1190)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19729618/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1178746&amp;pmid=19729618" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">109.</div><div>Walker, L.M. ∙ Huber, M. ∙ Doores, K.J. ..., Protocol G Principal Investigators</div><div><strong>Broad neutralization coverage of HIV by multiple highly potent antibodies</strong></div><div><em>Nature.</em> 2011; <strong>477</strong>:466-470</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10373" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_109_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-80053132436" target="_blank" aria-label="Open Scopus in new tab">Scopus (951)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21849977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10373&amp;pmid=21849977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but did not affect neutralization by 1-18 or other CD4bs bNAbs (<a id="crosref0595" href="#fig4">Figure&nbsp;4</a>). Similarly, removal of a PNGS adjacent to the CD4bs (N276<sub>gp120</sub>) reduced sensitivity to the gp120-gp41 interface bNAb 8ANC195 (<span class="dropBlock reference-citations"><a id="body-ref-sref86" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86" aria-controls="sref86">Scharf et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref86"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Scharf, L. ∙ Scheid, J.F. ∙ Lee, J.H. ...</div><div><strong>Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike</strong></div><div><em>Cell Rep.</em> 2014; <strong>7</strong>:785-795</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.celrep.2014.04.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.celrep.2014.04.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84899909771" target="_blank" aria-label="Open Scopus in new tab">Scopus (146)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24767986/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2014.04.001&amp;pmid=24767986" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) but had no effect on 1-18 (<a id="crosref0605" href="#fig4">Figure&nbsp;4</a>).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/1fa3f934-ae52-411f-9bd0-a4adf65e4ff2/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2020.01.010/asset/93b4e14c-ad27-4576-8cc3-094050d17f04/main.assets/gr4.jpg" height="639" width="754" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/1fa3f934-ae52-411f-9bd0-a4adf65e4ff2/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">1-18 Overcomes Typical bNAb Escape Mutations <i>In&nbsp;Vitro</i></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0120" role="paragraph">The top row shows bNAb IC<sub>50</sub> values against the YU2 wild-type pseudovirus. The panels show the change in bNAb sensitivity (fold change of IC<sub>50</sub>) for YU2 pseudovirus mutants compared with the wild type.</div></div></div></div></figcaption></figure></div><div id="p0110" role="paragraph">V<sub>H</sub>-restricted CD4bs bNAbs typically interact with loop D residues N279<sub>gp120</sub> and/or N280<sub>gp120</sub>, and changes in these residues have been associated with viral rebound from CD4bs therapy (<span class="dropBlock reference-citations"><a id="body-ref-sref64-5" href="#" role="doc-biblioref" data-xml-rid="bib24 bib44 bib51 bib53 bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-5" aria-controls="sref64-5">Diskin et&nbsp;al., 2013; Horwitz et&nbsp;al., 2013; Julg et&nbsp;al., 2017; Klein et&nbsp;al., 2012; Lynch et&nbsp;al., 2015a</a><div class="dropBlock__holder" data-db-target-of="sref64-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Diskin, R. ∙ Klein, F. ∙ Horwitz, J.A. ...</div><div><strong>Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2013; <strong>210</strong>:1235-1249</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20130221" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879523938" target="_blank" aria-label="Open Scopus in new tab">Scopus (65)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23712429/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20130221&amp;pmid=23712429" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Horwitz, J.A. ∙ Halper-Stromberg, A. ∙ Mouquet, H. ...</div><div><strong>HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:16538-16543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1315295110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84885338257" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24043801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1315295110&amp;pmid=24043801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Julg, B. ∙ Pegu, A. ∙ Abbink, P. ...</div><div><strong>Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys</strong></div><div><em>J.&nbsp;Virol.</em> 2017; <strong>91</strong>:e00498-17</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00498-17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85026310049" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28539448/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00498-17&amp;pmid=28539448" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). When we tested HIV-1<sub>YU2</sub> variants with mutations at these residues, we observed reduced or abrogated sensitivity to VRC01-class bNAbs and to the V<sub>H</sub>1-46-derived CD4bs bNAb 8ANC131 (<a id="crosref0610" href="#fig4">Figure&nbsp;4</a>). In contrast, these mutations had no or only minimal effects on 1-18 (<a id="crosref0615" href="#fig4">Figure&nbsp;4</a>). Maintained neutralizing activity against these variants might be mediated by increased contacts of 1-18’s extended CDRH1 that formed compensatory interactions, alleviating the necessity for loop D contacts normally required by CD4bs antibodies. Additionally, the portion of 1-18’s CDRL3 that contacts loop D utilizes a glycine-rich <sup>92</sup>GGT<sup>94</sup> motif rather than the <sup>92</sup>SST<sup>94</sup> motif in 8ANC131. This could accommodate mutations in loop D (N279K, N280Y) through increased flexibility. Finally, the 7-Å shift in CDRL2 location between 1-18 and 8ANC131 could allow greater accommodation of a glycan at N279<sub>gp120</sub> in two HIV-1<sub>YU2</sub> variants (A281T and T278I/A281T).</div><div id="p0115" role="paragraph">Mutations in the β23 and β24 strands surrounding the V5 loop (gp120 residues 451-471) were associated with viral resistance against 8ANC131 but were tolerated by 1-18 (<a id="crosref0620" href="#fig4">Figure&nbsp;4</a>). V5 loop residue D457<sub>gp120</sub> interacts with 1-18 R64<sub>HC</sub>, a somatic mutation from the V<sub>H</sub>1-46 germline that is present in 1-18 but not in 8ANC131. We hypothesize that the R64<sub>HC</sub>-D457<sub>gp120</sub> salt bridge is a crucial interaction between 1-18 and gp120 that potentially allows it to tolerate common routes of Env escape within the V5 loop.</div><div id="p0120" role="paragraph">We conclude that 1-18 maintains full activity against viruses carrying mutations associated with viral resistance against other CD4bs bNAbs <i>in&nbsp;vitro</i>.</div></section><section id="sec-2-5"><h3>Mutational Antigenic Profiling of 1-18 Reveals Restricted HIV-1 Escape</h3><div id="p0125" role="paragraph">To identify potential pathways of viral escape from 1-18, we used mutational antigenic profiling with libraries of HIV-1<sub>BG505</sub> variants containing all single amino acid substitutions within the ecto- and transmembrane domains of Env (<a id="crosref0625" href="#figs5">Figure&nbsp;S5</a>; <span class="dropBlock reference-citations"><a id="body-ref-sref42-1" href="#" role="doc-biblioref" data-xml-rid="bib21 bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-1" aria-controls="sref42-1">Dingens et&nbsp;al., 2017; Haddox et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref42-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Dingens, A.S. ∙ Haddox, H.K. ∙ Overbaugh, J. ...</div><div><strong>Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody</strong></div><div><em>Cell Host Microbe.</em> 2017; <strong>21</strong>:777-787.e4</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.chom.2017.05.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.chom.2017.05.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85020234897" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28579254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2017.05.003&amp;pmid=28579254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Haddox, H.K. ∙ Dingens, A.S. ∙ Hilton, S.K. ...</div><div><strong>Mapping mutational effects along the evolutionary landscape of HIV envelope</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e34420</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.34420" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29590010/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.34420&amp;pmid=29590010" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In this assay, the effects of Env mutations on antibody resistance are quantitatively determined by deep sequencing of cells that become infected in the presence versus the absence of an antibody.</div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/e8f2f646-d35c-4b41-b660-7037e1dfd8f5/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2020.01.010/asset/830e2ea7-cd81-4456-859c-267e5823498b/main.assets/figs5.jpg" height="941" width="737" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/e8f2f646-d35c-4b41-b660-7037e1dfd8f5/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Mutational Antigenic Profiling: Fractions Surviving, Correlation between Replicates, and Determination of Sites of Significant Escape, Related to <a id="crosref1440" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0315" role="paragraph">(A) Antibody concentration during selection, batch of mutant virus library, and fraction of library surviving antibody selection for each biological replicate.</div><div id="fspara0320" role="paragraph">(B–D) Correlation between biological replicate selections of average excess fraction surviving at each site in the presence of (B) 1-18, (C) VRC01, and (D) 3BNC117.</div><div id="fspara0325" role="paragraph">(E) Distribution of average fraction surviving at each site for each antibody (blue bars). The yellow line overlays the gamma distribution fit using robust regression to site fraction surviving data. Dotted lines mark sites that fall beyond this distribution at a false discovery rate of 0.01. Number of sites beyond this cutoff is labeled in green and individual sites are listed at the bottom. Data for 3BNC117 and VRC01 are from <span class="dropBlock reference-citations"><a id="body-ref-sref22-1" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-1" aria-controls="sref22-1">Dingens et&nbsp;al. (2019)</a><div class="dropBlock__holder" data-db-target-of="sref22-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>.</div></div></div></div></figcaption></figure></div><div id="p0130" role="paragraph">1-18 only selected escape mutants at a small number of residues, all of which were outside of the canonical CD4bs. In contrast to 3BNC117 and VRC01 (<span class="dropBlock reference-citations"><a id="body-ref-sref22-2" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-2" aria-controls="sref22-2">Dingens et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref22-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), we observed no statistically significant escape from 1-18 in loop D and the CD4 binding loop (<a id="crosref0635" href="#fig5">Figures 5</a>A–5C and <a id="crosref0640" href="#figs5">S5</a>). Rather, 1-18-mediated selection was localized to the V3 loop and the&nbsp;stem of the V1/V2 loop of gp120 (<a id="crosref0645" href="#fig5">Figure&nbsp;5</a>C). Among the four sites of significant escape, three residues (K207<sub>gp120</sub>, R304<sub>gp120</sub>, and Y318<sub>gp120</sub>) interact with the CDRH1 of 1-18 (<a id="crosref0650" href="#fig5">Figure&nbsp;5</a>C). The fourth residue, C119<sub>gp120</sub>, generally forms a disulfide bond with C205<sub>gp120</sub> at the stem of the V1/V2 loop. Thus, mutations at residue C119<sub>gp120</sub> may reduce 1-18 accessibility to the highly conserved K207<sub>gp120</sub> by disordering the V1/V2 loop structure (<span class="dropBlock reference-citations"><a id="body-ref-sref104" href="#" role="doc-biblioref" data-xml-rid="bib61 bib104" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref104" aria-controls="sref104">Leonard et&nbsp;al., 1990; van Anken et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref104"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Leonard, C.K. ∙ Spellman, M.W. ∙ Riddle, L. ...</div><div><strong>Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1990; <strong>265</strong>:10373-10382</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS0021-9258%2818%2986956-3&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS0021-9258%2818%2986956-3&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2355006/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2818%2986956-3&amp;pmid=2355006" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">104.</div><div>van Anken, E. ∙ Sanders, R.W. ∙ Liscaljet, I.M. ...</div><div><strong>Only five of 10 strictly conserved disulfide bonds are essential for folding and eight for function of the HIV-1 envelope glycoprotein</strong></div><div><em>Mol. Biol. Cell.</em> 2008; <strong>19</strong>:4298-4309</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1091/mbc.e07-12-1282" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18653472/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1091%2Fmbc.e07-12-1282&amp;pmid=18653472" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/df55d7f4-1305-465c-89f0-91f022a04472/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2020.01.010/asset/16234f9c-5850-4094-a5d0-7a841719f868/main.assets/gr5.jpg" height="935" width="675" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/df55d7f4-1305-465c-89f0-91f022a04472/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Restricted Pathways of Escape from 1-18 Identified by Mutational Antigenic Profiling</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0130" role="paragraph">(A) Line plots indicate the HIV-1<sub>BG505</sub> library excess fraction surviving antibody neutralization, averaged across all mutations at each site. Data for antibodies other than 1-18 in all panels are from <span class="dropBlock reference-citations"><a id="body-ref-sref22-3" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-3" aria-controls="sref22-3">Dingens et&nbsp;al. (2019)</a><div class="dropBlock__holder" data-db-target-of="sref22-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>. Regions in gray are detailed in (B).</div><div id="fspara0135" role="paragraph">(B) HIV-1<sub>BG505</sub> escape profiles, with letter heights indicating the excess fraction surviving for each mutation. Circles indicate HIV-1<sub>BG505</sub> residues interacting with 1-18 (cryo-EM). Asterisks indicate residues with statistically significant antibody escape.</div><div id="fspara0140" role="paragraph">(C) The BG505<sub>SOSIP.664</sub> trimer, colored according to the maximum excess fraction surviving 1-18 at each site, with 1-18 shown in blue. In the inset, structurally defined contacts are shown as spheres, and the CDRH1 is highlighted by the rectangle. Interactions of the CDRH1 with the adjacent gp120 protomer are indicated on the right.</div><div id="fspara0145" role="paragraph">(D) The top row indicates IC<sub>50</sub> of 1-18 against the BG505<sub>T332N</sub> pseudovirus, and the panels show fold change in IC<sub>50</sub> for BG505<sub>T332N</sub> pseudovirus variants with mutations in the six residues showing the highest excess fraction surviving 1-18 neutralization. Circles indicate interactions as in (B).</div><div id="fspara0150" role="paragraph">(E) Excess fraction surviving for the 40 mutations with the largest effect sizes for each antibody. Circles indicate the number of nucleotide changes required for the respective amino acid mutation.</div><div id="fspara0155" role="paragraph">See also <a id="crosref1380" href="#figs5">Figure&nbsp;S5</a>.</div></div></div></div></figcaption></figure></div><div id="p0135" role="paragraph">Mutational antigenic profiling allows identification of the strongest escape mutations for each antibody (<a id="crosref0655" href="#fig5">Figures 5</a>A–5C and <a id="crosref0660" href="#figs5">S5</a>E). Importantly, although VRC01 escape mutations were associated with a 3- to more than 175-fold increase in the antibody IC<sub>50</sub> values for HIV-1<sub>BG505</sub> pseudovirus variants (<span class="dropBlock reference-citations"><a id="body-ref-sref22-4" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-4" aria-controls="sref22-4">Dingens et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref22-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the effects were much less pronounced for potential 1-18 escape mutants (<a id="crosref0670" href="#fig5">Figure&nbsp;5</a>D). When we evaluated HIV-1<sub>BG505</sub> pseudoviruses carrying single mutations at the six residues with the highest level of 1-18-mediated selection, the sensitivity to 1-18 was reduced by less than 2.3-fold for 5 of the 6 tested viruses (<a id="crosref0675" href="#fig5">Figure&nbsp;5</a>D). The sixth virus, carrying an A316E mutation, showed a 3.2-fold decrease in sensitivity (IC<sub>50</sub> increased to 0.098&nbsp;μg/mL) (<a id="crosref0680" href="#fig5">Figure&nbsp;5</a>D). Therefore, all tested potential escape variants remained highly 1-18-sensitive when evaluated as pseudoviruses. To determine the ease of viral escape, we compared the effects of the 40 strongest mutations from antigenic profiling of 1-18 with those of VRC01, 3BNC117, 10-1074, or the combination of 3BNC117 and 10-1074 (<span class="dropBlock reference-citations"><a id="body-ref-sref22-5" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-5" aria-controls="sref22-5">Dingens et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref22-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The levels of escape observed for 1-18 were lower than those for the single bNAbs and similar to the combination of 3BNC117 and 10-1074 (<a id="crosref0690" href="#fig5">Figure&nbsp;5</a>E).</div><div id="p0140" role="paragraph">Overall, mutational antigenic profiling of 1-18 revealed a strong limitation of HIV-1<sub>BG505</sub> escape via single amino acid mutations, with no evidence of selection at the canonical CD4bs that is critical for resistance against VRC01-class bNAbs.</div></section><section id="sec-2-6"><h3>Full Suppression of Viremia by 1-18 Monotherapy <i>In&nbsp;Vivo</i></h3><div id="p0145" role="paragraph">To determine the antiviral activity of 1-18 <i>in&nbsp;vivo</i>, we used HIV-1<sub>YU2</sub>-infected humanized mice that can maintain stable viremia with a rate of HIV-1 diversification similar to what is observed in humans (<span class="dropBlock reference-citations"><a id="body-ref-sref120-1" href="#" role="doc-biblioref" data-xml-rid="bib38 bib49 bib53 bib120" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref120-1" aria-controls="sref120-1">Gruell and Klein, 2017; Ince et&nbsp;al., 2010; Klein et&nbsp;al., 2012; Zhang et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref120-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Gruell, H. ∙ Klein, F.</div><div><strong>Progress in HIV-1 antibody research using humanized mice</strong></div><div><em>Curr. Opin. HIV AIDS.</em> 2017; <strong>12</strong>:285-293</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/COH.0000000000000368" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85014193431" target="_blank" aria-label="Open Scopus in new tab">Scopus (5)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28422792/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FCOH.0000000000000368&amp;pmid=28422792" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Ince, W.L. ∙ Zhang, L. ∙ Jiang, Q. ...</div><div><strong>Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model</strong></div><div><em>J.&nbsp;Virol.</em> 2010; <strong>84</strong>:2740-2752</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02180-09" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77649099626" target="_blank" aria-label="Open Scopus in new tab">Scopus (33)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20042504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02180-09&amp;pmid=20042504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">120.</div><div>Zhang, Y.J. ∙ Hatziioannou, T. ∙ Zang, T. ...</div><div><strong>Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection</strong></div><div><em>J.&nbsp;Virol.</em> 2002; <strong>76</strong>:6332-6343</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.76.12.6332-6343.2002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_120_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0036100084" target="_blank" aria-label="Open Scopus in new tab">Scopus (83)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12021366/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.76.12.6332-6343.2002&amp;pmid=12021366" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0695" href="#figs6">Figure&nbsp;S6</a>A).</div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/c71947f0-56e7-4ea5-87ec-240a062d626c/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2020.01.010/asset/d42456bd-84d2-49ae-8a04-e1c52d885cdb/main.assets/figs6.jpg" height="815" width="753" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/c71947f0-56e7-4ea5-87ec-240a062d626c/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">1-18 and 1-55 Antiviral Activity in HIV-1<sub>YU2</sub>-Infected Humanized Mice, Pharmacokinetics, and Autoreactive Properties, Related to <a id="crosref1450" href="#fig6">Figures 6</a> and <a id="crosref1455" href="#fig7">7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0335" role="paragraph">(A) Absolute HIV-1 RNA copies (top) and log<sub>10</sub> viral load changes (bottom) in untreated HIV-1<sub>YU2</sub>-infected humanized mice. Red line shows average log<sub>10</sub> viral load change compared to baseline. Dashed line in top panel indicates quantitation limit of accuracy (384 copies/ml).</div><div id="fspara0340" role="paragraph">(B) Absolute HIV-1 RNA copies (top) and log<sub>10</sub> viral load changes (bottom) in HIV-1<sub>YU2</sub>-infected humanized mice treated with 1-55 (left) or 1-18 (right). Grey shading indicates duration of bNAb therapy. Dashed lines in top panels indicate quantitation limit of accuracy (384 copies/ml). Data points in white indicate viral loads&nbsp;&lt; 384 copies/ml. Red lines show average log<sub>10</sub> viral load change compared to baseline.</div><div id="fspara0345" role="paragraph">(C) Alignment of plasma SGS-derived <i>env</i> sequences from mouse 1730 obtained on day 0 (top) and day 28 (bottom) based on nucleotide sequences. Indicated changes are amino acid mutations (black bars), mutations resulting in frameshifts (red hash), and nucleotide deletions (black horizontal lines) compared to YU2 wild-type sequence. Amino acid numbering on top is based on HIV-1<sub>YU2</sub>, and indicated mutations are numbered based on HIV-1<sub>HXB2</sub>.</div><div id="fspara0350" role="paragraph">(D) Serum human IgG levels in NRG mice after intravenous injection of 0.5&nbsp;mg of antibody on day 0 (left). Data are represented as mean ± standard deviation, respectively.</div><div id="fspara0355" role="paragraph">(E) HEp-2 cell reactivity using the indicated monoclonal antibodies at a concentration of 100&nbsp;μg/ml.</div></div></div></div></figcaption></figure></div><div id="p0150" role="paragraph">Following a 1-mg loading dose of antibody administered subcutaneously (s.c.), we treated HIV-1<sub>YU2</sub>-infected mice (n&nbsp;= 6–10 per group) twice a week with s.c. injections of 0.5&nbsp;mg per bNAb for 4–8&nbsp;weeks (<a id="crosref0700" href="#fig6">Figure 6</a>A). Treatment with 3BNC117, VRC01, or the combination of both bNAbs resulted in mean viral load reductions of 0.5, 0.5, and 0.7 log<sub>10</sub> copies/mL, respectively. However, these effects were only transient, and viral rebound occurred within the first 2&nbsp;weeks in most animals, indicating rapid viral escape (<a id="crosref0710" href="#fig6">Figure&nbsp;6</a>A). Indeed, when plasma single-genome sequencing (SGS) (<span class="dropBlock reference-citations"><a id="body-ref-sref82-1" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-1" aria-controls="sref82-1">Salazar-Gonzalez et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref82-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Salazar-Gonzalez, J.F. ∙ Bailes, E. ∙ Pham, K.T. ...</div><div><strong>Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing</strong></div><div><em>J.&nbsp;Virol.</em> 2008; <strong>82</strong>:3952-3970</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02660-07" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-41949124934" target="_blank" aria-label="Open Scopus in new tab">Scopus (426)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18256145/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02660-07&amp;pmid=18256145" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was performed at week 4 after the start of treatment, 79 of 82 isolated viruses from 16 mice showed mutations in the VRC01 and 3BNC117 target sites in loop D and/or the β23/V5 loop regions of gp120 (<a id="crosref0720" href="#fig6">Figures 6</a>B and <a id="crosref0725" href="#fig7">7</a>A; <a id="crosref0730" href="#mmc7">Tables S7</a>A–S7C).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/ebe4ef24-9d27-47ab-98dd-f1f026cfbd10/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2020.01.010/asset/fb630772-44b8-44d4-bfdc-e19a250c554c/main.assets/gr6.jpg" height="739" width="659" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ebe4ef24-9d27-47ab-98dd-f1f026cfbd10/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Full Suppression of Viremia by 1-18 Monotherapy <i>In&nbsp;Vivo</i></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0165" role="paragraph">(A) HIV-1 RNA plasma copies (top) and log<sub>10</sub> viral load changes compared with baseline (day -1) (bottom). Dashed lines in the top panels indicate the quantitation limit of accuracy (384 copies/mL), and data points in white indicate viral loads of less than 384 copies/mL. Red lines show average log<sub>10</sub> viral load changes compared with baseline.</div><div id="fspara0170" role="paragraph">(B) <i>Env</i> sequences obtained from day 28 plasma RNA of indicated mice by SGS. Letters indicate amino acid mutations compared with wild-type YU2 shown on top. Residues are numbered according to HIV-1<sub>HXB2</sub>.</div><div id="fspara0175" role="paragraph">See also <a id="crosref1385" href="#figs6">Figure&nbsp;S6</a> and <a id="crosref1390" href="#mmc7">Table S7</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/ba8839b2-c0d1-41e8-bd95-421854aa90c7/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2020.01.010/asset/4dc1b35a-57e1-4915-a607-38afcb6018d6/main.assets/gr7.jpg" height="934" width="695" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ba8839b2-c0d1-41e8-bd95-421854aa90c7/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">bNAb 1-18 Overcomes VRC01-Class Escape <i>In&nbsp;Vivo</i></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0185" role="paragraph">(A) Pie charts indicate the number of plasma <i>env</i> sequences obtained from HIV-1<sub>YU2</sub>-infected humanized mice on day 28 of treatment with 3BNC117, VRC01, or 3BNC117+VRC01. Icons are as in <a id="crosref1395" href="#fig6">Figure&nbsp;6</a>A. Outer bars indicate mutations in loop D and/or the β23 strand/V5 loop. <sup>∗</sup>+ G471E mutation. <sup>∗∗</sup>+ ΔT462 &amp; ΔN463 mutations.</div><div id="fspara0190" role="paragraph">(B) IC<sub>50</sub>s of 1-18 SGS-derived day 28 <i>env</i> sequence pseudoviruses with mutations as indicated in (A).</div><div id="fspara0195" role="paragraph">(C) Addition of 1-18 treatment on day 28 to HIV-1<sub>YU2</sub>-infected humanized mice that showed viral rebound during 3BNC117, VRC01, or 3BNC117+VRC01 therapy (<a id="crosref1400" href="#fig6">Figure&nbsp;6</a>A). The previous treatment regimen was continued. HIV-1 RNA plasma copies are shown at the top and log<sub>10</sub> viral load changes compared with baseline (day 28) at the bottom. Dashed lines in the top panels indicate the quantitation limit of accuracy (384 copies/mL), and data points in white indicate viral loads of less than 384 copies/mL. Red lines show average log<sub>10</sub> viral load changes compared with baseline (day 28).</div><div id="fspara0200" role="paragraph">(D) HIV-1 RNA plasma copies (left y axis) and plasma bNAb levels determined by BG505<sub>SOSIP.664</sub>-ELISA (right y axis) after interruption of bNAb therapy on day 56 as indicated in (C). Only mice that could be followed for 58&nbsp;days are included. Dashed lines indicate the HIV-1 RNA quantitation limit of accuracy (384 copies/mL). White circles show viral loads of less than 384 copies/mL, and gray circles indicate antibody levels of less than 1&nbsp;μg/mL.</div><div id="fspara0205" role="paragraph">(E) Plasma SGS-derived <i>env</i> sequences obtained on day 114. Black bars indicate amino acid mutations compared with the YU2 wild-type found previously; red bars indicate mutations only found on day 114 within individual mice. Numbering is according to HIV-1<sub>YU2</sub>. Boxes indicate IC<sub>50</sub> values of 1-18 against the corresponding pseudoviruses (right).</div><div id="fspara0210" role="paragraph">See also <a id="crosref1405" href="#mmc7">Table S7</a>.</div></div></div></div></figcaption></figure></div><div id="p0155" role="paragraph">In contrast to the transient effects of 3BNC117 and VRC01, monotherapy of HIV-1<sub>YU2</sub>-infected humanized mice with 1-18 resulted in sustained viral suppression over a period of 8&nbsp;weeks in all treated animals (average drop of 1.7 log<sub>10</sub> copies/mL; <a id="crosref0735" href="#fig6">Figure&nbsp;6</a>A). Moreover, in all but one mouse, viremia dropped to levels below the level of quantitation (384 copies/mL) by day 35. From the one mouse (1069) that had quantifiable levels of viremia but was suppressed (drop of 1.9 log<sub>10</sub> copies/mL), we analyzed HIV-1 <i>env</i> sequences at week 4 (<a id="optCOtijctU5E" href="#fig6">Figures 6</a>A and 6B). We detected no recurrent mutations at contact residues of 1-18 or typical CD4bs bNAbs, and pseudoviruses derived from these sequences remained sensitive to 1-18 (<a id="crosref0745" href="#fig6">Figure&nbsp;6</a>B; <a id="crosref0750" href="#mmc7">Table S7</a>D). These results were confirmed in an independent repeat experiment for 1-18 as well as for 1-55, another member of clone 4.1 (<a id="crosref0755" href="#figs6">Figure&nbsp;S6</a>B). Although five of six 1-18-treated mice in this experiment were fully suppressed, one mouse (1730) continued to show high HIV-1 RNA copy numbers (<a id="crosref0760" href="#figs6">Figure&nbsp;S6</a>B). However, all <i>env</i> sequences obtained from this mouse carried large V4 loop deletions as well as early stop codons (<a id="crosref0765" href="#figs6">Figure&nbsp;S6</a>C). Thus, despite detectable rebound of viremia in 1 of 18 mice treated with 1-18 or 1-55, no functional escape viruses were observed by SGS and evaluation of pseudoviruses.</div><div id="p0160" role="paragraph">Effective clinical application of bNAbs depends on favorable safety and pharmacokinetic profiles. Following a single injection of 1-18 or 1-55, their decline in serum of immunodeficient mice was slower compared with VRC01-class bNAbs and more similar to 10-1074, which has a longer half-life than 3BNC117 and VRC01 in humans (<span class="dropBlock reference-citations"><a id="body-ref-sref69-4" href="#" role="doc-biblioref" data-xml-rid="bib5 bib9 bib10 bib59 bib64 bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-4" aria-controls="sref69-4">Bar-On et&nbsp;al., 2018; Caskey et&nbsp;al., 2015, 2017; Ledgerwood et&nbsp;al., 2015; Lynch et&nbsp;al., 2015a; Mendoza et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref69-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bar-On, Y. ∙ Gruell, H. ∙ Schoofs, T. ...</div><div><strong>Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1701-1707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0186-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054012075" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0186-4&amp;pmid=30258217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Caskey, M. ∙ Schoofs, T. ∙ Gruell, H. ...</div><div><strong>Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</strong></div><div><em>Nat. Med.</em> 2017; <strong>23</strong>:185-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4268" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85009820387" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28092665/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4268&amp;pmid=28092665" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Ledgerwood, J.E. ∙ Coates, E.E. ∙ Yamshchikov, G. ..., VRC 602 Study Team</div><div><strong>Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults</strong></div><div><em>Clin. Exp. Immunol.</em> 2015; <strong>182</strong>:289-301</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cei.12692" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84946480939" target="_blank" aria-label="Open Scopus in new tab">Scopus (118)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26332605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcei.12692&amp;pmid=26332605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0770" href="#figs6">Figure&nbsp;S6</a>D). In addition, whereas some bNAbs demonstrate binding to self-antigens (<span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Haynes et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Haynes, B.F. ∙ Fleming, J. ∙ St Clair, E.W. ...</div><div><strong>Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies</strong></div><div><em>Science.</em> 2005; <strong>308</strong>:1906-1908</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1111781" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-21344434534" target="_blank" aria-label="Open Scopus in new tab">Scopus (579)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15860590/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1111781&amp;pmid=15860590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), we found no indication for autoreactivity of 1-18 or 1-55 when tested against HEp-2 cells (<a id="crosref0780" href="#figs6">Figure&nbsp;S6</a>E).</div><div id="p0165" role="paragraph">In summary, we conclude that 1-18 has exceptional antiviral <i>in&nbsp;vivo</i> activity against HIV-1<sub>YU2</sub>. This activity is superior to the CD4bs antibodies 3BNC117 and VRC01, which are currently being evaluated in clinical trials. Importantly, single bNAb therapy with 1-18 is sufficient to effectively prevent development of viral escape variants that rapidly emerge during HIV-1<sub>YU2</sub> monotherapy with other bNAbs (<span class="dropBlock reference-citations"><a id="body-ref-sref53-4" href="#" role="doc-biblioref" data-xml-rid="bib44 bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-4" aria-controls="sref53-4">Horwitz et&nbsp;al., 2013; Klein et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref53-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Horwitz, J.A. ∙ Halper-Stromberg, A. ∙ Mouquet, H. ...</div><div><strong>HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:16538-16543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1315295110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84885338257" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24043801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1315295110&amp;pmid=24043801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-2-7"><h3>1-18 Overcomes VRC01-Class Escape Mutations <i>In&nbsp;Vivo</i></h3><div id="p0170" role="paragraph">To confirm that mutations occurring during 3BNC117 and/or VRC01 therapy conferred antibody resistance, we generated 30 pseudoviruses derived from day 28 <i>env</i> sequences of 11 VRC01-class-treated mice. We found 23 viral variants that were fully resistant to the administered antibodies (IC<sub>50</sub> &gt; 25&nbsp;μg/mL) or showed increased VRC01-class resistance (&gt;5-fold increase in IC<sub>50</sub> values). Notably, however, all of these pseudoviruses remained sensitive to 1-18 <i>in&nbsp;vitro</i> (<a id="crosref0785" href="#fig7">Figure&nbsp;7</a>B; <a id="crosref0790" href="#mmc7">Table S7</a>).</div><div id="p0175" role="paragraph">To determine whether 1-18 can overcome escape from VRC01-class bNAbs <i>in&nbsp;vivo</i>, we added bNAb 1-18 therapy (1-mg loading dose s.c. followed by 0.5&nbsp;mg s.c. twice weekly) to 3BNC117- and/or VRC01-pretreated animals while continuing 3BNC117 and/or VRC01 administrations (<a id="crosref0795" href="#fig7">Figure&nbsp;7</a>C). Despite circulating VRC01-class-resistant viral variants, 1-18 effectively reduced viremia and maintained viral suppression in 17 of 18 mice (<a id="crosref0800" href="#fig7">Figure&nbsp;7</a>C). Following interruption of bNAb therapy, viral rebound occurred in all fully suppressed mice when Env-reactive&nbsp;antibody plasma concentrations declined to a median of 0.1&nbsp;μg/mL (<a id="crosref0805" href="#fig7">Figure&nbsp;7</a>D). To determine whether declining 1-18 levels resulted in selection of 1-18-resistant escape variants, we performed plasma SGS of rebound viruses 8&nbsp;weeks after treatment interruption (day 114) (<a id="crosref0810" href="#fig7">Figure&nbsp;7</a>E). Although we found novel mutations compared with day 0 and day 28 in 39 of 60 sequences from 12 mice, there was no recurrent pattern of mutations that developed after 1-18 therapy (<a id="crosref0815" href="#fig7">Figure&nbsp;7</a>E). Indeed, all 20 sequences tested as pseudoviruses were demonstrated to be fully sensitive to 1-18 (<a id="crosref0820" href="#fig7">Figure&nbsp;7</a>E; <a id="crosref0825" href="#mmc7">Table S7</a>).</div><div id="p0180" role="paragraph">We conclude that bNAb 1-18 effectively overcomes VRC01-class resistance <i>in&nbsp;vivo</i> and maintains viral suppression without the development of 1-18-resistant HIV-1<sub>YU2</sub> variants.</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0185" role="paragraph">Implementation of HIV-1-neutralizing antibodies for clinical practice requires antibodies with specific characteristics. These include safety, a favorable pharmacokinetic profile, and broad and highly potent neutralizing activity to effectively target the remarkable diversity of HIV-1 (<span class="dropBlock reference-citations"><a id="body-ref-sref11-3" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-3" aria-controls="sref11-3">Caskey et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref11-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Caskey, M. ∙ Klein, F. ∙ Nussenzweig, M.C.</div><div><strong>Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:547-553</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0412-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85063768243" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936546/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0412-8&amp;pmid=30936546" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In addition, as for any drug against HIV-1, viral escape represents one of the biggest challenges for clinical application. This became evident when (1) single bNAbs were used for therapy and HIV-1 resistance developed within a few weeks (<span class="dropBlock reference-citations"><a id="body-ref-sref89-5" href="#" role="doc-biblioref" data-xml-rid="bib4 bib9 bib10 bib53 bib64 bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89-5" aria-controls="sref89-5">Bar et&nbsp;al., 2016; Caskey et&nbsp;al., 2015, 2017; Klein et&nbsp;al., 2012; Lynch et&nbsp;al., 2015a; Scheid et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref89-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bar, K.J. ∙ Sneller, M.C. ∙ Harrison, L.J. ...</div><div><strong>Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2037-2050</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1608243" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84997817411" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1608243&amp;pmid=27959728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Caskey, M. ∙ Schoofs, T. ∙ Gruell, H. ...</div><div><strong>Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</strong></div><div><em>Nat. Med.</em> 2017; <strong>23</strong>:185-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4268" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85009820387" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28092665/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4268&amp;pmid=28092665" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Scheid, J.F. ∙ Horwitz, J.A. ∙ Bar-On, Y. ...</div><div><strong>HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption</strong></div><div><em>Nature.</em> 2016; <strong>535</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18929" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84976406858" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338952/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18929&amp;pmid=27338952" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and (2) antibody combinations resulted in improved viral control by preventing early development of resistance (<span class="dropBlock reference-citations"><a id="body-ref-sref69-5" href="#" role="doc-biblioref" data-xml-rid="bib5 bib53 bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69-5" aria-controls="sref69-5">Bar-On et&nbsp;al., 2018; Klein et&nbsp;al., 2012; Mendoza et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref69-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bar-On, Y. ∙ Gruell, H. ∙ Schoofs, T. ...</div><div><strong>Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1701-1707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0186-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054012075" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0186-4&amp;pmid=30258217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, restriction of HIV-1 escape will be an antibody-dependent feature of utmost importance for successful bNAb applications.</div><div id="p0190" role="paragraph">VRC01-class antibodies targeting the functionally critical CD4bs have broad and potent neutralizing activity but fail to prevent viral escape <i>in&nbsp;vivo</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref89-6" href="#" role="doc-biblioref" data-xml-rid="bib4 bib9 bib44 bib53 bib64 bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89-6" aria-controls="sref89-6">Bar et&nbsp;al., 2016; Caskey et&nbsp;al., 2015; Horwitz et&nbsp;al., 2013; Klein et&nbsp;al., 2012; Lynch et&nbsp;al., 2015a; Scheid et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref89-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bar, K.J. ∙ Sneller, M.C. ∙ Harrison, L.J. ...</div><div><strong>Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2037-2050</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1608243" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84997817411" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1608243&amp;pmid=27959728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Horwitz, J.A. ∙ Halper-Stromberg, A. ∙ Mouquet, H. ...</div><div><strong>HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:16538-16543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1315295110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84885338257" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24043801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1315295110&amp;pmid=24043801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Scheid, J.F. ∙ Horwitz, J.A. ∙ Bar-On, Y. ...</div><div><strong>HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption</strong></div><div><em>Nature.</em> 2016; <strong>535</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18929" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84976406858" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338952/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18929&amp;pmid=27338952" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Through a combination of functional <i>in&nbsp;vitro</i> mapping and <i>in&nbsp;vivo</i> therapy of HIV-1-infected humanized mice, we demonstrated that the V<sub>H</sub>1-46-derived CD4bs bNAb 1-18 effectively restricts development of HIV-1 resistance. Contrasting other CD4bs bNAbs, we did not identify single amino acid mutations resulting in 1-18 resistance in two viral strains of different clades (BG505, clade A; YU2, clade B). Most importantly, in the setting of viral replication and diversification in HIV-1<sub>YU2</sub>-infected humanized mice, 1-18 monotherapy resulted in effective and sustained viral suppression. Notably, the <i>in&nbsp;vivo</i> activity of 1-18 was not affected by VRC01-class-resistant viral variants. Thus, despite mutations in up to two sites associated with escape from CD4bs antibodies, 1-18 effectively suppressed viremia and restricted the development of additional escape mutations.</div><div id="p0195" role="paragraph">In our cryo-EM analysis of a 1-18-BG505 complex, the highest-resolution HIV-1 Env trimer structure obtained to date (2.5&nbsp;Å), the details of 1-18 recognition of Env were determined. The structure demonstrated that 1-18 combines favorable features found in potent V<sub>H</sub>1-2 bNAbs that likely contribute to its exceptional potency and breadth. These characteristics include (1) an aromatic residue that mimics residue Phe43 of CD4 to target the ‘Phe43<sub>gp120</sub> pocket’, as seen in bNAb N6 (<span class="dropBlock reference-citations"><a id="body-ref-sref47-4" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-4" aria-controls="sref47-4">Huang et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref47-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Huang, J. ∙ Kang, B.H. ∙ Ishida, E. ...</div><div><strong>Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth</strong></div><div><em>Immunity.</em> 2016; <strong>45</strong>:1108-1121</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84999836139" target="_blank" aria-label="Open Scopus in new tab">Scopus (116)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27851912/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.10.027&amp;pmid=27851912" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); (2) contacts with the adjacent gp120 protomer, as seen for bNAb 3BNC117 (<span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib60 bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">Lee et&nbsp;al., 2017; Lyumkis et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Lee, J.H. ∙ Andrabi, R. ∙ Su, C.Y. ...</div><div><strong>A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure</strong></div><div><em>Immunity.</em> 2017; <strong>46</strong>:690-702</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85019040760" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28423342/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2017.03.017&amp;pmid=28423342" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Lyumkis, D. ∙ Julien, J.P. ∙ de Val, N. ...</div><div><strong>Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer</strong></div><div><em>Science.</em> 2013; <strong>342</strong>:1484-1490</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1245627" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84890859441" target="_blank" aria-label="Open Scopus in new tab">Scopus (445)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24179160/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1245627&amp;pmid=24179160" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) but with increased buried surface area (via its six-residue insertion in CDRH1); and (3) a larger buried surface area on gp120 than other V<sub>H</sub>1-2 bNAbs: 1,530&nbsp;Å<sup>2</sup> compared with 1,260&nbsp;Å<sup>2</sup> (VRC01) and 1,290&nbsp;Å<sup>2</sup> (3BNC117). Finally, 1-18’s unique mode of binding enables it to make additional contacts with conserved residues on gp120 not found in other CD4bs bNAbs, allowing 1-18 to rely less on classical CD4bs bNAb contacts and making viral escape more difficult. These characteristics may explain 1-18’s exceptional potency, breadth, and resistance to viral escape. Notably, functional antigenic mapping demonstrated that 1-18-mediated selection was focused on contact residues within the CDRH1. Moreover, the lack of the CDRH1 insertion in antibodies 1-18Δins and 2-12 was associated with reduced neutralizing activity compared with 1-18.</div><div id="p0200" role="paragraph">Despite the remarkable neutralization breadth of 1-18 (covering 256 of 271 evaluated primary viruses and pseudoviruses), a small number of viruses was found to be 1-18 resistant. However, sequence analysis (<span class="dropBlock reference-citations"><a id="body-ref-sref111-3" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111-3" aria-controls="sref111-3">West et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref111-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>West, Jr., A.P. ∙ Scharf, L. ∙ Horwitz, J. ...</div><div><strong>Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:10598-10603</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1309215110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879538530" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23754383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1309215110&amp;pmid=23754383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) did not identify single residues that were associated with 1-18 resistance. In addition, we analyzed viruses from individual IDC561, from whom 1-18 was identified. Although viremia was controlled in the absence of ART for more than 15 years, it was detectable by the time of 1-18 isolation. Indeed, viruses obtained at this time showed resistance against 1-18 and clonal members (<a id="crosref0845" href="#figs7">Figure&nbsp;S7</a>). Remarkably, however, their CD4bs sequences presented with highly infrequent amino acid residues (<a id="crosref0850" href="#figs7">Figure&nbsp;S7</a>). For example, among 2,351 clade B <i>env</i> sequences in the Los Alamos HIV Sequence Database, only 0.8% carried a glycine at the loop D residue 281<sub>gp120</sub>, and not a single virus had a glutamic acid at position 474<sub>gp120</sub> (<a id="crosref0855" href="#figs7">Figure&nbsp;S7</a>). Similarly, uncommon amino acids were found in other loop D (282<sub>gp120</sub>) and V5 loop (471<sub>gp120</sub>) positions as well as at residue 208<sub>gp120</sub>, which neighbors K207<sub>gp120</sub> that strongly interacts with the CDRH1 of 1-18 (<a id="crosref0860" href="#figs7">Figure&nbsp;S7</a>). Taking the results from profiling escape pathways <i>in&nbsp;vitro</i> together with the lack of viral escape in humanized mouse experiments, the occurrence of multiple uncommon amino acid residues in 1-18-resistant viruses suggests a restricted escape pathway from 1-18 that may require accumulation of multiple rare mutations.</div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.01.010/asset/ffa05378-a5df-47fc-bb81-170494fe67ca/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2020.01.010/asset/fb6d9992-5abd-4268-bd2a-a7ceb494d86d/main.assets/figs7.jpg" height="444" width="714" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ffa05378-a5df-47fc-bb81-170494fe67ca/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Plasma SGS-Derived <i>env</i> Sequences Obtained from Donor IDC561, Related to <a id="crosref1460" href="#fig1">Figures 1</a> and <a id="crosref1465" href="#figs1">S1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0365" role="paragraph">(A) Letter heights indicate amino acid frequency among 2,351 clade B sequences obtained from the Los Alamos National Laboratory (LANL) database (top). Bottom panels show selected sites of plasma SGS-derived <i>env</i> sequences obtained from IDC561 from the leukapheresis sample from which 1-18 and 1-55 were isolated. Boxes indicate amino acids for which IDC561 consensus sequence is represented in ≤ 1% (red) or 1%–5% (blue) of the LANL clade B sequences. Numbering relative to HIV-1<sub>HXB2</sub> reference strain.</div><div id="fspara0370" role="paragraph">(B) Neutralization sensitivity of pseudoviruses based on IDC561 sequences indicated in (A). Maximum percent inhibition (MPI) determined when tested at maximum concentrations of 500&nbsp;μg/ml (purified IgG) or 25&nbsp;μg/ml (monoclonal antibodies). Plasma IgG was obtained at the time of leukapheresis from which 1-18 was isolated.</div></div></div></div></figcaption></figure></div><div id="p0205" role="paragraph">Current strategies to combine bNAbs are based on the use of&nbsp;antibodies targeting non-overlapping epitopes (<span class="dropBlock reference-citations"><a id="body-ref-sref114" href="#" role="doc-biblioref" data-xml-rid="bib5 bib6 bib48 bib53 bib69 bib95 bib114" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref114" aria-controls="sref114">Bar-On et&nbsp;al., 2018; Barouch et&nbsp;al., 2013; Huang et&nbsp;al., 2016b; Klein et&nbsp;al., 2012; Mendoza et&nbsp;al., 2018; Shingai et&nbsp;al., 2013; Xu et&nbsp;al.,&nbsp;2017</a><div class="dropBlock__holder" data-db-target-of="sref114"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bar-On, Y. ∙ Gruell, H. ∙ Schoofs, T. ...</div><div><strong>Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1701-1707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0186-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054012075" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0186-4&amp;pmid=30258217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Barouch, D.H. ∙ Whitney, J.B. ∙ Moldt, B. ...</div><div><strong>Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys</strong></div><div><em>Nature.</em> 2013; <strong>503</strong>:224-228</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature12744" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84887626950" target="_blank" aria-label="Open Scopus in new tab">Scopus (395)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24172905/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12744&amp;pmid=24172905" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Huang, Y. ∙ Yu, J. ∙ Lanzi, A. ...</div><div><strong>Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:1621-1631</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.05.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.05.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84975221851" target="_blank" aria-label="Open Scopus in new tab">Scopus (91)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27315479/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.05.024&amp;pmid=27315479" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">95.</div><div>Shingai, M. ∙ Nishimura, Y. ∙ Klein, F. ...</div><div><strong>Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia</strong></div><div><em>Nature.</em> 2013; <strong>503</strong>:277-280</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature12746" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84887627657" target="_blank" aria-label="Open Scopus in new tab">Scopus (292)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24172896/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12746&amp;pmid=24172896" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">114.</div><div>Xu, L. ∙ Pegu, A. ∙ Rao, E. ...</div><div><strong>Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques</strong></div><div><em>Science.</em> 2017; <strong>358</strong>:85-90</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aan8630" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_114_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85029757883" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28931639/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aan8630&amp;pmid=28931639" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To this end, the combination of 1-18 with bNAbs targeting other epitopes (e.g., the MPER antibody DH511.2_K3, which neutralizes 100% of tested clade C viruses; <span class="dropBlock reference-citations"><a id="body-ref-sref112" href="#" role="doc-biblioref" data-xml-rid="bib112" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref112" aria-controls="sref112">Williams et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref112"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">112.</div><div>Williams, L.D. ∙ Ofek, G. ∙ Schätzle, S. ...</div><div><strong>Potent and broad HIV-neutralizing antibodies in memory B cells and plasma</strong></div><div><em>Sci. Immunol.</em> 2017; <strong>2</strong>:eaal2200</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/sciimmunol.aal2200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28783671/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fsciimmunol.aal2200&amp;pmid=28783671" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) may be a promising option. Because the most potent known CD4bs bNAbs are of the VRC01-class, synergistic effects by combinations of these antibodies are not expected. However, given their different binding, neutralization, and escape patterns, a combination of 1-18 with VRC01-class CD4bs bNAbs may be highly beneficial. The capacity of 1-18 to overcome VRC01-class escape mutations <i>in&nbsp;vivo</i> as well as a calculated breadth of more than 99% when 1-18 is combined with VRC01-class bNAbs (e.g., N6 or 3BNC117) offers new possibilities of bNAb combinations, such as a dual anti-CD4bs therapy. Finally, CD4bs bNAbs have been demonstrated to induce escape variants with reduced viral fitness (<span class="dropBlock reference-citations"><a id="body-ref-sref85" href="#" role="doc-biblioref" data-xml-rid="bib65 bib72 bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85" aria-controls="sref85">Lynch et&nbsp;al., 2015b; Otsuka et&nbsp;al., 2018; Sather et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref85"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Lynch, R.M. ∙ Wong, P. ∙ Tran, L. ...</div><div><strong>HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2015; <strong>89</strong>:4201-4213</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.03608-14" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84925431182" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25631091/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.03608-14&amp;pmid=25631091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Otsuka, Y. ∙ Schmitt, K. ∙ Quinlan, B.D. ...</div><div><strong>Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies</strong></div><div><em>PLoS Pathog.</em> 2018; <strong>14</strong>:e1007238</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1007238" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85053086212" target="_blank" aria-label="Open Scopus in new tab">Scopus (4)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30125330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1007238&amp;pmid=30125330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Sather, D.N. ∙ Carbonetti, S. ∙ Kehayia, J. ...</div><div><strong>Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus</strong></div><div><em>J.&nbsp;Virol.</em> 2012; <strong>86</strong>:12676-12685</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.01893-12" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84869204900" target="_blank" aria-label="Open Scopus in new tab">Scopus (36)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22973035/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.01893-12&amp;pmid=22973035" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Applying double CD4bs-targeting pressure may force the virus to more extensively mutate this functionally critical epitope and, therefore, result in impaired viral variants and prolonged viral control.</div><div id="p0210" role="paragraph">In summary, by combining outstanding neutralizing activity and a high barrier for viral escape, 1-18 provides a new option for highly effective treatment and prevention of HIV-1 infection.</div></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key Resources Table</h3><div id="p0215" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>Anti-Human CD19-Alexa Fluor 700 (Clone HIB19)</td><td>BD Biosciences</td><td>Cat#557921; RRID: <a id="intref0010" href="https://antibodyregistry.org/AB_396942" target="_blank">AB_396942</a></td></tr><tr><td>Anti-Human IgG-APC (Clone G18-145)</td><td>BD Biosciences</td><td>Cat#550931; RRID: <a id="intref0015" href="https://antibodyregistry.org/AB_398478" target="_blank">AB_398478</a></td></tr><tr><td>Anti-Human CD20-Alexa Fluor 700 (Clone 2H7)</td><td>BD Biosciences</td><td>Cat#560631; RRID: <a id="intref0020" href="https://antibodyregistry.org/AB_1727447" target="_blank">AB_1727447</a></td></tr><tr><td>Anti-Human IgD-Pe-Cy7 (Clone IA6-2)</td><td>BD Biosciences</td><td>Cat#561314; RRID: <a id="intref0025" href="https://antibodyregistry.org/AB_10642457" target="_blank">AB_10642457</a></td></tr><tr><td>Anti-Human IgM-FITC (Clone G20-127)</td><td>BD Biosciences</td><td>Cat#555782; RRID: <a id="intref0030" href="https://antibodyregistry.org/AB_396117" target="_blank">AB_396117</a></td></tr><tr><td>Anti-Human CD27-PE (Clone M-T271)</td><td>BD Biosciences</td><td>Cat#560985; RRID: <a id="intref0035" href="https://antibodyregistry.org/AB_10563213" target="_blank">AB_10563213</a></td></tr><tr><td>Peroxidase AffiniPure Goat Anti-Human IgG, Fcγ fragment specific</td><td>Jackson ImmunoResearch</td><td>Cat#109-035-098; RRID: <a id="intref0040" href="https://antibodyregistry.org/AB_2337586" target="_blank">AB_2337586</a></td></tr><tr><td>AffiniPure Goat Anti-Human IgG, Fcγ fragment specific</td><td>Jackson ImmunoResearch</td><td>Cat#109-005-098; RRID: <a id="intref0045" href="https://antibodyregistry.org/AB_2337541" target="_blank">AB_2337541</a></td></tr><tr><td>Anti-6X His tag antibody</td><td>Abcam</td><td>Cat#ab9108; RRID: <a id="intref0050" href="https://antibodyregistry.org/AB_307016" target="_blank">AB_307016</a></td></tr><tr><td>IgG1, Kappa from human myeloma plasma</td><td>Sigma-Aldrich</td><td>Cat#I5154; RRID: <a id="intref0055" href="https://antibodyregistry.org/AB_1163610" target="_blank">AB_1163610</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env 3BNC117</td><td>NIH Aids Reagent Program</td><td>Cat#12474; RRID: <a id="intref0060" href="https://antibodyregistry.org/AB_2491033" target="_blank">AB_2491033</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env VRC01</td><td>NIH Aids Reagent Program</td><td>Cat#12033; RRID: <a id="intref0065" href="https://antibodyregistry.org/AB_2491019" target="_blank">AB_2491019</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env N6</td><td>NIH Aids Reagent Program</td><td>Cat#12968</td></tr><tr><td>Monoclonal anti-HIV-1 Env NIH45-46<sup>G54W</sup></td><td>NIH Aids Reagent Program</td><td>Cat#12174</td></tr><tr><td>Monoclonal anti-HIV-1 Env 2F5</td><td>NIH Aids Reagent Program</td><td>Cat#1475; RRID: <a id="intref0070" href="https://antibodyregistry.org/AB_2491015" target="_blank">AB_2491015</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env 4E10</td><td>NIH Aids Reagent Program</td><td>Cat#10091; RRID: <a id="intref0075" href="https://antibodyregistry.org/AB_2491029" target="_blank">AB_2491029</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env 10-1074</td><td>NIH Aids Reagent Program</td><td>Cat#12477; RRID: <a id="intref0080" href="https://antibodyregistry.org/AB_2491062" target="_blank">AB_2491062</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env PGDM14000</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref99-2" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-2" aria-controls="sref99-2">Sok et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref99-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Sok, D. ∙ van Gils, M.J. ∙ Pauthner, M. ...</div><div><strong>Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2014; <strong>111</strong>:17624-17629</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1415789111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_99_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84917705974" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25422458/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1415789111&amp;pmid=25422458" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Monoclonal anti-HIV-1 Env 8ANC131</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref88-3" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-3" aria-controls="sref88-3">Scheid et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref88-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Scheid, J.F. ∙ Mouquet, H. ∙ Ueberheide, B. ...</div><div><strong>Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding</strong></div><div><em>Science.</em> 2011; <strong>333</strong>:1633-1637</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1207227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-80052925616" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21764753/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1207227&amp;pmid=21764753" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Monoclonal anti-HIV-1 Env 8ANC195</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref88-4" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-4" aria-controls="sref88-4">Scheid et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref88-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Scheid, J.F. ∙ Mouquet, H. ∙ Ueberheide, B. ...</div><div><strong>Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding</strong></div><div><em>Science.</em> 2011; <strong>333</strong>:1633-1637</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1207227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-80052925616" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21764753/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1207227&amp;pmid=21764753" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID: <a id="intref0085" href="https://antibodyregistry.org/AB_2491037" target="_blank">AB_2491037</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env PGT128</td><td>NIH Aids Reagent Program</td><td>Cat#13352; RRID: <a id="intref0090" href="https://antibodyregistry.org/AB_2491047" target="_blank">AB_2491047</a></td></tr><tr><td>Monoclonal anti-HIV-1 Env 561_01_18</td><td>This paper</td><td>N/A</td></tr><tr><td>Monoclonal anti-HIV-1 Env 561_01_55</td><td>This paper</td><td>N/A</td></tr><tr><td>Monoclonal anti-HIV-1 Env 561_02_12</td><td>This paper</td><td>N/A</td></tr><tr><td>Monoclonal anti-HIV-1 Env 1-18Δins</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Monoclonal anti-HIV-1 Env Patient IDC561-derived antibodies</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Bacterial and Virus Strains</b></td></tr><tr><td>Global Panel: 12 HIV-1 Env-pseudotyped viruses</td><td>NIH Aids Reagent Program</td><td>Cat#12670</td></tr><tr><td>f61 Panel: 20 HIV-1 Env-pseudotyped viruses</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref25-2" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-2" aria-controls="sref25-2">Doria-Rose et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref25-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Doria-Rose, N.A. ∙ Altae-Tran, H.R. ∙ Roark, R.S. ...</div><div><strong>Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting</strong></div><div><em>PLoS Pathog.</em> 2017; <strong>13</strong>:e1006148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011002666" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28052137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006148&amp;pmid=28052137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Cross Clade Panel: 119 HIV-1 Env-pseudotyped viruses</td><td>M.S. Seaman, BIDMC; <span class="dropBlock reference-citations"><a id="body-ref-sref93-1" href="#" role="doc-biblioref" data-xml-rid="bib93" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref93-1" aria-controls="sref93-1">Seaman et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref93-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Seaman, M.S. ∙ Janes, H. ∙ Hawkins, N. ...</div><div><strong>Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2010; <strong>84</strong>:1439-1452</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02108-09" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-73949127978" target="_blank" aria-label="Open Scopus in new tab">Scopus (416)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19939925/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02108-09&amp;pmid=19939925" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Clade C Panel: 100 HIV-1 Env-pseudotyped viruses</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref46-1" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46-1" aria-controls="sref46-1">Hraber et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref46-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Hraber, P. ∙ Rademeyer, C. ∙ Williamson, C. ...</div><div><strong>Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments</strong></div><div><em>J.&nbsp;Virol.</em> 2017; <strong>91</strong>:e00991-17</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00991-17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85029229191" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28747500/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00991-17&amp;pmid=28747500" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Replication-competent HIV-1<sub>YU2</sub> (YU2 <i>env</i> in pNL4-3)</td><td>P.D. Bieniasz, The Rockefeller University; <span class="dropBlock reference-citations"><a id="body-ref-sref120-2" href="#" role="doc-biblioref" data-xml-rid="bib120" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref120-2" aria-controls="sref120-2">Zhang et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref120-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">120.</div><div>Zhang, Y.J. ∙ Hatziioannou, T. ∙ Zang, T. ...</div><div><strong>Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection</strong></div><div><em>J.&nbsp;Virol.</em> 2002; <strong>76</strong>:6332-6343</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.76.12.6332-6343.2002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_120_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0036100084" target="_blank" aria-label="Open Scopus in new tab">Scopus (83)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12021366/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.76.12.6332-6343.2002&amp;pmid=12021366" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>YU2-pseudotyped viruses carrying mutations in common anti-HIV-1-mAb binding sites</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref53-9" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-9" aria-controls="sref53-9">Klein et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref53-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>BG505.T332N-pseudotyped viruses carrying mutations in 1-18-selected residues</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Biological Samples</b></td></tr><tr><td>PBMCs of donor IDC561</td><td>This paper</td><td>N/A</td></tr><tr><td>IgGs of donor IDC561</td><td>This paper</td><td>N/A</td></tr><tr><td>Plasma of donor IDC561</td><td>This paper</td><td>N/A</td></tr><tr><td>Viral outgrowth culture of donor IDC561</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Placental tissue and human cord blood for isolation of human CD34+ cells</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, Peptides, and Recombinant Proteins</b></td></tr><tr><td>DMSO</td><td>Sigma-Aldrich</td><td>Cat#D2650; CAS: 67-68-5</td></tr><tr><td>DAPI</td><td>Thermo Fisher</td><td>Cat#D1306; CAS: 581-88-4</td></tr><tr><td>RC1</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref30-2" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-2" aria-controls="sref30-2">Escolano et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref30-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Escolano, A. ∙ Gristick, H.B. ∙ Abernathy, M.E. ...</div><div><strong>Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques</strong></div><div><em>Nature.</em> 2019; <strong>570</strong>:468-473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1250-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85066803291" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31142836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1250-z&amp;pmid=31142836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>BG505<sub>SOSIP.664</sub></td><td>J.P. Moore, Weill Cornell Medical College; <span class="dropBlock reference-citations"><a id="body-ref-sref83-2" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-2" aria-controls="sref83-2">Sanders et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref83-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Sanders, R.W. ∙ Derking, R. ∙ Cupo, A. ...</div><div><strong>A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies</strong></div><div><em>PLoS Pathog.</em> 2013; <strong>9</strong>:e1003618</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1003618" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84884678235" target="_blank" aria-label="Open Scopus in new tab">Scopus (436)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24068931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1003618&amp;pmid=24068931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>BG505<sub>SOSIP.664</sub>-GFP</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref97-2" href="#" role="doc-biblioref" data-xml-rid="bib97" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref97-2" aria-controls="sref97-2">Sliepen et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref97-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Sliepen, K. ∙ van Montfort, T. ∙ Ozorowski, G. ...</div><div><strong>Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer</strong></div><div><em>Biomolecules.</em> 2015; <strong>5</strong>:2919-2934</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/biom5042919" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85012065361" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26512709/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3390%2Fbiom5042919&amp;pmid=26512709" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>BG505<sub>SOSIP.664</sub>-His</td><td>J.P. Moore, Weill Cornell Medical College; <span class="dropBlock reference-citations"><a id="body-ref-sref83-3" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-3" aria-controls="sref83-3">Sanders et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref83-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Sanders, R.W. ∙ Derking, R. ∙ Cupo, A. ...</div><div><strong>A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies</strong></div><div><em>PLoS Pathog.</em> 2013; <strong>9</strong>:e1003618</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1003618" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84884678235" target="_blank" aria-label="Open Scopus in new tab">Scopus (436)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24068931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1003618&amp;pmid=24068931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>YU2<sub>gp140</sub> (fold-on trimer)</td><td>R. Wyatt, The Scripps Research Institute; <span class="dropBlock reference-citations"><a id="body-ref-sref116-2" href="#" role="doc-biblioref" data-xml-rid="bib116" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref116-2" aria-controls="sref116-2">Yang et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref116-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">116.</div><div>Yang, X. ∙ Farzan, M. ∙ Wyatt, R. ...</div><div><strong>Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins</strong></div><div><em>J.&nbsp;Virol.</em> 2000; <strong>74</strong>:5716-5725</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.74.12.5716-5725.2000" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_116_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0034087050" target="_blank" aria-label="Open Scopus in new tab">Scopus (149)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10823881/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.74.12.5716-5725.2000&amp;pmid=10823881" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>YU2<sub>gp120</sub></td><td>J. Sodroski, Dana Farber Cancer Institute</td><td>N/A</td></tr><tr><td>BAL<sub>gp140</sub></td><td><span class="dropBlock reference-citations"><a id="body-ref-sref75-1" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-1" aria-controls="sref75-1">Pietzsch et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref75-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Pietzsch, J. ∙ Scheid, J.F. ∙ Mouquet, H. ...</div><div><strong>Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2010; <strong>207</strong>:1995-2002</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20101176" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77956237048" target="_blank" aria-label="Open Scopus in new tab">Scopus (53)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20679402/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20101176&amp;pmid=20679402" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>93THO57<sub>gp120</sub></td><td><span class="dropBlock reference-citations"><a id="body-ref-sref2-1" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-1" aria-controls="sref2-1">Anderson et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref2-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Anderson, J.P. ∙ Rodrigo, A.G. ∙ Learn, G.H. ...</div><div><strong>Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E</strong></div><div><em>J.&nbsp;Virol.</em> 2000; <strong>74</strong>:10752-10765</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.74.22.10752-10765.2000" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0033766134" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11044120/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.74.22.10752-10765.2000&amp;pmid=11044120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>RSC3</td><td>N.A. Doria-Rose, VRC; <span class="dropBlock reference-citations"><a id="body-ref-sref113-3" href="#" role="doc-biblioref" data-xml-rid="bib113" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref113-3" aria-controls="sref113-3">Wu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref113-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">113.</div><div>Wu, X. ∙ Yang, Z.Y. ∙ Li, Y. ...</div><div><strong>Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1</strong></div><div><em>Science.</em> 2010; <strong>329</strong>:856-861</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1187659" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_113_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77954920017" target="_blank" aria-label="Open Scopus in new tab">Scopus (1099)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20616233/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1187659&amp;pmid=20616233" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>eOD-GT8</td><td>L. Stamatatos, Fred Hutch; <span class="dropBlock reference-citations"><a id="body-ref-sref26-1" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-1" aria-controls="sref26-1">Dosenovic et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref26-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Dosenovic, P. ∙ Pettersson, A.K. ∙ Wall, A. ...</div><div><strong>Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2316-2330</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20190446" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072985424" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31345931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20190446&amp;pmid=31345931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Streptavidin PE</td><td>BD Biosciences</td><td>Cat#349023</td></tr><tr><td>DTT</td><td>Promega</td><td>Cat#P1171</td></tr><tr><td>RNasin</td><td>Promega</td><td>Cat#N2515</td></tr><tr><td>RNaseOUT</td><td>Thermo Fisher</td><td>Cat#10777019</td></tr><tr><td>SuperScript III Reverse Transcriptase</td><td>Thermo Fisher</td><td>Cat#18080044</td></tr><tr><td>SuperScript IV Reverse Transcriptase</td><td>Thermo Fisher</td><td>Cat#18090050</td></tr><tr><td>Platinum Taq DNA Polymerase</td><td>Thermo Fisher</td><td>Cat#10966034</td></tr><tr><td>Q5 Hot Start High Fidelity DNA Polymerase</td><td>NEB</td><td>Cat#M0493L</td></tr><tr><td>Branched Polyethylenimine, 25&nbsp;kDa</td><td>Sigma-Aldrich</td><td>Cat#408727; CAS: 9002-98-6</td></tr><tr><td>FreeStyle Expression Medium</td><td>Thermo Fisher</td><td>Cat#12338001</td></tr><tr><td>Protein G Sepharose 4 Fast Flow</td><td>GE Life Sciences</td><td>Cat#17061805</td></tr><tr><td>HiTrap MabSelect Protein A column</td><td>GE Life Sciences</td><td>Cat#8408255</td></tr><tr><td>ABTS solution</td><td>Thermo Fisher</td><td>Cat#002024</td></tr><tr><td>Peroxidase streptavidin</td><td>Jackson ImmunoResearch</td><td>Cat#016-030-084</td></tr><tr><td>Platinum Taq Green Hot Start DNA Polymerase</td><td>Thermo Fisher</td><td>Cat#11966034</td></tr><tr><td>KAPA HiFI HotStart ReadyMix (2X)</td><td>Roche</td><td>Cat#KK2602</td></tr><tr><td>RNase-free DNase I</td><td>QIAGEN</td><td>Cat#79254</td></tr><tr><td>RNase H</td><td>Thermo Fisher</td><td>Cat#18021071</td></tr><tr><td>Phusion Hot Start Flex DNA Polymerase</td><td>New England Biolabs</td><td>Cat#M0535L</td></tr><tr><td>Phytohemagglutinin PHA-M</td><td>Sigma-Aldrich</td><td>Cat#L8902</td></tr><tr><td>Human IL-2, premium grade</td><td>Miltenyi Biotec</td><td>Cat#130-097-746</td></tr><tr><td>Polybrene</td><td>Sigma-Aldrich</td><td>Cat#H9268; CAS: 28728-55-4</td></tr><tr><td>FuGENE 6 Transfection Reagent</td><td>Promega</td><td>Cat#E2691</td></tr><tr><td>Taqman RNA-to-Ct 1-Step Kit</td><td>Thermo Fisher</td><td>Cat#4392938</td></tr><tr><td>Triton X-100</td><td>Carl Roth</td><td>Cat#3051.4; CAS: 9036-19-5</td></tr><tr><td>Dulbecco’s Modified Eagle Medium (DMEM)</td><td>Thermo Fisher</td><td>Cat#11960-044</td></tr><tr><td>Fetal bovine serum (FBS)</td><td>Sigma-Aldrich</td><td>Cat#F9665</td></tr><tr><td>Sodium Pyruvate</td><td>Thermo Fisher</td><td>Cat#11360-070</td></tr><tr><td>L-Glutamine</td><td>Thermo Fisher</td><td>Cat#25030024</td></tr><tr><td>Gentamicin</td><td>Sigma-Aldrich</td><td>Cat#G1397; CAS: 1405-41-0</td></tr><tr><td>ProCHO-5 media</td><td>Lonza</td><td>Cat#12-766Q</td></tr><tr><td>HEPES</td><td>Thermo Fisher</td><td>Cat#15630-080</td></tr><tr><td>GlutaMAX</td><td>Thermo Fisher</td><td>Cat#35050-061</td></tr><tr><td>MEM NEAA</td><td>Thermo Fisher</td><td>Cat#11140-050</td></tr><tr><td>Hygromycin B</td><td>Thermo Fisher</td><td>Cat#10687-010</td></tr><tr><td>Bright-Glo Luciferase Assay System</td><td>Promega</td><td>Cat#E2650</td></tr><tr><td>D-Luciferin, Sodium Salt</td><td>GoldBio</td><td>Cat#LUCNA-1G; CAS: 103404-75-7</td></tr><tr><td>IGEPAL</td><td>Sigma-Aldrich</td><td>Cat#I8896; CAS: 9002-93-1</td></tr><tr><td>ATP</td><td>Sigma-Aldrich</td><td>Cat#A26209; CAS: 34369-07-8</td></tr><tr><td>MgCl<sub>2</sub></td><td>Sigma-Aldrich</td><td>Cat#M8266; CAS: 7786-30-3</td></tr><tr><td>Coenzyme A sodium salt hydrate</td><td>Sigma-Aldrich</td><td>Cat#C3144; CAS: 55672-92-9</td></tr><tr><td>T4 DNA Polymerase</td><td>New England Biolabs</td><td>Cat#M0203L</td></tr><tr><td>Platinum Taq Green Hot Start</td><td>Thermo Fisher</td><td>Cat#11966034</td></tr><tr><td>Platinum Taq High Fidelity</td><td>Thermo Fisher</td><td>Cat#11304029</td></tr><tr><td>NP-40</td><td>Thermo Fisher</td><td>Cat#85124</td></tr><tr><td>dNTP Mix</td><td>Thermo Fisher</td><td>Cat#R1122</td></tr><tr><td>DTT</td><td>Sigma-Aldrich</td><td>Cat#GE17-1318-01</td></tr><tr><td>Ni-NTA Agarose</td><td>Macherey-Nagel</td><td>Cat#745400.25</td></tr><tr class="rowsep"><td>SMARTScribe Reverse Transcriptase</td><td>Takara Bio</td><td>Cat#639537</td></tr><tr class="rowsep"><td colspan="3"><b>Critical Commercial Assays</b></td></tr><tr class="rowsep"><td>NOVA Lite HEp-2 ANA Kit</td><td>Inova Diagnostics</td><td>Cat#708100</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited Data</b></td></tr><tr><td>1-18/10-1074/BG505SOSIP.664 coordinates</td><td>This paper</td><td>PDB: <a id="intref0095" href="http://firstglance.jmol.org/fg.htm?mol6UDJ" target="_blank">6UDJ</a></td></tr><tr><td>1-18/10-1074/BG505SOSIP.664 EM map</td><td>This paper</td><td>EMDB: EMDB-20739</td></tr><tr><td>1-55/10-1074/RC1SOSIP.664 coordinates</td><td>This paper</td><td>PDB: <a id="intref0100" href="http://firstglance.jmol.org/fg.htm?mol6UDK" target="_blank">6UDK</a></td></tr><tr><td>1-55/10-1074/RC1SOSIP.664 EM map</td><td>This paper</td><td>EMDB: EMDB-20740</td></tr><tr><td>Cloned and tested antibodies of IDC561</td><td>This paper</td><td>GenBank: MN867951 - MN868062</td></tr><tr><td>Mouse plasma SGS-derived gp160 sequences</td><td>This paper</td><td>GenBank: MN870987 - MN871327</td></tr><tr><td>IDC 561 plasma SGS-derived gp160 sequences</td><td>This paper</td><td>GenBank: MN871328 - MN871333</td></tr><tr><td>Mutational antigenic profiling analysis of 1-18</td><td>This paper</td><td><a id="intref0105" href="https://github.com/jbloomlab/MAP_118" target="_blank">https://github.com/jbloomlab/MAP_118</a></td></tr><tr class="rowsep"><td>Mutational antigenic profiling sequencing data of 1-18</td><td>This paper</td><td>SRA: SRX6752366 - SRX6752371</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Cell Lines</b></td></tr><tr><td>293-6E cells</td><td>NRC</td><td>NRC file 11565</td></tr><tr><td>HEK293T cells</td><td>ATCC</td><td>Cat#CRL-11268</td></tr><tr><td>TZM-bl cells</td><td>NIH AIDS Reagent Program; <span class="dropBlock reference-citations"><a id="body-ref-sref76-1" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76-1" aria-controls="sref76-1">Platt et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref76-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Platt, E.J. ∙ Wehrly, K. ∙ Kuhmann, S.E. ...</div><div><strong>Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1</strong></div><div><em>J.&nbsp;Virol.</em> 1998; <strong>72</strong>:2855-2864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.72.4.2855-2864.1998" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9525605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.72.4.2855-2864.1998&amp;pmid=9525605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>Cat#8129</td></tr><tr><td>SupT1-R5 cells</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref20-1" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-1" aria-controls="sref20-1">Didigu et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref20-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Didigu, C.A. ∙ Wilen, C.B. ∙ Wang, J. ...</div><div><strong>Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T&nbsp;cells from HIV-1 infection</strong></div><div><em>Blood.</em> 2014; <strong>123</strong>:61-69</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2013-08-521229" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84891772031" target="_blank" aria-label="Open Scopus in new tab">Scopus (94)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24162716/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2013-08-521229&amp;pmid=24162716" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Expi293 cells</td><td>Thermo Fisher</td><td>Cat#A14635</td></tr><tr class="rowsep"><td>Chinese Hamster Ovary (CHO) cells</td><td>J.P. Moore and A. Cupo, Weill Cornell Medical College; <span class="dropBlock reference-citations"><a id="body-ref-sref14-1" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-1" aria-controls="sref14-1">Chung et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref14-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chung, N.P. ∙ Matthews, K. ∙ Kim, H.J. ...</div><div><strong>Stable 293&nbsp;T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies</strong></div><div><em>Retrovirology.</em> 2014; <strong>11</strong>:33</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1742-4690-11-33" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84901499773" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24767177/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1742-4690-11-33&amp;pmid=24767177" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Organisms/Strains</b></td></tr><tr class="rowsep"><td>NOD.Cg-<i>Rag1</i><sup><i>tm1mom</i></sup> <i>Il2rg</i><sup><i>tm1Wjl</i></sup>/SzJ (NRG) mice</td><td>The Jackson Laboratory</td><td>Cat#007799</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>HIV-1 qPCR primer and probe set</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref44-5" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-5" aria-controls="sref44-5">Horwitz et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref44-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Horwitz, J.A. ∙ Halper-Stromberg, A. ∙ Mouquet, H. ...</div><div><strong>HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:16538-16543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1315295110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84885338257" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24043801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1315295110&amp;pmid=24043801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>SGS primer for humanized mice</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref53-10" href="#" role="doc-biblioref" data-xml-rid="bib53 bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-10" aria-controls="sref53-10">Klein et&nbsp;al., 2012; Horwitz et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref53-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Horwitz, J.A. ∙ Bar-On, Y. ∙ Lu, C.L. ...</div><div><strong>Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In&nbsp;Vivo</strong></div><div><em>Cell.</em> 2017; <strong>170</strong>:637-648.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2017.06.048&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2017.06.048&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85026236863" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28757252/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.06.048&amp;pmid=28757252" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>SGS primer for patient samples</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref91-1" href="#" role="doc-biblioref" data-xml-rid="bib52 bib91" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref91-1" aria-controls="sref91-1">Kirchherr et&nbsp;al., 2007; Schoofs et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref91-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kirchherr, J.L. ∙ Lu, X. ∙ Kasongo, W. ...</div><div><strong>High throughput functional analysis of HIV-1 env genes without cloning</strong></div><div><em>J.&nbsp;Virol. Methods.</em> 2007; <strong>143</strong>:104-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jviromet.2007.02.015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-34249336735" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17416428/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jviromet.2007.02.015&amp;pmid=17416428" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">91.</div><div>Schoofs, T. ∙ Klein, F. ∙ Braunschweig, M. ...</div><div><strong>HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:997-1001</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf0972" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84966341056" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27199429/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf0972&amp;pmid=27199429" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>CG_RT</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref73-1" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-1" aria-controls="sref73-1">Ozawa et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref73-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Ozawa, T. ∙ Kishi, H. ∙ Muraguchi, A.</div><div><strong>Amplification and analysis of cDNA generated from a single cell by 5′-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells</strong></div><div><em>Biotechniques.</em> 2006; <strong>40</strong>:469-470, 472, 474 passim</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2144/000112123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33646841994" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16629394/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2144%2F000112123&amp;pmid=16629394" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>IgG_Internal RT</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref102-1" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102-1" aria-controls="sref102-1">Tiller et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref102-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2007.09.017" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-36849031722" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17996249/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2007.09.017&amp;pmid=17996249" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>OPT5/oPR-Primer-Mix</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref54-2" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-2" aria-controls="sref54-2">Kreer et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref54-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Kreer, C. ∙ Döring, M. ∙ Lehnen, N. ...</div><div><strong>openPrimeR for multiplex amplification of highly diverse templates</strong></div><div><em>bioRxiv.</em> 2019;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/847574" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2F847574" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>Random Hexamer Primer</td><td>Thermo Fisher</td><td>Cat#SO142</td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>pSG3Δenv</td><td>NIH Aids Reagent Program</td><td>Cat#11051</td></tr><tr><td>YU2 Env expression plasmid</td><td>M.S. Seaman, BIDMC</td><td>N/A</td></tr><tr><td>pBG505.T332N Env expression plasmid</td><td>Rogier W. Sanders, Amsterdam Medical Center</td><td>N/A</td></tr><tr class="rowsep"><td>Human antibody expression vectors (IgG1, Igκ, Igλ)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref102-2" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102-2" aria-controls="sref102-2">Tiller et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref102-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2007.09.017" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-36849031722" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17996249/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2007.09.017&amp;pmid=17996249" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and Algorithms</b></td></tr><tr><td>Geneious R10 and Geneious Prime</td><td>Geneious</td><td>RRID: <a id="intref0110" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_010519" target="_blank">SCR_010519</a></td></tr><tr><td>Prism</td><td>GraphPad</td><td>RRID: <a id="intref0115" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_002798" target="_blank">SCR_002798</a></td></tr><tr><td>Neutralization fingerprinting analysis</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref25-3" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-3" aria-controls="sref25-3">Doria-Rose et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref25-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Doria-Rose, N.A. ∙ Altae-Tran, H.R. ∙ Roark, R.S. ...</div><div><strong>Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting</strong></div><div><em>PLoS Pathog.</em> 2017; <strong>13</strong>:e1006148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011002666" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28052137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006148&amp;pmid=28052137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>IgBlast</td><td>National Library of Medicine; <span class="dropBlock reference-citations"><a id="body-ref-sref117-1" href="#" role="doc-biblioref" data-xml-rid="bib117" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref117-1" aria-controls="sref117-1">Ye et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref117-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">117.</div><div>Ye, J. ∙ Ma, N. ∙ Madden, T.L. ...</div><div><strong>IgBLAST: an immunoglobulin variable domain sequence analysis tool</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:W34-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkt382" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_117_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84883563447" target="_blank" aria-label="Open Scopus in new tab">Scopus (297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23671333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkt382&amp;pmid=23671333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID: <a id="intref0120" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_002873" target="_blank">SCR_002873</a></td></tr><tr><td>Antibody Database v2.0</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref111-4" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111-4" aria-controls="sref111-4">West et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref111-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>West, Jr., A.P. ∙ Scharf, L. ∙ Horwitz, J. ...</div><div><strong>Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:10598-10603</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1309215110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879538530" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23754383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1309215110&amp;pmid=23754383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>PyMOL (Version 1.8.2.1)</td><td>Schrodinger, LLC</td><td>RRID: <a id="intref0125" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_000305" target="_blank">SCR_000305</a></td></tr><tr><td>UCSF Chimera</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref37-1" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-1" aria-controls="sref37-1">Goddard et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref37-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Goddard, T.D. ∙ Huang, C.C. ∙ Ferrin, T.E.</div><div><strong>Visualizing density maps with UCSF Chimera</strong></div><div><em>J.&nbsp;Struct. Biol.</em> 2007; <strong>157</strong>:281-287</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2006.06.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33845345287" target="_blank" aria-label="Open Scopus in new tab">Scopus (449)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16963278/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2006.06.010&amp;pmid=16963278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID: <a id="intref0130" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_004097" target="_blank">SCR_004097</a></td></tr><tr><td>APBS/PDB2PQR</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref103-1" href="#" role="doc-biblioref" data-xml-rid="bib103" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref103-1" aria-controls="sref103-1">Unni et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref103-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Unni, S. ∙ Huang, Y. ∙ Hanson, R.M. ...</div><div><strong>Web servers and services for electrostatics calculations with APBS and PDB2PQR</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2011; <strong>32</strong>:1488-1491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.21720" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-79952994820" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21425296/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.21720&amp;pmid=21425296" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>PDBePISA</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref55-1" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-1" aria-controls="sref55-1">Krissinel and Henrick, 2007</a><div class="dropBlock__holder" data-db-target-of="sref55-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Krissinel, E. ∙ Henrick, K.</div><div><strong>Inference of macromolecular assemblies from crystalline state</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2007; <strong>372</strong>:774-797</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jmb.2007.05.022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-34548232365" target="_blank" aria-label="Open Scopus in new tab">Scopus (5056)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17681537/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jmb.2007.05.022&amp;pmid=17681537" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID: <a id="intref0135" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_015749" target="_blank">SCR_015749</a></td></tr><tr><td>Local Res</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref57-1" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-1" aria-controls="sref57-1">Kucukelbir et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref57-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Kucukelbir, A. ∙ Sigworth, F.J. ∙ Tagare, H.D.</div><div><strong>Quantifying the local resolution of cryo-EM density maps</strong></div><div><em>Nat. Methods.</em> 2014; <strong>11</strong>:63-65</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2727" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84894623755" target="_blank" aria-label="Open Scopus in new tab">Scopus (678)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24213166/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2727&amp;pmid=24213166" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Coot</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref29-1" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-1" aria-controls="sref29-1">Emsley et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref29-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (11218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID: <a id="intref0140" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_014222" target="_blank">SCR_014222</a></td></tr><tr><td>Phenix</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref1-1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-1" aria-controls="sref1-1">Adams et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref1-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adams, P.D. ∙ Afonine, P.V. ∙ Bunkóczi, G. ...</div><div><strong>PHENIX: a comprehensive Python-based system for macromolecular structure solution</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:213-221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909052925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-76449098262" target="_blank" aria-label="Open Scopus in new tab">Scopus (12062)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124702/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909052925&amp;pmid=20124702" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID: <a id="intref0145" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_014224" target="_blank">SCR_014224</a></td></tr><tr><td>MolProbity</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref12-1" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-1" aria-controls="sref12-1">Chen et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref12-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Chen, V.B. ∙ Arendall, 3rd, W.B. ∙ Headd, J.J. ...</div><div><strong>MolProbity: all-atom structure validation for macromolecular crystallography</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:12-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909042073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-74549178560" target="_blank" aria-label="Open Scopus in new tab">Scopus (7139)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20057044/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909042073&amp;pmid=20057044" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>RRID: <a id="intref0150" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_014226" target="_blank">SCR_014226</a></td></tr><tr><td>Python (Version 3)</td><td>Python Software Foundation</td><td>RRID: <a id="intref0155" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_008394" target="_blank">SCR_008394</a></td></tr><tr><td>SciPy</td><td>SciPy developers</td><td>RRID: <a id="intref0160" href="https://scicrunch.org/resources/Any/search?q=undefined&amp;l=SCR_008058" target="_blank">SCR_008058</a></td></tr><tr><td>Dms_tools2 (Version 2.5.1)</td><td><a id="intref0165" href="https://jbloomlab.github.io/dms_tools2/" target="_blank">https://jbloomlab.github.io/dms_tools2/</a>; <span class="dropBlock reference-citations"><a id="body-ref-sref7-1" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-1" aria-controls="sref7-1">Bloom, 2015</a><div class="dropBlock__holder" data-db-target-of="sref7-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bloom, J.D.</div><div><strong>Software for the analysis and visualization of deep mutational scanning data</strong></div><div><em>BMC Bioinformatics.</em> 2015; <strong>16</strong>:168</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12859-015-0590-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84930207201" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25990960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12859-015-0590-4&amp;pmid=25990960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>HIV Assembler</td><td>T.Y. Oliveira, The Rockefeller University; <span class="dropBlock reference-citations"><a id="body-ref-sref31-1" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-1" aria-controls="sref31-1">Gaebler et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref31-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gaebler, C. ∙ Lorenzi, J.C.C. ∙ Oliveira, T.Y. ...</div><div><strong>Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2253-2264</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20190896" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072992920" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31350309/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20190896&amp;pmid=31350309" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Other</b></td></tr><tr><td>Pan B Cell Isolation Kit, human</td><td>Miltenyi Biotec</td><td>Cat#131-101-638</td></tr><tr><td>B Cell Isolation Kit II, human</td><td>Miltenyi Biotec</td><td>Cat#130-091-151</td></tr><tr><td>IgG<sup>+</sup> Memory B Cell Isolation Kit, human</td><td>Miltenyi Biotec</td><td>Cat#130-094-350</td></tr><tr><td>EZ Link Sulfo NHS Biotin and Labeling Kit</td><td>Thermo Fisher</td><td>Cat#21326</td></tr><tr><td>QuikChange II XL Site-Directed Mutagenesis Kit</td><td>Agilent</td><td>Cat#200521</td></tr><tr><td>Q5 Site-Directed Mutagenesis Kit</td><td>New England Biolabs</td><td>Cat#E0554S</td></tr><tr><td>Nextera DNA Library Prep Kit</td><td>Illumina</td><td>Cat#FC-121-1031</td></tr><tr><td>Nextera Index Kit</td><td>Illumina</td><td>Cat#FC-121-1012</td></tr><tr><td>AMPure XP Beads</td><td>Beckman Coulter</td><td>Cat#A63880</td></tr><tr><td>MiSeq Reagent Nano Kit v2 (300-cycles)</td><td>Illumina</td><td>Cat#MS-103-1002</td></tr><tr><td>MiSeq Reagent Kit v3 (600-cycle)</td><td>Illumina</td><td>Cat#MS-102-3003</td></tr><tr><td>MinElute Virus Spin Kit</td><td>QIAGEN</td><td>Cat#57704</td></tr><tr><td>CD4<sup>+</sup> T Cell Isolation Kit, human</td><td>Miltenyi Biotec</td><td>Cat#130-096-533</td></tr><tr><td>CD8 MicroBeads, human</td><td>Miltenyi Biotec</td><td>Cat#130-045-201</td></tr><tr><td>CD34 MicroBeads, human</td><td>Miltenyi Biotec</td><td>Cat#130-046-703</td></tr><tr><td>CD19 MicroBeads, human</td><td>Miltenyi Biotec</td><td>Cat#130-050-301</td></tr><tr><td>Superdex-200 Increase 10/300 Column</td><td>GE Life Sciences</td><td>Cat#28990944</td></tr><tr><td>HiLoad Superdex-200 16/60 Column</td><td>GE Life Sciences</td><td>Cat#28989335</td></tr><tr><td>IGHV 1-46<sup>∗</sup>1 sequence</td><td>GenBank</td><td>X92343.1</td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2820%2930057-X" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Lead Contact and Materials Availability</h3><div id="p0220" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Florian Klein (<a id="intref0170" href="mailto:florian.klein@uk-koeln.de">florian.klein@uk-koeln.de</a>). Nucleotide sequences of all generated antibodies were deposited at GenBank, and expression plasmids for 1-18, 1-55, 2-12, and clonal members will be shared upon request.</div></section><section id="sec-4-3"><h3>Experimental Model and Subject Details</h3><section id="sec-4-3-1"><h4>Human Subjects</h4><div id="p0225" role="paragraph">Blood and leukapheresis samples were obtained under protocols approved by the Institutional Review Board of the University of Cologne (protocols 13-364 and 16-054) and the local IRBs. All participants provided written informed consent. Participants of the neutralization screening cohort are recruited at hospitals and/or private practices in Germany (Cologne, Essen, and Frankfurt), Cameroon (Yaoundé), Nepal (Kathmandu), and Tanzania (Mbeya). At the time of leukapheresis, IDC561 was a 48-year-old male who was diagnosed with HIV-1 infection 21 years earlier. He was recruited at the University Hospital Cologne. PBMCs for bulk viral outgrowth cultures were obtained from individuals recruited in Germany (Cologne).</div></section><section id="sec-4-3-2"><h4>Mouse Models</h4><div id="p0230" role="paragraph">NOD.Cg-<i>Rag1</i><sup><i>tm1mom</i></sup><i>Il2rg</i><sup><i>tm1Wjl</i></sup>/SzJ (NRG) mice were purchased at The Jackson Laboratory and bred and maintained at the Decentralized Animal Husbandry Network (Dezentrales Tierhaltungsnetzwerk) of the University of Cologne under specific pathogen-free (SPF) conditions with 12-hour light/dark cycles. For breeding purposes, mice were provided with ssniff 1124 breeding feed; for experimental purposes, mice were provided with ssniff 1543 maintenance feed. Humanized mice were generated as previously described with modifications (<span class="dropBlock reference-citations"><a id="body-ref-sref53-11" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-11" aria-controls="sref53-11">Klein et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref53-11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, human CD34<sup>+</sup> hematopoietic stem cells were isolated from cord blood and perfused placental tissues using CD34 microbeads (Miltenyi Biotec). Collection of cord blood and placental tissues was conducted under a protocol approved by the Institutional Review Board of the University of Cologne (16-110), and all donors provided written informed consent. NRG mice were sublethally irradiated within 5&nbsp;days of birth and intrahepatically injected with purified human CD34<sup>+</sup> stem cells 4 to 6 hours later. Success of humanization was determined approximately 12&nbsp;weeks later by FACS analysis of blood for human PBMCs. All mouse experiments were authorized by the State Agency for Nature, Environmental Protection, and Consumer Protection North Rhine-Westphalia (LANUV).</div></section><section id="sec-4-3-3"><h4>Cell Lines</h4><div id="p0235" role="paragraph">HEK293T cells (American Type Culture Collection) were maintained at 37°C and 5% CO<sub>2</sub> in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich), 1&nbsp;mM sodium pyruvate, 2&nbsp;mM L-glutamine, and 1x antibiotic-antimycotic (all from Thermo Fisher). TZM-bl cells (<span class="dropBlock reference-citations"><a id="body-ref-sref76-2" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76-2" aria-controls="sref76-2">Platt et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref76-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Platt, E.J. ∙ Wehrly, K. ∙ Kuhmann, S.E. ...</div><div><strong>Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1</strong></div><div><em>J.&nbsp;Virol.</em> 1998; <strong>72</strong>:2855-2864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.72.4.2855-2864.1998" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9525605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.72.4.2855-2864.1998&amp;pmid=9525605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) were maintained at 37°C in 5% CO<sub>2</sub> in DMEM supplemented with 10% FBS, 1&nbsp;mM sodium pyruvate, 2&nbsp;mM L-glutamine, 50&nbsp;μg/ml gentamicin (Merck), and 25&nbsp;mM HEPES (Millipore). 293-6E cells (National Research Council of Canada) were maintained at 37°C and 6% CO<sub>2</sub> in FreeStyle Expression Medium (Thermo Fisher) and kept under constant shaking at 90-120&nbsp;rpm. Expi293 cells (Thermo Fisher) were maintained at 37°C and 8% CO<sub>2</sub> in Expi293 Expression medium (Thermo Fisher) and kept under constant shaking at 130&nbsp;rpm. CHO cells were maintained at 37°C and 5% CO2 in ProCHO-5 media (Lonza) supplemented with 0.1&nbsp;M HEPES, 1x GlutaMAX, 1x MEM NEAA, 1&nbsp;mM sodium pyruvate, and 0.5&nbsp;mg/ml hygromycin B (all from Thermo Fisher). SupT1-R5 cells (<span class="dropBlock reference-citations"><a id="body-ref-sref20-2" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-2" aria-controls="sref20-2">Didigu et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref20-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Didigu, C.A. ∙ Wilen, C.B. ∙ Wang, J. ...</div><div><strong>Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T&nbsp;cells from HIV-1 infection</strong></div><div><em>Blood.</em> 2014; <strong>123</strong>:61-69</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2013-08-521229" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84891772031" target="_blank" aria-label="Open Scopus in new tab">Scopus (94)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24162716/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2013-08-521229&amp;pmid=24162716" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) were maintained at 37°C and 5% CO<sub>2</sub> in RPMI 1640 supplemented with 300&nbsp;mg/l L-glutamine (Thermo Fisher), 10% FBS (Sigma-Aldrich), and 1% penicillin/streptomycin (Thermo Fisher). The sex of HEK293T, TZM-bl, 293-6E, Expi293, and CHO cell lines is female, and the sex of SupT1-R5 cells is male. Cell lines were not specifically authenticated.</div></section></section><section id="sec-4-4"><h3>Method Details</h3><section id="sec-4-4-1"><h4>Clinical Samples</h4><div id="p0240" role="paragraph">Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient centrifugation and stored at −150°C in 90% FBS and 10% DMSO (Sigma-Aldrich) until further use. Plasma and serum samples were stored at −80°C until further use.</div></section><section id="sec-4-4-2"><h4>Serum and Plasma IgG Isolation</h4><div id="p0245" role="paragraph">Serum and plasma samples were heat-inactivated (56°C for 40&nbsp;min) and incubated with Protein G Sepharose (GE Life Sciences) overnight at 4°C. IgGs were eluted from Protein G in chromatography columns using 0.1&nbsp;M glycine (pH&nbsp;= 3.0) and buffered in 1&nbsp;M Tris (pH&nbsp;= 8.0). Subsequently, buffer exchange to PBS and antibody concentration was performed using Amicon 30&nbsp;kDa spin membranes (Millipore). Purified IgGs were stored at 4°C until further use.</div></section><section id="sec-4-4-3"><h4>Single Cell Sort</h4><div id="p0250" role="paragraph">B cells were isolated from PBMCs using the Pan B Cell Isolation Kit, B Cell Isolation Kit II, or IgG<sup>+</sup> Memory B Cell Isolation Kit (Miltenyi Biotec). Isolated cells were labeled with anti-human CD19-AF700 (BD), anti-human IgG-APC (BD), DAPI (Thermo Fisher), and the respective HIV-1 Env bait for 30&nbsp;minutes on ice. BG505<sub>SOSIP.664</sub>-GFP or biotinylated YU2<sub>gp140</sub> that was labeled with Streptavidin-PE (BD) were used as HIV-1 Env baits. Env-reactive CD19<sup>+</sup>IgG<sup>+</sup>DAPI<sup>-</sup> single cells were sorted into 96-well plates containing 4&nbsp;μl of lysis buffer (0.5x PBS, 10&nbsp;mM DTT (Thermo Fisher), 2&nbsp;U/μl RNasin (Promega), and 1&nbsp;U/μl RNaseOUT (Thermo Fisher)) per well using a BD FACSAria Fusion. Plates were stored at −80°C until further use.</div></section><section id="sec-4-4-4"><h4>Single Cell cDNA Synthesis and PCR</h4><div id="p0255" role="paragraph">Sorted cells were incubated with 0.75&nbsp;μl Random Hexamer Primer (Thermo Fisher), 0.5&nbsp;μl NP-40 (Thermo Fisher), and 5.6&nbsp;μl RNase-free H<sub>2</sub>O for 1&nbsp;min at 65°C. Subsequently, 3&nbsp;μl of 5x RT Buffer (Thermo Fisher), 0.5&nbsp;μl dNTPs mix (25&nbsp;mM, Thermo Fisher), 1&nbsp;μl DTT (100&nbsp;mM, Sigma Aldrich), 2.05&nbsp;μl of RNase-free H<sub>2</sub>O, 0.1&nbsp;μl RNasin (40&nbsp;U/μl, Promega), 0.1&nbsp;μl RNaseOUT (40&nbsp;U/μl, Promega), and 0.25&nbsp;μl Superscript IV (200&nbsp;U/μl, Thermo Fisher) were added and samples were incubated at 42°C for 10&nbsp;min, 25°C for 10&nbsp;min, 50°C for 10&nbsp;min, and 94°C for 5&nbsp;min. Antibody sequences for single cell analysis were amplified by semi-nested PCRs using Platinum Taq DNA Polymerase or Platinum Taq Green Hot Start DNA Polymerase (Thermo Fisher) and previously described primers, including the novel OPT5/oPR-primer set optimized for detection of highly mutated IgG sequences (<span class="dropBlock reference-citations"><a id="body-ref-sref54-3" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-3" aria-controls="sref54-3">Kreer et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref54-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Kreer, C. ∙ Döring, M. ∙ Lehnen, N. ...</div><div><strong>openPrimeR for multiplex amplification of highly diverse templates</strong></div><div><em>bioRxiv.</em> 2019;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/847574" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2F847574" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), using the OPT5/oPR-primer mix and CG_RT 5′-AGGTGTGCACGCCGCTGGTC (<span class="dropBlock reference-citations"><a id="body-ref-sref73-2" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-2" aria-controls="sref73-2">Ozawa et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref73-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Ozawa, T. ∙ Kishi, H. ∙ Muraguchi, A.</div><div><strong>Amplification and analysis of cDNA generated from a single cell by 5′-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells</strong></div><div><em>Biotechniques.</em> 2006; <strong>40</strong>:469-470, 472, 474 passim</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2144/000112123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33646841994" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16629394/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2144%2F000112123&amp;pmid=16629394" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) for the 1<sup>st</sup> PCR, and the OPT5/oPR-primer mix and IgG_Internal RT 5′-GTTCGGGGAAGTAGTCCTTGAC (<span class="dropBlock reference-citations"><a id="body-ref-sref102-3" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102-3" aria-controls="sref102-3">Tiller et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref102-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2007.09.017" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-36849031722" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17996249/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2007.09.017&amp;pmid=17996249" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) for the 2<sup>nd</sup> PCR. First-round PCR was run at 94°C for 2&nbsp;min; followed by 50 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 55 s. Second-round PCR was run at 94°C for 2&nbsp;min; followed by 50 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 45 s. Second-round PCR products were sequenced by Sanger sequencing and used for further sequence analyses.</div></section><section id="sec-4-4-5"><h4>Antibody Sequence Analysis</h4><div id="p0260" role="paragraph">Sequences with a mean Phred score ≥ 28 and a minimal length of 240 nucleotides were annotated with IgBLAST (<span class="dropBlock reference-citations"><a id="body-ref-sref117-2" href="#" role="doc-biblioref" data-xml-rid="bib117" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref117-2" aria-controls="sref117-2">Ye et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref117-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">117.</div><div>Ye, J. ∙ Ma, N. ∙ Madden, T.L. ...</div><div><strong>IgBLAST: an immunoglobulin variable domain sequence analysis tool</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:W34-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkt382" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_117_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84883563447" target="_blank" aria-label="Open Scopus in new tab">Scopus (297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23671333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkt382&amp;pmid=23671333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and trimmed from framework region (FWR) 1 of the variable region to the end of the J gene. Base calls with a Phred score&nbsp;&lt; 16 were masked and sequences with &gt; 15 masked nucleotides, frameshifts, or stop codons were excluded from further analyses. To analyze the sequences for potential clonalities, all productive heavy chain sequences were grouped by identical V genes and the pairwise Levenshtein distance of their CDRH3s was determined. Individual sequences were grouped into clones when they shared the same V gene and had a minimal CDRH3 identity of 75%. After 10 rounds with a randomized input of sequences, the result that yielded the lowest number of unassigned (non-clonal) sequences was selected for further analyses. All clones were re-validated manually by the investigators in order to identify shared mutations. Sequences that were initially assigned to different clones but shared the same VDJ genes and amino acid and/or silent nucleotide mutations were subsequently grouped into subclones. Nucleotide sequence identity to germline was calculated using IgBLAST. The maximum-likelihood phylogenetic tree in <a id="crosref1080" href="#fig1">Figure&nbsp;1</a>D was generated using nucleotide sequences of heavy-chain V genes (FWRH1-FWRH3) of subclones 4.1, 4.2, 4.3, and 4.4 (n&nbsp;= 86 sequences) and of the IGHV1-46<sup>∗</sup>01 <i>Homo sapiens</i> allele (GenBank <a id="intref0175" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=X92343.1" target="_blank">X92343.1</a>). All sequences were aligned using ClustalW (Geneious R10; cost matrix: IUB; gap open cost: 15; gap extend cost: 6.66) and the maximum-likelihood phylogenetic tree was calculated using PhyML with 1,000 bootstrap replicates (<span class="dropBlock reference-citations"><a id="body-ref-sref40" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40" aria-controls="sref40">Guindon et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Guindon, S. ∙ Dufayard, J.F. ∙ Lefort, V. ...</div><div><strong>New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0</strong></div><div><em>Syst. Biol.</em> 2010; <strong>59</strong>:307-321</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/sysbio/syq010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77950806408" target="_blank" aria-label="Open Scopus in new tab">Scopus (7702)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20525638/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fsysbio%2Fsyq010&amp;pmid=20525638" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (substitution model: general time reversible [GTR]; Geneious R10). The best-scoring tree was then rooted to IGHV1-46<sup>∗</sup>01.</div></section><section id="sec-4-4-6"><h4>Antibody Cloning and Production</h4><div id="p0265" role="paragraph">For cloning of single cell-derived antibodies, the 1<sup>st</sup> PCR product of single cell-PCR was used as template and amplified using Q5 Hot Start High Fidelity DNA Polymerase (New England Biolabs) and specific forward- and reverse primers that resembled the respective nucleotide sequence of the V- and J-regions (<span class="dropBlock reference-citations"><a id="body-ref-sref102-4" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102-4" aria-controls="sref102-4">Tiller et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref102-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2007.09.017" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-36849031722" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17996249/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2007.09.017&amp;pmid=17996249" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) with expression vector overhangs for subsequent sequence and ligation independent cloning (SLIC). PCR was run at 98°C for 30 s; 35 cycles of 98°C for 10 s, 65°C for 30 s, and 72°C for 30 s; and 72°C for 2&nbsp;min. 561_01_18_ΔINS was generated by cloning a synthesized (Eurofins Genomics) heavy-chain variable region DNA fragment of 1-18 lacking the CDRH1 insertion (<sup>28</sup>PYTDDD<sup>33</sup>). PCR products or synthesized DNA fragments were cloned into human antibody expression vectors (IgG1, kappa, or lambda chain) by SLIC assembly as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref105" href="#" role="doc-biblioref" data-xml-rid="bib105" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref105" aria-controls="sref105">von Boehmer et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref105"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">105.</div><div>von Boehmer, L. ∙ Liu, C. ∙ Ackerman, S. ...</div><div><strong>Sequencing and cloning of antigen-specific antibodies from mouse memory B cells</strong></div><div><em>Nat. Protoc.</em> 2016; <strong>11</strong>:1908-1923</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2016.102" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_105_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84988632777" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27658009/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2016.102&amp;pmid=27658009" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Antibodies were produced in 293-6E cells (National Research Council Canada) by transfection using 25&nbsp;kDa branched polyethylenimine (PEI) (Sigma-Aldrich). Cells were maintained at 37°C and 6% CO2 in FreeStyle 293 Expression Medium (Thermo Fisher) and 0.2% penicillin/streptomycin (Thermo Fisher). 5-7&nbsp;days after transfection, culture supernatants were harvested, filtered, and incubated with Protein G Sepharose (GE Life Sciences) overnight at 4°C. Antibodies were eluted from chromatography columns using 0.1&nbsp;M glycine (pH&nbsp;= 3.0) and buffered in 1&nbsp;M Tris (pH&nbsp;= 8.0). Subsequent buffer exchange to PBS and antibody concentration was performed using Amicon 30&nbsp;kDa spin membranes (Millipore). Antibodies were filter-sterilized using Ultrafree-CL or Ultrafree-MC 0.22&nbsp;μm membranes (Millipore) and stored at 4°C.</div></section><section id="sec-4-4-7"><h4>Pseudovirus Production</h4><div id="p0270" role="paragraph">Pseudoviruses for the 12-strain global screening panel and f61 finger printing panel were produced in HEK293T cells by co-transfection with pSG3ΔEnv plasmid as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref93-2" href="#" role="doc-biblioref" data-xml-rid="bib25 bib46 bib84 bib93" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref93-2" aria-controls="sref93-2">Doria-Rose et&nbsp;al., 2017; Hraber et&nbsp;al., 2017; Sarzotti-Kelsoe et&nbsp;al., 2014; Seaman et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref93-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Doria-Rose, N.A. ∙ Altae-Tran, H.R. ∙ Roark, R.S. ...</div><div><strong>Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting</strong></div><div><em>PLoS Pathog.</em> 2017; <strong>13</strong>:e1006148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011002666" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28052137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006148&amp;pmid=28052137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Hraber, P. ∙ Rademeyer, C. ∙ Williamson, C. ...</div><div><strong>Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments</strong></div><div><em>J.&nbsp;Virol.</em> 2017; <strong>91</strong>:e00991-17</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00991-17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85029229191" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28747500/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00991-17&amp;pmid=28747500" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Sarzotti-Kelsoe, M. ∙ Bailer, R.T. ∙ Turk, E. ...</div><div><strong>Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2014; <strong>409</strong>:131-146</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2013.11.022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84906084946" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24291345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2013.11.022&amp;pmid=24291345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Seaman, M.S. ∙ Janes, H. ∙ Hawkins, N. ...</div><div><strong>Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2010; <strong>84</strong>:1439-1452</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02108-09" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-73949127978" target="_blank" aria-label="Open Scopus in new tab">Scopus (416)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19939925/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02108-09&amp;pmid=19939925" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Single genome sequencing (SGS)-derived pseudoviruses were generated by co-transfection of SGS-derived CMV promoter-Env products and pSG3ΔEnv as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref52-2" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52-2" aria-controls="sref52-2">Kirchherr et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref52-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kirchherr, J.L. ∙ Lu, X. ∙ Kasongo, W. ...</div><div><strong>High throughput functional analysis of HIV-1 env genes without cloning</strong></div><div><em>J.&nbsp;Virol. Methods.</em> 2007; <strong>143</strong>:104-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jviromet.2007.02.015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-34249336735" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17416428/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jviromet.2007.02.015&amp;pmid=17416428" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For sequences obtained from mice, <i>env/rev</i> cassettes were amplified from the first-round SGS PCR product using primers env1Atopo 5′-CACCGGCTTAGGCATCTCCTATGGCAGGAAGAA and envB3in 5′-CACCTTAGGCATCTCCTATGGCAGGAAGAAG. Pseudoviruses were only produced from sequences containing no ambiguities. For patient-derived sequences, <i>env/rev</i> cassettes were amplified from the first-round SGS product using primers env1Atopo and Rev19 5′-ACTTTTTGACCACTTGCCACCCAT. CMV promoter and <i>env/rev</i> overlap PCR was performed using primers CMVenv 5′-AGTAATCAATTACGGGGTCATTAGTTCAT and Rev19. Mouse-derived sequences were amplified using the Platinum Taq High Fidelity Polymerase (Thermo Fisher), patient-derived sequences using the Phusion Hot Start Flex Polymerase (New England Biolabs).</div></section><section id="sec-4-4-8"><h4>Neutralization Assays</h4><div id="p0275" role="paragraph">Neutralization assays were performed as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref84-3" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84-3" aria-controls="sref84-3">Sarzotti-Kelsoe et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref84-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Sarzotti-Kelsoe, M. ∙ Bailer, R.T. ∙ Turk, E. ...</div><div><strong>Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2014; <strong>409</strong>:131-146</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2013.11.022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84906084946" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24291345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2013.11.022&amp;pmid=24291345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, pseudoviruses and dilution series of antibodies or purified IgG were mixed and co-incubated at 37°C for 1 h, followed by the addition of TZM-bl cells at a final concentration of 10<sup>4</sup> cells per well on a 96-well plate in 250&nbsp;μl medium supplemented with DEAE-dextran at a final concentration of 10&nbsp;μg/ml. Following a 2-day incubation at 37°C and 5% CO<sub>2</sub>, 150&nbsp;μl of culture supernatant was removed and 100&nbsp;μl luciferase assay reagent was added. After a 2&nbsp;min incubation, 150&nbsp;μl of lysate was transferred to a black microtiter assay plate and luminescence was determined using a luminometer. After subtracting background relative luminescence units (RLUs) of non-infected TZM-bl cells, 50% and 80% inhibitory concentrations (IC<sub>50</sub>s and IC<sub>80</sub>s) were determined as the antibody/IgG concentrations resulting in a 50%/80% RLU reduction compared to untreated virus control wells. Murine leukemia virus (MuLV)-pseudotyped virus was used to determine unspecific activity. Initial screening of isolated antibody clonal members was performed using a single dilution series per antibody. Antibodies or purified serum IgG in all further neutralization assays were tested in duplicates. For screening assays, assays against culture-derived viruses, assays of pseudovirus mutant variants, and assays of IDC561-derived pseudoviruses, bioluminescence was determined after adding a luciferin/lysis-buffer (10&nbsp;mM MgCl2, 0.3&nbsp;mM ATP, 0.5 mM Coenzyme A, 17&nbsp;mM IGEPAL (all&nbsp;Sigma-Aldrich), and 1 mM D-Luciferin (GoldBio) in Tris-HCL). For assays against the 119-pseudovirus panel, the 100-pseudovirus clade C panel, and the f61 panel, bioluminescence was determined after adding Bright-Glo reagent (Promega).</div></section><section id="sec-4-4-9"><h4>Neutralization Fingerprinting Panel-Based Antibody Epitope Prediction</h4><div id="p0280" role="paragraph">Computational epitope prediction of serum IgG neutralizing activity was conducted as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref25-5" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-5" aria-controls="sref25-5">Doria-Rose et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref25-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Doria-Rose, N.A. ∙ Altae-Tran, H.R. ∙ Roark, R.S. ...</div><div><strong>Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting</strong></div><div><em>PLoS Pathog.</em> 2017; <strong>13</strong>:e1006148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011002666" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28052137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006148&amp;pmid=28052137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, neutralizing serum IgG activity was determined against the 20 pseudoviruses included in the f61 fingerprinting panel by a TZM-bl cell neutralization assay as described above. The determined IgG neutralization fingerprint is compared to the fingerprint of 10 bNAbs picked as reference for their specific epitope, and the prevalence of these reference antibody epitope specificities is computationally predicted and assigned a delineation score between 0 (low) and 1 (high).</div></section><section id="sec-4-4-10"><h4>HIV-1 Envelope Protein Production and Purification</h4><div id="p0285" role="paragraph">YU2<sub>gp120</sub>, YU2<sub>gp140</sub> (foldon trimer), and BaL<sub>gp140</sub> (foldon trimer) (<span class="dropBlock reference-citations"><a id="body-ref-sref75-2" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75-2" aria-controls="sref75-2">Pietzsch et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref75-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Pietzsch, J. ∙ Scheid, J.F. ∙ Mouquet, H. ...</div><div><strong>Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2010; <strong>207</strong>:1995-2002</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20101176" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77956237048" target="_blank" aria-label="Open Scopus in new tab">Scopus (53)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20679402/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20101176&amp;pmid=20679402" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) were produced in 293-6E cells after transfection with polyethylenimine. Proteins were purified from culture supernatants using Ni-NTA Agarose beads (Macherey-Nagel) according to the manufacturer’s instructions and stored at −80°C until further use after buffer exchange to PBS. eOD-GT8 was produced as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref26-2" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-2" aria-controls="sref26-2">Dosenovic et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref26-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Dosenovic, P. ∙ Pettersson, A.K. ∙ Wall, A. ...</div><div><strong>Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2316-2330</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20190446" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072985424" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31345931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20190446&amp;pmid=31345931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). 93THO527 (<span class="dropBlock reference-citations"><a id="body-ref-sref2-2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-2" aria-controls="sref2-2">Anderson et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref2-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Anderson, J.P. ∙ Rodrigo, A.G. ∙ Learn, G.H. ...</div><div><strong>Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E</strong></div><div><em>J.&nbsp;Virol.</em> 2000; <strong>74</strong>:10752-10765</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.74.22.10752-10765.2000" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0033766134" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11044120/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.74.22.10752-10765.2000&amp;pmid=11044120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was produced in 293-6E cells in the presence of kifunensine at a concentration of 1&nbsp;mg/l.</div></section><section id="sec-4-4-11"><h4>HIV-1 Env ELISAs</h4><div id="p0290" role="paragraph">High-binding ELISA plates (Corning) were coated with HIV-1 Env antigens at 2&nbsp;μg/ml in PBS overnight at 4°C. Wells were blocked with 3% BSA (Sigma Aldrich) in PBS for 60&nbsp;min at 37°C. HIV-1 antibodies were diluted in PBS and incubated for 60&nbsp;min at RT, followed by horseradish peroxidase (HRP)-conjugated anti-human IgG (Jackson ImmunoResearch) diluted 1:1,000 in 3% BSA in PBS for 60&nbsp;min at room temperature (RT). Absorbance was determined on a microplate reader (Tecan) after addition of ABTS solution (Thermo Fisher). Plates were washed with 0.05% Tween 20 (Carl Roth) in PBS between each step.</div></section><section id="sec-4-4-12"><h4>Competition ELISAs</h4><div id="p0295" role="paragraph">Antibodies of interest were biotinylated using the EZ Link Sulfo NHS Biotin and Labeling Kit (Thermo Fisher) according to the manufacturer’s instructions, followed by a buffer exchange to PBS using Amicon 10&nbsp;kDa centrifugation filter membranes (Millipore). High-binding ELISA plates (Corning) were coated with anti-6x His tag antibody (Abcam) at 2&nbsp;μg/ml overnight at 4°C. Wells were blocked with 3% BSA in PBS for 60&nbsp;min at 37°C, and incubated with BG505<sub>SOSIP.664</sub>-His at 2&nbsp;μg/ml in PBS for 60&nbsp;min at 37°C. Competing antibodies were incubated in a 1:3 dilution series starting at a concentration of 32&nbsp;μg/ml in PBS for 60&nbsp;min at RT. Biotinylated antibodies of interest were diluted to 0.5&nbsp;μg/ml in 3% BSA in PBS and incubated for 60&nbsp;min at RT, followed by peroxidase-streptavidin (Jackson ImmunoResearch) diluted 1:5,000 in 1% BSA/0.05%Tween 20 in PBS. Absorbance at 415&nbsp;nm was determined on a microplate reader (Tecan) after addition of ABTS solution (Thermo Fisher). Plates were washed with 0.05% Tween 20 in PBS between each step.</div></section><section id="sec-4-4-13"><h4>Generation of HIV-1<sub>YU2</sub> and HIV-1<sub>BG505</sub> Pseudovirus Mutants</h4><div id="p0300" role="paragraph">Point mutations were introduced into HIV-1<sub>YU2</sub> and HIV-1<sub>BG505</sub> envelope expression plasmids using either the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent) or the Q5 Site-Directed Mutagenesis Kit (New England Biolabs). Pseudoviruses were produced as described above.</div></section><section id="sec-4-4-14"><h4>Recombinant HIV-1 Production</h4><div id="p0305" role="paragraph">Replication-competent recombinant HIV-1 (YU2 <i>env</i> in NL4-3 backbone (<span class="dropBlock reference-citations"><a id="body-ref-sref120-3" href="#" role="doc-biblioref" data-xml-rid="bib120" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref120-3" aria-controls="sref120-3">Zhang et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref120-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">120.</div><div>Zhang, Y.J. ∙ Hatziioannou, T. ∙ Zang, T. ...</div><div><strong>Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection</strong></div><div><em>J.&nbsp;Virol.</em> 2002; <strong>76</strong>:6332-6343</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.76.12.6332-6343.2002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_120_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0036100084" target="_blank" aria-label="Open Scopus in new tab">Scopus (83)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12021366/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.76.12.6332-6343.2002&amp;pmid=12021366" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)) was produced by transfection of HEK293T cells using FuGENE 6 Transfection Reagent (Promega). Harvested viral supernatants were stored at −80°C to −150°C.</div></section><section id="sec-4-4-15"><h4>HIV-1-Infected Humanized Mice and Viral Load Measurements</h4><div id="p0310" role="paragraph">Humanized NRG mice were challenged with replication-competent HIV-1 intraperitoneally. HIV-1-infected mice were treated using 0.22&nbsp;μm-filtered monoclonal antibodies diluted in PBS, starting 25–26 days after viral challenge. Antibodies were injected subcutaneously. Following a 1-mg loading dose per antibody, doses of 0.5&nbsp;mg per antibody were injected every 3-4&nbsp;days. Plasma RNA was extracted from EDTA plasma samples using the MinElute Virus Mini Spin Kit (QIAGEN), including an on-column DNase I (QIAGEN) digestion step. Viral loads were determined by quantitative real-time PCR using <i>pol</i>-specific primers 5′-TAATGGCAGCAATTTCACCA and 5′-GAATGCCAAATTCCTGCTTGA, and&nbsp;5′-/56-FAM/CCCACCAACARGCRGCCTTAACTG/ZenDQ/ as probe, as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref44-6" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-6" aria-controls="sref44-6">Horwitz et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref44-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Horwitz, J.A. ∙ Halper-Stromberg, A. ∙ Mouquet, H. ...</div><div><strong>HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:16538-16543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1315295110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84885338257" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24043801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1315295110&amp;pmid=24043801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). qPCR was performed on a LightCycler 480 II (Roche) using the Taqman RNA-to-Ct 1-Step-Kit (Thermo Fisher). An HIV-1<sub>YU2</sub> standard produced by infection of SupT1-R5 cells was included for every PCR run, and HIV-1 copy number of the standard was determined using the quantitative cobas 6800 HIV-1 kit (Roche). The limit of accuracy of the qPCR was determined as 384 copies/ml. Log<sub>10</sub> changes for viral loads&nbsp;&lt; 384 copies/ml were calculated by assigning a copy number of 383 copies/ml.</div></section><section id="sec-4-4-16"><h4>Humanized Mouse Plasma RNA-Derived Single Genome Sequencing</h4><div id="p0315" role="paragraph">Single genome sequencing has been described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref82-2" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-2" aria-controls="sref82-2">Salazar-Gonzalez et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref82-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Salazar-Gonzalez, J.F. ∙ Bailes, E. ∙ Pham, K.T. ...</div><div><strong>Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing</strong></div><div><em>J.&nbsp;Virol.</em> 2008; <strong>82</strong>:3952-3970</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02660-07" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-41949124934" target="_blank" aria-label="Open Scopus in new tab">Scopus (426)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18256145/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02660-07&amp;pmid=18256145" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Plasma RNA was extracted using the MinElute Virus Spin Kit (QIAGEN), including a DNase I (QIAGEN) digestion step. cDNA was generated from plasma RNA using the antisense primer YB383 5′-TTTTTTTTTTTTTTTTTTTTTTTTRAAGCAC (<span class="dropBlock reference-citations"><a id="body-ref-sref45-2" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-2" aria-controls="sref45-2">Horwitz et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Horwitz, J.A. ∙ Bar-On, Y. ∙ Lu, C.L. ...</div><div><strong>Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In&nbsp;Vivo</strong></div><div><em>Cell.</em> 2017; <strong>170</strong>:637-648.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2017.06.048&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2017.06.048&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85026236863" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28757252/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.06.048&amp;pmid=28757252" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and Superscript IV (Thermo Fisher) according to the manufacturer’s protocol, followed by incubation with 0.25&nbsp;U/μl RNase H (Thermo Fisher) at 37°C for 20&nbsp;min. <i>Env</i> cDNA was subsequently amplified by nested PCR at dilutions that yield&nbsp;&lt; 30% positive PCR reactions so that &gt; 80% of positive reactions would be amplified from a single virion (based on Poisson distribution). First-round PCR was conducted using primers YB383 5′-TTTTTTTTTTTTTTTTTTTTTTTTRAAGCAC and YB50 5′-GGCTTAGGCATCTCCTATGGCAGGAAGAA, and run at 94°C for 2&nbsp;min; 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 4&nbsp;min; and 72°C for 15&nbsp;min. 1&nbsp;μL of first-round PCR product was used as template for the second-round PCR that was conducted using primers YB49 5′-TAGAAAGAGCAGAAGACAGTGGCAATGA and YB52 5′-GGTGTGTAGTTCTGCCAATCAGGGAAGWAGCCTTGTG, and run at 94°C for 2&nbsp;min; 45 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 4&nbsp;min; and 72°C for 15&nbsp;min. PCR was performed using the Platinum Taq Green Hot Start DNA Polymerase (Thermo Fisher) or Phusion Hot Start Flex DNA Polymerase (New England Biolabs).</div></section><section id="sec-4-4-17"><h4>Illumina Dye Sequencing of Humanized Mouse SGS-Derived <i>env</i> Amplicons</h4><div id="p0320" role="paragraph">Libraries of purified PCR products were prepared for Illumina dye sequencing as described before with modifications (<span class="dropBlock reference-citations"><a id="body-ref-sref91-2" href="#" role="doc-biblioref" data-xml-rid="bib56 bib91" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref91-2" aria-controls="sref91-2">Kryazhimskiy et&nbsp;al., 2014; Schoofs et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref91-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Kryazhimskiy, S. ∙ Rice, D.P. ∙ Jerison, E.R. ...</div><div><strong>Microbial evolution. Global epistasis makes adaptation predictable despite sequence-level stochasticity</strong></div><div><em>Science.</em> 2014; <strong>344</strong>:1519-1522</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1250939" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84903291815" target="_blank" aria-label="Open Scopus in new tab">Scopus (149)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24970088/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1250939&amp;pmid=24970088" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">91.</div><div>Schoofs, T. ∙ Klein, F. ∙ Braunschweig, M. ...</div><div><strong>HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:997-1001</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf0972" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84966341056" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27199429/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf0972&amp;pmid=27199429" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, PCR products were cleaved by tagmentation using the Nextera DNA Library Prep Kit (Illumina). Indices (Nextera Index Kit, Illumina) were added by limited cycle PCR using the KAPA HiFi HotStart ReadyMix (Roche), followed by adaptor addition (P1, 5′-AATGATACGGCGACCACCGA; P2, 5′-CAAGCAGAAGACGGCATACGA) by limited cycle PCR using the KAPA HiFi HotStart ReadyMix. PCR products were purified using AMPure XP beads (Beckman Coulter), pooled, and sequenced using the MiSeq 300-cycle Nano Kit v2 (Illumina) spiked with approximately 10% PhiX. Paired-end reads were assembled as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref31-2" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-2" aria-controls="sref31-2">Gaebler et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref31-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gaebler, C. ∙ Lorenzi, J.C.C. ∙ Oliveira, T.Y. ...</div><div><strong>Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2253-2264</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20190896" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072992920" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31350309/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20190896&amp;pmid=31350309" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For further analyses, a consensus sequence was generated and nucleotides with&nbsp;&lt; 75% identity across reads were defined as ambiguities. Only full-length envelope sequences with high base call quality, less than 10 ambiguities, and no early stop-codons (unless due to ambiguities) were analyzed. Otherwise acceptable sequences showing ambiguities resulting in stop-codons or a frameshift were corrected manually.</div></section><section id="sec-4-4-18"><h4>Human Plasma RNA-Derived Single Genome Sequencing</h4><div id="p0325" role="paragraph">Plasma RNA was extracted using the MinElute Virus Spin Kit (QIAGEN), including a DNase I (QIAGEN) digestion step. cDNA was generated using the antisense primer envB3out 5′-TTGCTACTTGTGATTGCTCCATGT and SuperScript III Reverse Transcriptase (Thermo Fisher), followed by an RNase H digest (Thermo Fisher). <i>Env</i> cDNA was subsequently amplified as described previously with modifications (<span class="dropBlock reference-citations"><a id="body-ref-sref82-3" href="#" role="doc-biblioref" data-xml-rid="bib69 bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-3" aria-controls="sref82-3">Mendoza et&nbsp;al., 2018; Salazar-Gonzalez et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref82-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Salazar-Gonzalez, J.F. ∙ Bailes, E. ∙ Pham, K.T. ...</div><div><strong>Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing</strong></div><div><em>J.&nbsp;Virol.</em> 2008; <strong>82</strong>:3952-3970</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02660-07" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-41949124934" target="_blank" aria-label="Open Scopus in new tab">Scopus (426)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18256145/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02660-07&amp;pmid=18256145" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). PCR was performed using the Phusion Hot Start Flex DNA Polymerase (New England Biolabs). First-round PCR was run at 98°C for 45 s; 35 cycles of 98°C for 15 s, 55°C for 30 s, and 72°C for 4&nbsp;min; and 72°C for 15&nbsp;min. 1&nbsp;μL of first-round PCR product was used as template for the second-round PCR which was run at 98°C for 45 s; 45 cycles of 98°C for 15 s, 55°C for 30 s, and 72°C for 4&nbsp;min; and 72°C for 15&nbsp;min. Purified PCR products were sequenced using Sanger sequencing and analyzed using Geneious software (Geneious).</div></section><section id="sec-4-4-19"><h4>Bulk Viral Outgrowth Cultures</h4><div id="p0330" role="paragraph">CD4<sup>+</sup> T&nbsp;cells were isolated from PBMCs of HIV-1-infected individuals using the CD4<sup>+</sup> T&nbsp;cell isolation MACS kit (Miltenyi Biotec) and stimulated by co-culture with irradiated (50 Gy) healthy donor PBMCs in T&nbsp;cell medium (RPMI 1640 supplemented with 300&nbsp;mg/l L-glutamine (Thermo Fisher), 10% FBS (Sigma-Aldrich), and 1% penicillin/streptomycin (Thermo Fisher)) in the presence of 1&nbsp;μg/ml PHA-M (Sigma-Aldrich) and 100&nbsp;U/ml interleukin-2 (IL-2) (Miltenyi Biotec). One day later, medium was changed to T&nbsp;cell medium supplemented with 100&nbsp;U/ml IL-2 and 5&nbsp;μg/ml polybrene (Sigma-Aldrich). In addition, healthy donor PBMCs were added that had been stimulated for two days in T&nbsp;cell medium supplemented with 1&nbsp;μg/ml PHA-M and 100&nbsp;U/ml IL-2. Before addition, donor PBMCs were depleted of CD8<sup>+</sup> T&nbsp;cells using CD8 MACS microbeads (Miltenyi Biotec). Additional CD8<sup>+</sup> T&nbsp;cell-depleted donor PBMCs were added weekly. Culture supernatants were monitored for p24 production using the Architect HIV Ag/Ab combo assay (Abbott), and p24-positive culture supernatants were stored at −80°C to −150°C after harvesting.</div></section><section id="sec-4-4-20"><h4><i>In&nbsp;vivo</i> Antibody Pharmacokinetic Analysis</h4><div id="p0335" role="paragraph">NOD.Cg-<i>Rag1</i><sup><i>tm1mom</i></sup> <i>Il2rg</i><sup><i>tm1Wjl</i></sup>/SzJ mice (The Jackson Laboratory) aged 33-42&nbsp;weeks were intravenously injected (tail vein) with 0.5&nbsp;mg of purified antibody in PBS. Total serum concentrations of human IgG were determined by ELISA as previously described with minor modifications (<span class="dropBlock reference-citations"><a id="body-ref-sref53-12" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-12" aria-controls="sref53-12">Klein et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref53-12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, high-binding ELISA plates (Corning) were coated with anti-human IgG (Jackson ImmunoResearch) at a concentration of 2.5&nbsp;μg/ml overnight at RT. Subsequently, wells were blocked with blocking buffer (2% BSA (Carl Roth), 1&nbsp;μM EDTA (Thermo Fisher), and 0.1% Tween 20 (Carl Roth) in PBS). To generate a standard curve, human IgG1 kappa purified from myeloma plasma (Sigma-Aldrich) was diluted in PBS. Serial dilutions of the IgG standard (in duplicates)&nbsp;and serum samples in PBS were incubated for 90&nbsp;min at RT, followed by HRP-conjugated anti-human IgG (Jackson ImmunoResearch) diluted 1:1,000 in blocking buffer for 90&nbsp;min at RT. Following the addition of ABTS (Thermo Fisher), optical density at 415&nbsp;nm was determined using a microplate reader (Tecan). Plates were washed with 0.05% Tween 20 in PBS between each step. Serum samples obtained before the antibody injection confirmed baseline absence of human serum IgG.</div><div id="p0340" role="paragraph">For determination of bNAb-levels following treatment interruption in HIV-1-infected humanized mice, high-binding ELISA plates (Corning) were coated overnight with BG505<sub>SOSIP.664</sub> at a concentration of 2&nbsp;μg/ml at 4°C. Subsequently, wells were blocked with 3% BSA in PBS for 5&nbsp;h at RT. Plasma samples were inactivated in 1% Triton X-100 (Carl Roth) for 1&nbsp;h at RT. Triton X-100-treated 1-18 diluted in PBS was used as standard in duplicates. Serial dilutions of plasma samples in PBS and standard were incubated for 90&nbsp;min at RT, followed by HRP-conjugated anti-human IgG (Jackson ImmunoResearch) diluted 1:2,000 in 3% BSA in PBS for 90&nbsp;min at RT. Following the addition of ABTS (Thermo Fisher), optical density at 415&nbsp;nm was determined using a microplate reader (Tecan). Plates were washed with 0.05% Tween 20 in PBS between each step.</div></section><section id="sec-4-4-21"><h4>HEp-2 Cell Assay</h4><div id="p0345" role="paragraph">HEp-2 cell autoreactivity analysis was performed using the NOVA Lite Hep-2 ANA Kit (Inova Diagnostics) according to the manufacturer’s instructions using monoclonal antibodies at a concentration of 100&nbsp;μg/ml in PBS. Images were acquired using a DMI 6000 B&nbsp;fluorescence microscope (Leica) with 3&nbsp;s exposure at 100% intensity and gain 10.</div></section><section id="sec-4-4-22"><h4>Unbiased B Cell Repertoire Analyses</h4><div id="p0350" role="paragraph">B cells were isolated from PBMCs using CD19 microbeads (Miltenyi Biotec) and stained with DAPI (Thermo Fisher), CD20-AF 700, IgG-APC, IgD-Pe-Cy7, IgM-FITC, and CD27-PE (all BD Biosciences) for 30&nbsp;min on ice. 200,000 CD20<sup>+</sup>IgG<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD27<sup>-</sup> B cells were sorted into FBS (Sigma-Aldrich) using a BD FACSAria Fusion, and RNA of sorted B cells was isolated with the RNeasy Micro Kit (QIAGEN). cDNA was generated by template-switch reverse transcription according to the SMARTer RACE 5′/3′ manual using the SMARTScribe Reverse Transcriptase (Takara) with a template-switch oligo including an 18-nucleotide unique molecular identifier. Heavy-chain variable regions were amplified with an IgG-specific nested PCR and amplicons were used for library preparation and MiSeq 2x300&nbsp;bp sequencing (Illumina). Raw NGS reads were pre-processed and assembled to final sequences as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Ehrhardt et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Ehrhardt, S.A. ∙ Zehner, M. ∙ Krähling, V. ...</div><div><strong>Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1589-1600</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0602-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85074202467" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31591605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0602-4&amp;pmid=31591605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-23"><h4>Mutational Antigenic Profiling</h4><div id="p0355" role="paragraph">Mutational antigenic profiling has been previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref22-6" href="#" role="doc-biblioref" data-xml-rid="bib21 bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-6" aria-controls="sref22-6">Dingens et&nbsp;al., 2017, 2019</a><div class="dropBlock__holder" data-db-target-of="sref22-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Dingens, A.S. ∙ Haddox, H.K. ∙ Overbaugh, J. ...</div><div><strong>Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody</strong></div><div><em>Cell Host Microbe.</em> 2017; <strong>21</strong>:777-787.e4</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.chom.2017.05.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.chom.2017.05.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85020234897" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28579254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2017.05.003&amp;pmid=28579254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, 5x10<sup>5</sup> infectious units of two independently generated HIV-1<sub>BG505</sub> mutant virus libraries (<span class="dropBlock reference-citations"><a id="body-ref-sref42-2" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-2" aria-controls="sref42-2">Haddox et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref42-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Haddox, H.K. ∙ Dingens, A.S. ∙ Hilton, S.K. ...</div><div><strong>Mapping mutational effects along the evolutionary landscape of HIV envelope</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e34420</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.34420" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29590010/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.34420&amp;pmid=29590010" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) were neutralized with both 4&nbsp;μg/ml or 8&nbsp;μg/ml of 1-18 for one hour. Neutralized libraries were then used to infect 1x10<sup>6</sup> SupT1.CCR5 cells in R10 (RPMI (GE Life Sciences) supplemented with 10% FBS, 2&nbsp;mM L-glutamine, and 100&nbsp;U/ml of penicillin and streptomycin) containing 100&nbsp;μg/ml DEAE-dextran. Three hours post infection, the cells were resuspended in 1&nbsp;mL R10. At twelve hours post infection, the non-integrated viral cDNA was isolated from cells via a miniprep. Each mutant virus library was also subjected to a mock selection, and four 10-fold serial dilutions of each mutant virus library were infected into 1x10<sup>6</sup> cells to serve as an infectivity standard curve from which the overall fraction of the library that survived antibody neutralization was quantified using qPCR (<span class="dropBlock reference-citations"><a id="body-ref-sref22-7" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-7" aria-controls="sref22-7">Dingens et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref22-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Viral cDNA from antibody- and mock-selected samples was then sequenced on an Illumina MiSeq using the previously described barcoded subamplicon sequencing approach (<span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Haddox et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Haddox, H.K. ∙ Dingens, A.S. ∙ Bloom, J.D.</div><div><strong>Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV’s Envelope Protein on Viral Replication in Cell Culture</strong></div><div><em>PLoS Pathog.</em> 2016; <strong>12</strong>:e1006114</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006114" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85008164772" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006114&amp;pmid=27959955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Details on the analysis of the resulting data are provided in the <a id="crosref1180" href="#sec-4-5">Quantification and Statistical Analysis</a> and <a id="crosref1185" href="#sec-4-6">Data and Code Availability</a> subsections below.</div></section><section id="sec-4-4-24"><h4>Protein Expression and Purification for Cryo-EM Structures</h4><div id="p0360" role="paragraph">1-18 IgG was expressed by transient transfection in Expi293 cells (Thermo Fisher) and purified from transfected cell supernatants using a HiTrap MabSelect Protein A column (GE Life Sciences). Fab fragments were isolated as described (<span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">Diskin et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Diskin, R. ∙ Scheid, J.F. ∙ Marcovecchio, P.M. ...</div><div><strong>Increasing the potency and breadth of an HIV antibody by using structure-based rational design</strong></div><div><em>Science.</em> 2011; <strong>334</strong>:1289-1293</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1213782" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-82755184131" target="_blank" aria-label="Open Scopus in new tab">Scopus (271)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22033520/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1213782&amp;pmid=22033520" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) after papain cleavage of 1-18 IgG, removal of Fc by protein A chromatography, and then purification by size exclusion chromatography (SEC) on a Superdex-200 Increase 10/300 column (GE Life Sciences) equilibrated with TBS (20&nbsp;mM Tris pH 8.0, 150&nbsp;mM NaCl). 1-55 Fab was expressed as a light-chain C-terminal His<sub>6</sub>-tagged Fab by transient transfection in 293-6E cells (National Research Council of Canada) and purified from supernatants using Ni<sup>2+</sup>-NTA affinity chromatography (GE Life Sciences) followed by SEC purification with a Superdex-200 Increase 10/300 column equilibrated with TBS. All Fabs were stored at 4°C.</div><div id="p0365" role="paragraph">BG505<sub>SOSIP.664</sub> trimer was stably expressed in Chinese hamster ovary cells (kind gift of J.P. Moore and A. Cupo) as described (<span class="dropBlock reference-citations"><a id="body-ref-sref14-2" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-2" aria-controls="sref14-2">Chung et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref14-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chung, N.P. ∙ Matthews, K. ∙ Kim, H.J. ...</div><div><strong>Stable 293&nbsp;T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies</strong></div><div><em>Retrovirology.</em> 2014; <strong>11</strong>:33</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1742-4690-11-33" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84901499773" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24767177/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1742-4690-11-33&amp;pmid=24767177" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and purified from cell culture supernatant over a 2G12 immunoaffinity column followed by SEC purification on a Superdex-200 16/60 column (GE Life Sciences) equilibrated with TBS. RC1<sub>SOSIP.664</sub> was expressed by transient transfection in 293-6E cells and purified as described (<span class="dropBlock reference-citations"><a id="body-ref-sref30-3" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-3" aria-controls="sref30-3">Escolano et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref30-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Escolano, A. ∙ Gristick, H.B. ∙ Abernathy, M.E. ...</div><div><strong>Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques</strong></div><div><em>Nature.</em> 2019; <strong>570</strong>:468-473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1250-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85066803291" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31142836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1250-z&amp;pmid=31142836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Individual SEC fractions of each SOSIP trimer were stored at 4°C.</div></section><section id="sec-4-4-25"><h4>Cryo-EM Sample Preparation</h4><div id="p0370" role="paragraph">1-18 or 1-55 Fab and 10-1074 Fab were incubated with BG505<sub>SOSIP.664</sub> or RC1 in a 3:3:1 molar ratio per protomer overnight at room temperature and then purified by SEC on a Superdex-200 Increase 10/300 column. Fab–Env complexes were concentrated to 2.2&nbsp;mg/ml (1-18 complex) or 0.75&nbsp;mg/mL (1-55 complex) in TBS, and 3&nbsp;μL was added to a Quantifoil grid (R2/2 Cu 400 mesh for the 1-18 complex and R1.2/1.3 Cu 300 mesh for 1-55 complex; Electron Microscopy Services) that had been freshly glow-discharged using a PELCO easiGLOW (Ted Pella). Samples were vitrified in 100% liquid ethane using a Mark IV Vitrobot (Thermo Fisher) after blotting for 3-3.5&nbsp;s with Whatman No. 1 filter paper at 22°C and 100% humidity.</div></section><section id="sec-4-4-26"><h4>Cryo-EM Data Collection and Processing</h4><div id="p0375" role="paragraph">For the 1-18–BG505–10-1074 complex, micrographs were collected on a Titan Krios transmission electron microscope (Thermo Fisher) operating at 300 kV using EPU automated software (Thermo Fisher). Movies were obtained on a Gatan K2 Summit direct electron detector operating in counting mode at a nominal magnification of 130,000x (1.057&nbsp;Å/pixel calibrated) using a defocus range of&nbsp;−1 to −2.6&nbsp;μm. Movies were collected with an 8&nbsp;s exposure time with a rate of 8 e<sup>-</sup>/pix/s, which resulted in a total dose of ~60&nbsp;e<sup>-</sup>/Å<sup>2</sup> over 40 fractions. Movies were motion corrected including dose-weighting using Motioncor2 (<span class="dropBlock reference-citations"><a id="body-ref-sref121" href="#" role="doc-biblioref" data-xml-rid="bib121" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref121" aria-controls="sref121">Zheng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref121"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">121.</div><div>Zheng, S.Q. ∙ Palovcak, E. ∙ Armache, J.P. ...</div><div><strong>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:331-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4193" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_121_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85014129582" target="_blank" aria-label="Open Scopus in new tab">Scopus (955)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28250466/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4193&amp;pmid=28250466" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) within Relion-3 (<span class="dropBlock reference-citations"><a id="body-ref-sref126" href="#" role="doc-biblioref" data-xml-rid="bib126" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref126" aria-controls="sref126">Zivanov et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref126"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">126.</div><div>Zivanov, J. ∙ Nakane, T. ∙ Forsberg, B.O. ...</div><div><strong>New tools for automated high-resolution cryo-EM structure determination in RELION-3</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e42166</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.42166" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_126_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85056950318" target="_blank" aria-label="Open Scopus in new tab">Scopus (297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30412051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.42166&amp;pmid=30412051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The non-dose-weighted images were used for CTF estimation using Gctf (<span class="dropBlock reference-citations"><a id="body-ref-sref119" href="#" role="doc-biblioref" data-xml-rid="bib119" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref119" aria-controls="sref119">Zhang, 2016</a><div class="dropBlock__holder" data-db-target-of="sref119"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">119.</div><div>Zhang, K.</div><div><strong>Gctf: Real-time CTF determination and correction</strong></div><div><em>J.&nbsp;Struct. Biol.</em> 2016; <strong>193</strong>:1-12</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2015.11.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_119_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84955216953" target="_blank" aria-label="Open Scopus in new tab">Scopus (701)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26592709/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2015.11.003&amp;pmid=26592709" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and micrographs with power spectra that showed poor CTF fits or signs of crystalline ice were discarded. Particles were then picked in a reference-free manner using the Laplacian-of-Gaussian auto-picking function in Relion-3. A total of 352,598 particles were extracted, binned 4x4 (4.23&nbsp;Å/pixel), and subjected to reference-free 2D classification in Relion-3. Particles corresponding to good classes were re-extracted and un-binned (1.057&nbsp;Å/pixel). An <i>ab initio</i> volume was generated in cryoSPARC (<span class="dropBlock reference-citations"><a id="body-ref-sref77" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77" aria-controls="sref77">Punjani et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref77"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Punjani, A. ∙ Rubinstein, J.L. ∙ Fleet, D.J. ...</div><div><strong>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:290-296</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011645437" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28165473/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4169&amp;pmid=28165473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) from micrographs that were collected from the same grid in a Talos Arctica that was used as an initial model for homogeneous 3D-refinement in Relion 3 (assuming C1 symmetry). Particles were then subjected to 3D classification (C1 symmetry), and classes with low-resolution features were removed. Selected classes that appeared 3-fold symmetric were thus subjected to homogeneous 3D refinement assuming C3 symmetry with a soft mask applied that did not include the Fab C<sub>H</sub>C<sub>L</sub> domains. Per-particle motion correction and CTF refinement were performed in Relion-3, followed by a final homogeneous 3D refinement. A masked post-processed volume of 230,924 particles resulted in a gold-standard FSC (GSFSC) calculation of 2.5&nbsp;Å (<span class="dropBlock reference-citations"><a id="body-ref-sref90" href="#" role="doc-biblioref" data-xml-rid="bib90" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref90" aria-controls="sref90">Scheres and Chen, 2012</a><div class="dropBlock__holder" data-db-target-of="sref90"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">90.</div><div>Scheres, S.H. ∙ Chen, S.</div><div><strong>Prevention of overfitting in cryo-EM structure determination</strong></div><div><em>Nat. Methods.</em> 2012; <strong>9</strong>:853-854</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2115" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84866078359" target="_blank" aria-label="Open Scopus in new tab">Scopus (510)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22842542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2115&amp;pmid=22842542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0380" role="paragraph">For the 1-55–RC1–10-1074 complex, data collection on a Thermo Fisher 200 kV Talos Arctica cryo-electron microscope equipped with a Falcon 3EC camera, and 10-1074 interactions with RC1 were previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref30-4" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-4" aria-controls="sref30-4">Escolano et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref30-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Escolano, A. ∙ Gristick, H.B. ∙ Abernathy, M.E. ...</div><div><strong>Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques</strong></div><div><em>Nature.</em> 2019; <strong>570</strong>:468-473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1250-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85066803291" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31142836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1250-z&amp;pmid=31142836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For analysis of the 1-55–RC1 interaction, we reprocessed the data using Relion-3, following a similar procedure as described above for the 1-18–BG505–10-1074 complex. Compared to the original reconstruction, per-particle motion correction and CTF refinement were done in Relion-3, followed by a final homogeneous 3D refinement. A masked post-processed volume of 110,126 particles resulted in a GSFSC calculation of 3.9&nbsp;Å.</div></section><section id="sec-4-4-27"><h4>Structure Modeling and Refinement</h4><div id="p0385" role="paragraph">Initial coordinates were generated by docking individual chains from reference structures into cryo-EM density using UCSF Chimera (<span class="dropBlock reference-citations"><a id="body-ref-sref37-2" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-2" aria-controls="sref37-2">Goddard et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref37-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Goddard, T.D. ∙ Huang, C.C. ∙ Ferrin, T.E.</div><div><strong>Visualizing density maps with UCSF Chimera</strong></div><div><em>J.&nbsp;Struct. Biol.</em> 2007; <strong>157</strong>:281-287</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2006.06.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33845345287" target="_blank" aria-label="Open Scopus in new tab">Scopus (449)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16963278/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2006.06.010&amp;pmid=16963278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The following PDB coordinates were used: gp120: 5T3Z; gp41: 6MTJ; 10-1074: 5T3Z; 1-18 and 1-55: 4RWY. These initial models were then refined into cryo-EM maps using one round of rigid body refinement followed by real space refinement. Sequence-updated models were built manually in Coot (<span class="dropBlock reference-citations"><a id="body-ref-sref29-2" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29-2" aria-controls="sref29-2">Emsley et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref29-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (11218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and then refined using iterative rounds of refinement in Coot and Phenix (<span class="dropBlock reference-citations"><a id="body-ref-sref1-2" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-2" aria-controls="sref1-2">Adams et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref1-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adams, P.D. ∙ Afonine, P.V. ∙ Bunkóczi, G. ...</div><div><strong>PHENIX: a comprehensive Python-based system for macromolecular structure solution</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:213-221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909052925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-76449098262" target="_blank" aria-label="Open Scopus in new tab">Scopus (12062)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124702/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909052925&amp;pmid=20124702" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Glycans were modeled at PNGSs in Coot using ‘blurred’ maps processed with a variety of B-factors (<span class="dropBlock reference-citations"><a id="body-ref-sref101" href="#" role="doc-biblioref" data-xml-rid="bib101" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref101" aria-controls="sref101">Terwilliger et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref101"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">101.</div><div>Terwilliger, T.C. ∙ Sobolev, O.V. ∙ Afonine, P.V. ...</div><div><strong>Automated map sharpening by maximization of detail and connectivity</strong></div><div><em>Acta Crystallogr. D Struct. Biol.</em> 2018; <strong>74</strong>:545-559</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S2059798318004655" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85048334770" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29872005/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS2059798318004655&amp;pmid=29872005" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Water molecules were added to the 1-18–BG505–10-1074 model based on local density and distance to hydrogen bonding partners. Validation of model coordinates was performed using MolProbity (<span class="dropBlock reference-citations"><a id="body-ref-sref12-2" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-2" aria-controls="sref12-2">Chen et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref12-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Chen, V.B. ∙ Arendall, 3rd, W.B. ∙ Headd, J.J. ...</div><div><strong>MolProbity: all-atom structure validation for macromolecular crystallography</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:12-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909042073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-74549178560" target="_blank" aria-label="Open Scopus in new tab">Scopus (7139)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20057044/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909042073&amp;pmid=20057044" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and is reported in <a id="crosref1260" href="#mmc6">Table S6</a>.</div></section><section id="sec-4-4-28"><h4>Structural Analyses</h4><div id="p0390" role="paragraph">Structural figures were made using PyMOL (Version 1.8.2.1 Schrodinger, LLC) or UCSF Chimera (<span class="dropBlock reference-citations"><a id="body-ref-sref37-3" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-3" aria-controls="sref37-3">Goddard et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref37-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Goddard, T.D. ∙ Huang, C.C. ∙ Ferrin, T.E.</div><div><strong>Visualizing density maps with UCSF Chimera</strong></div><div><em>J.&nbsp;Struct. Biol.</em> 2007; <strong>157</strong>:281-287</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2006.06.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33845345287" target="_blank" aria-label="Open Scopus in new tab">Scopus (449)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16963278/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2006.06.010&amp;pmid=16963278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Electrostatic calculations were done using the APBS and PDB2PQR servers (<span class="dropBlock reference-citations"><a id="body-ref-sref103-2" href="#" role="doc-biblioref" data-xml-rid="bib103" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref103-2" aria-controls="sref103-2">Unni et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref103-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Unni, S. ∙ Huang, Y. ∙ Hanson, R.M. ...</div><div><strong>Web servers and services for electrostatics calculations with APBS and PDB2PQR</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2011; <strong>32</strong>:1488-1491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.21720" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-79952994820" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21425296/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.21720&amp;pmid=21425296" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Buried surface areas (BSAs) were calculated using the PDBePISA server (<span class="dropBlock reference-citations"><a id="body-ref-sref55-2" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-2" aria-controls="sref55-2">Krissinel and Henrick, 2007</a><div class="dropBlock__holder" data-db-target-of="sref55-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Krissinel, E. ∙ Henrick, K.</div><div><strong>Inference of macromolecular assemblies from crystalline state</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2007; <strong>372</strong>:774-797</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jmb.2007.05.022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-34548232365" target="_blank" aria-label="Open Scopus in new tab">Scopus (5056)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17681537/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jmb.2007.05.022&amp;pmid=17681537" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Local resolution maps were calculated using the Local Res program embedded in Relion-3 (<span class="dropBlock reference-citations"><a id="body-ref-sref57-2" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-2" aria-controls="sref57-2">Kucukelbir et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref57-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Kucukelbir, A. ∙ Sigworth, F.J. ∙ Tagare, H.D.</div><div><strong>Quantifying the local resolution of cryo-EM density maps</strong></div><div><em>Nat. Methods.</em> 2014; <strong>11</strong>:63-65</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2727" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84894623755" target="_blank" aria-label="Open Scopus in new tab">Scopus (678)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24213166/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2727&amp;pmid=24213166" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section></section><section id="sec-4-5"><h3>Quantification and Statistical Analysis</h3><div id="p0395" role="paragraph">The mutational antigenic profiling data were analyzed with dms_tools2 version 2.5.1 (<a id="intref0180" href="https://jbloomlab.github.io/dms_tools2/" target="_blank">https://jbloomlab.github.io/dms_tools2/</a>; <span class="dropBlock reference-citations"><a id="body-ref-sref7-2" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-2" aria-controls="sref7-2">Bloom, 2015</a><div class="dropBlock__holder" data-db-target-of="sref7-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Bloom, J.D.</div><div><strong>Software for the analysis and visualization of deep mutational scanning data</strong></div><div><em>BMC Bioinformatics.</em> 2015; <strong>16</strong>:168</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12859-015-0590-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84930207201" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25990960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12859-015-0590-4&amp;pmid=25990960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The fraction surviving and excess fraction surviving statistics have been previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref27" href="#" role="doc-biblioref" data-xml-rid="bib22 bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27" aria-controls="sref27">Dingens et&nbsp;al., 2019; Doud et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Doud, M.B. ∙ Lee, J.M. ∙ Bloom, J.D.</div><div><strong>How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:1386</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-03665-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85045389473" target="_blank" aria-label="Open Scopus in new tab">Scopus (28)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29643370/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-03665-3&amp;pmid=29643370" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and are documented at <a id="intref0185" href="https://jbloomlab.github.io/dms_tools2/fracsurvive.html" target="_blank">https://jbloomlab.github.io/dms_tools2/fracsurvive.html</a>. Sequencing wild-type DNA plasmid served as the error control during the calculation of the fraction surviving. The HIV Antibody Database (<span class="dropBlock reference-citations"><a id="body-ref-sref111-5" href="#" role="doc-biblioref" data-xml-rid="bib111" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref111-5" aria-controls="sref111-5">West et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref111-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">111.</div><div>West, Jr., A.P. ∙ Scharf, L. ∙ Horwitz, J. ...</div><div><strong>Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:10598-10603</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1309215110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879538530" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23754383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1309215110&amp;pmid=23754383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was used for the calculation of Env conservation in 1-18 contact residues and for the analysis of neutralization panel data. Clade B reference sequences were obtained through the Los Alamos National Laboratory HIV Database (Filtered Web Alignment, <a id="intref0190" href="https://www.hiv.lanl.gov/" target="_blank">https://www.hiv.lanl.gov/</a>). Median germline nucleotide identity and CDRH3 lengths of HIV-1 Env-reactive and total IgG<sup>+</sup> B cells of IDC561 were compared using the Mann-Whitney U-test in Python 3 using the “stats” module in the “scipy” package. For the correlation of the neutralizing activity of 1-18 and serum IgG of IDC561, spearman’s rank correlation coefficient was calculated in Prism (GraphPad). The neutralizing activity of 1-18 and 1-18Δins was compared using the Wilcoxon matched-pairs signed rank test in Prism (GraphPad).</div></section><section id="sec-4-6"><h3>Data and Code Availability</h3><div id="p0400" role="paragraph">Heavy and light chain sequences of tested monoclonal antibodies have been deposited at GenBank (accession numbers MN867951&nbsp;- MN868062). SGS-derived HIV-1 <i>env</i> obtained from HIV-1<sub>YU2</sub>-infected humanized mice and from individual IDC561 have been deposited at GenBank (accession numbers MN870987 - MN871327 and MN871328 - MN871333, respectively). Density maps and atomic coordinates for the 1-18–BG505–10-1074 and 1-55–RC1–10-1074 complexes were deposited in the Electron Microscopy Data Bank (EMDB) and Protein Data Bank (PDB) with accession numbers EMD-20739 and PDB <a id="intref0195" href="http://firstglance.jmol.org/fg.htm?mol6UDJ" target="_blank">6UDJ</a> (1-18 complex) and EMD-20740 and PDB <a id="intref0200" href="http://firstglance.jmol.org/fg.htm?mol6UDK" target="_blank">6UDK</a> (1-55 complex). The entire mutational antigenic profiling analysis is available at <a id="intref0205" href="https://github.com/jbloomlab/MAP_118" target="_blank">https://github.com/jbloomlab/MAP_118</a>, and the accompanying Illumina sequencing data is on the NCBI SRA with accession numbers SRX6752366&nbsp;- SRX6752371.</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0405" role="paragraph">We thank all study participants who devoted time to our research; members of the Klein and Bjorkman laboratories for helpful discussion; A.P. West, Jr. for sequence analysis; M.S. Ercanoglu and K. Jain for cell sorting; K. Jain, H. Janicki, C. Ruping, and J. Schmatz for antibody production and sample processing; S. Arzberger and F. Bach for generating humanized mice; A. Adhikari, R.&nbsp;Duerr, S. Esser, O. Geisenberger, C. Geldmacher, M. Hölscher, A. Kroidl, T. Kümmerle, K. Römer, S. Scholten, C. Stephan, H. Streeck, T. Wolf, C.&nbsp;Wyen, and S. Zolla-Pazner for contributing to the screening cohort; J.P. Moore and A. Cupo for the stable CHO cell line expressing BG505<sub>SOSIP.664</sub>; E. Heger for SupT1-R5 cells; T.Y. Oliveira for providing sequence assembly software; I.S. Georgiev for neutralizing fingerprint analysis; N.A. Doria-Rose for providing RSC3; L. Stamatatos for providing eOD-GT8; Z. Yang and A. Malyutin for assistance with cryo-EM data collection; the Cologne Center for Genomics for sequencing support; and the staff of the Animal Care Facility Weyertal at the University of Cologne. The panel of global HIV-1 clones was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH (ARP) from David Montefiori (<span class="dropBlock reference-citations"><a id="body-ref-sref19-3" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-3" aria-controls="sref19-3">deCamp et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref19-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>deCamp, A. ∙ Hraber, P. ∙ Bailer, R.T. ...</div><div><strong>Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2014; <strong>88</strong>:2489-2507</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02853-13" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84896739535" target="_blank" aria-label="Open Scopus in new tab">Scopus (122)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24352443/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02853-13&amp;pmid=24352443" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and TZM-bl cells were obtained through the ARP from John C. Kappes and Xiaoyun Wu (<span class="dropBlock reference-citations"><a id="body-ref-sref76-3" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76-3" aria-controls="sref76-3">Platt et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref76-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Platt, E.J. ∙ Wehrly, K. ∙ Kuhmann, S.E. ...</div><div><strong>Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1</strong></div><div><em>J.&nbsp;Virol.</em> 1998; <strong>72</strong>:2855-2864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.72.4.2855-2864.1998" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9525605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.72.4.2855-2864.1998&amp;pmid=9525605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Cryo-EM was done at the Beckman Institute Resource Center for Transmission Electron Microscopy at Caltech. Support was provided by fellowships from the German Center for Infection Research (DZIF) (to P.S. and H.G.), the Graduate Research Fellowship Program (GRFP) of the National Science Foundation (NSF) (to M.E.A), scholarships from the Hans‐Böckler Foundation and the Köln Fortune Program of the Faculty of Medicine of the University of Cologne (to M.-K.T), the Ernst Jung Career Advancement Award for Medical Research (to T.S.), and the Federal Joint Committee (G-BA) (01VSF18036 to C.L.). J.D.B. is an Investigator of the Howard Hughes Medical Institute. This work was supported by Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grant OPP1146996 (to M.S.S.); National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) grants R01 AI140891 (to J.D.B.), HIVRAD P01 AI110657 (to R.W.S.), and HIVRAD P01 AI100148 (to P.J.B.); NIH grant P50 GM082545-06 (to P.J.B.); and grants from the German Center for Infection Research (DZIF; to F.K.), the German Research Foundation (CRC 1279 and CRC 1310 to F.K.), the DFG Heisenberg Program (KL2389/2-1 to F.K.), and the European Research Council (ERC-StG639961 to F.K.).</div><section id="sec-5"><h3>Author Contributions</h3><div id="p0410" role="paragraph">Conceptualization, F.K; Methodology, P.S., H.G., M.E.A., A.S.D., J.D.B., P.J.B., and F.K.; Investigation, P.S., H.G., M.E.A., M.-K.T., A.S.D., H.B.G., C.O.B., T.S., M.S., K.V., C.K., and M.S.S.; Resources, K.V., D.W., U.H., C.S., M.M.V., M.J.v.G., R.W.S., J.J.V., O.A.C., C.L., and G.F.; Software, A.S.D. and C.K.; Formal Analysis, P.S., H.G., A.S.D., C.K., and M.S.S.; Writing&nbsp;– Original Draft, P.S., H.G., M.E.A., H.B.G., P.J.B., and F.K.; Writing – Review &amp; Editing, A.S.D., T.S., K.V., C.K., R.W.S., and J.D.B.; Visualization, P.S., H.G., M.E.A., A.S.D., and F.K.; Supervision, J.D.B., P.J.B., and F.K.; Funding Acquisition, P.J.B. and F.K.</div></section><section id="sec-6"><h3>Declaration of Interests</h3><div id="p0415" role="paragraph">A patent application encompassing aspects of this work has been filed by the University of Cologne, listing P.S., H.G., and F.K. as inventors.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental Information (7)</h2><div id="p0425" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.01.010/attachment/6fb2a939-510d-4154-9a17-e5f03d397e6f/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (306.35 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table S1. HIV-1-Reactive Antibody Clones Isolated by Single-Cell Cloning from Individual IDC561, Related to Figure&nbsp;1</div></div></div><div id="mmc2" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.01.010/attachment/8e672388-15fa-49da-b1eb-e1a2002ee3e6/mmc2.pdf" download="mmc2.pdf" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">PDF (516.78 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S2. Binding of Members of Isolated Antibody Clones Against HIV-1 Env by ELISA, Related to Figure&nbsp;1</div></div></div><div id="mmc3" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.01.010/attachment/167fd972-0a27-4ad1-a88e-2acfe09cf61e/mmc3.pdf" download="mmc3.pdf" aria-labelledby="mmc3-heading mmc3-link"><span id="mmc3-link">PDF (318.14 KB)</span></a></div><div class="core-description"><div id="mmc3-heading" class="heading">Table S3. Neutralizing Activity against Global Pseudovirus Panel, Related to Figures 1 and 2</div></div></div><div id="mmc4" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.01.010/attachment/c8a4b5b1-2b39-4de7-b5e4-d634273ef511/mmc4.pdf" download="mmc4.pdf" aria-labelledby="mmc4-heading mmc4-link"><span id="mmc4-link">PDF (508.24 KB)</span></a></div><div class="core-description"><div id="mmc4-heading" class="heading">Table S4. Sequences of V<sub>H</sub>1-46-Derived bNAbs from Individual IDC561, Related to Figures 1 and 2</div></div></div><div id="mmc5" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.01.010/attachment/d879e3a5-20b0-4bad-999b-56ce5d9e1697/mmc5.pdf" download="mmc5.pdf" aria-labelledby="mmc5-heading mmc5-link"><span id="mmc5-link">PDF (591.05 KB)</span></a></div><div class="core-description"><div id="mmc5-heading" class="heading">Table S5. Neutralizing Activity Against Multiclade, Clade C, and Primary Virus Panels, Related to Figure&nbsp;2</div></div></div><div id="mmc6" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.01.010/attachment/62acfcb3-7903-4fa9-9127-d87f10736660/mmc6.pdf" download="mmc6.pdf" aria-labelledby="mmc6-heading mmc6-link"><span id="mmc6-link">PDF (455.30 KB)</span></a></div><div class="core-description"><div id="mmc6-heading" class="heading">Table S6. Cryo-EM Data Collection, Refinement, and Validation Statistics, Related to Figure&nbsp;3</div></div></div><div id="mmc7" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.01.010/attachment/a0dde207-4ab0-48e3-a344-2f3589b0b8e9/mmc7.pdf" download="mmc7.pdf" aria-labelledby="mmc7-heading mmc7-link"><span id="mmc7-link">PDF (1.35 MB)</span></a></div><div class="core-description"><div id="mmc7-heading" class="heading">Table S7. Plasma SGS-Derived <i>env</i> Sequences Obtained from HIV-1<sub>YU2</sub>-Infected Humanized Mice and Antibody Sensitivity, Related to Figures 6 and 7</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1-1" title="View in article">1.</a></div><div>Adams, P.D. ∙ Afonine, P.V. ∙ Bunkóczi, G. ...</div><div><strong>PHENIX: a comprehensive Python-based system for macromolecular structure solution</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:213-221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909052925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-76449098262" target="_blank" aria-label="Open Scopus in new tab">Scopus (12062)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124702/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909052925&amp;pmid=20124702" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2-1" title="View in article">2.</a></div><div>Anderson, J.P. ∙ Rodrigo, A.G. ∙ Learn, G.H. ...</div><div><strong>Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E</strong></div><div><em>J.&nbsp;Virol.</em> 2000; <strong>74</strong>:10752-10765</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.74.22.10752-10765.2000" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0033766134" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11044120/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.74.22.10752-10765.2000&amp;pmid=11044120" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">3.</a></div><div>Balazs, A.B. ∙ Chen, J. ∙ Hong, C.M. ...</div><div><strong>Antibody-based protection against HIV infection by vectored immunoprophylaxis</strong></div><div><em>Nature.</em> 2011; <strong>481</strong>:81-84</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10660" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84855466746" target="_blank" aria-label="Open Scopus in new tab">Scopus (340)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22139420/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10660&amp;pmid=22139420" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-1" title="View in article">4.</a></div><div>Bar, K.J. ∙ Sneller, M.C. ∙ Harrison, L.J. ...</div><div><strong>Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2037-2050</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1608243" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84997817411" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1608243&amp;pmid=27959728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-1" title="View in article">5.</a></div><div>Bar-On, Y. ∙ Gruell, H. ∙ Schoofs, T. ...</div><div><strong>Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1701-1707</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0186-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054012075" target="_blank" aria-label="Open Scopus in new tab">Scopus (51)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258217/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0186-4&amp;pmid=30258217" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref114" title="View in article">6.</a></div><div>Barouch, D.H. ∙ Whitney, J.B. ∙ Moldt, B. ...</div><div><strong>Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys</strong></div><div><em>Nature.</em> 2013; <strong>503</strong>:224-228</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature12744" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84887626950" target="_blank" aria-label="Open Scopus in new tab">Scopus (395)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24172905/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12744&amp;pmid=24172905" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7-1" title="View in article">7.</a></div><div>Bloom, J.D.</div><div><strong>Software for the analysis and visualization of deep mutational scanning data</strong></div><div><em>BMC Bioinformatics.</em> 2015; <strong>16</strong>:168</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12859-015-0590-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84930207201" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25990960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12859-015-0590-4&amp;pmid=25990960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-2" title="View in article">8.</a></div><div>Bonsignori, M. ∙ Zhou, T. ∙ Sheng, Z. ..., NISC Comparative Sequencing Program</div><div><strong>Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:449-463</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.02.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84959296091" target="_blank" aria-label="Open Scopus in new tab">Scopus (138)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26949186/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.02.022&amp;pmid=26949186" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-1" title="View in article">9.</a></div><div>Caskey, M. ∙ Klein, F. ∙ Lorenzi, J.C. ...</div><div><strong>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</strong></div><div><em>Nature.</em> 2015; <strong>522</strong>:487-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14411" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84928405730" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25855300/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14411&amp;pmid=25855300" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-1" title="View in article">10.</a></div><div>Caskey, M. ∙ Schoofs, T. ∙ Gruell, H. ...</div><div><strong>Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</strong></div><div><em>Nat. Med.</em> 2017; <strong>23</strong>:185-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4268" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85009820387" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28092665/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4268&amp;pmid=28092665" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">11.</a></div><div>Caskey, M. ∙ Klein, F. ∙ Nussenzweig, M.C.</div><div><strong>Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:547-553</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0412-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85063768243" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936546/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0412-8&amp;pmid=30936546" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12-1" title="View in article">12.</a></div><div>Chen, V.B. ∙ Arendall, 3rd, W.B. ∙ Headd, J.J. ...</div><div><strong>MolProbity: all-atom structure validation for macromolecular crystallography</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:12-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909042073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-74549178560" target="_blank" aria-label="Open Scopus in new tab">Scopus (7139)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20057044/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909042073&amp;pmid=20057044" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">13.</a></div><div>Chuang, G.Y. ∙ Zhou, J. ∙ Acharya, P. ...</div><div><strong>Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition</strong></div><div><em>Structure.</em> 2019; <strong>27</strong>:196-206.e6</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.str.2018.10.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.str.2018.10.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85059495283" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30471922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.str.2018.10.007&amp;pmid=30471922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14-1" title="View in article">14.</a></div><div>Chung, N.P. ∙ Matthews, K. ∙ Kim, H.J. ...</div><div><strong>Stable 293&nbsp;T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies</strong></div><div><em>Retrovirology.</em> 2014; <strong>11</strong>:33</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1742-4690-11-33" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84901499773" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24767177/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1742-4690-11-33&amp;pmid=24767177" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-3" title="View in article">15.</a></div><div>Cohen, Y.Z. ∙ Lorenzi, J.C.C. ∙ Krassnig, L. ...</div><div><strong>Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2018; <strong>215</strong>:2311-2324</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20180936" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054152954" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30072495/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20180936&amp;pmid=30072495" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">16.</a></div><div>Cohen, Y.Z. ∙ Lorenzi, J.C.C. ∙ Seaman, M.S. ...</div><div><strong>Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells</strong></div><div><em>J.&nbsp;Virol.</em> 2018; <strong>92</strong>:e01883-17</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.01883-17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85042032314" target="_blank" aria-label="Open Scopus in new tab">Scopus (13)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29237833/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.01883-17&amp;pmid=29237833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-3" title="View in article">17.</a></div><div>Crowell, T.A. ∙ Colby, D.J. ∙ Pinyakorn, S. ..., RV397 Study Group</div><div><strong>Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial</strong></div><div><em>Lancet HIV.</em> 2019; <strong>6</strong>:e297-e306</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930053-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930053-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85064867914" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31000477/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS2352-3018%2819%2930053-0&amp;pmid=31000477" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62-2" title="View in article">18.</a></div><div>de Taeye, S.W. ∙ Ozorowski, G. ∙ Torrents de la Peña, A. ...</div><div><strong>Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes</strong></div><div><em>Cell.</em> 2015; <strong>163</strong>:1702-1715</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.11.056&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.11.056&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84950267324" target="_blank" aria-label="Open Scopus in new tab">Scopus (157)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26687358/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.11.056&amp;pmid=26687358" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref84-1" title="View in article">19.</a></div><div>deCamp, A. ∙ Hraber, P. ∙ Bailer, R.T. ...</div><div><strong>Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2014; <strong>88</strong>:2489-2507</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02853-13" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84896739535" target="_blank" aria-label="Open Scopus in new tab">Scopus (122)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24352443/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02853-13&amp;pmid=24352443" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20-1" title="View in article">20.</a></div><div>Didigu, C.A. ∙ Wilen, C.B. ∙ Wang, J. ...</div><div><strong>Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T&nbsp;cells from HIV-1 infection</strong></div><div><em>Blood.</em> 2014; <strong>123</strong>:61-69</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2013-08-521229" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84891772031" target="_blank" aria-label="Open Scopus in new tab">Scopus (94)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24162716/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2013-08-521229&amp;pmid=24162716" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42-1" title="View in article">21.</a></div><div>Dingens, A.S. ∙ Haddox, H.K. ∙ Overbaugh, J. ...</div><div><strong>Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody</strong></div><div><em>Cell Host Microbe.</em> 2017; <strong>21</strong>:777-787.e4</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.chom.2017.05.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.chom.2017.05.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85020234897" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28579254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.chom.2017.05.003&amp;pmid=28579254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#figs5" title="View in article">22.</a></div><div>Dingens, A.S. ∙ Arenz, D. ∙ Weight, H. ...</div><div><strong>An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes</strong></div><div><em>Immunity.</em> 2019; <strong>50</strong>:520-532.e3</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2018.12.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061333610" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30709739/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2018.12.017&amp;pmid=30709739" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">23.</a></div><div>Diskin, R. ∙ Scheid, J.F. ∙ Marcovecchio, P.M. ...</div><div><strong>Increasing the potency and breadth of an HIV antibody by using structure-based rational design</strong></div><div><em>Science.</em> 2011; <strong>334</strong>:1289-1293</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1213782" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-82755184131" target="_blank" aria-label="Open Scopus in new tab">Scopus (271)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22033520/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1213782&amp;pmid=22033520" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-5" title="View in article">24.</a></div><div>Diskin, R. ∙ Klein, F. ∙ Horwitz, J.A. ...</div><div><strong>Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2013; <strong>210</strong>:1235-1249</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20130221" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879523938" target="_blank" aria-label="Open Scopus in new tab">Scopus (65)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23712429/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20130221&amp;pmid=23712429" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25-1" title="View in article">25.</a></div><div>Doria-Rose, N.A. ∙ Altae-Tran, H.R. ∙ Roark, R.S. ...</div><div><strong>Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting</strong></div><div><em>PLoS Pathog.</em> 2017; <strong>13</strong>:e1006148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011002666" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28052137/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006148&amp;pmid=28052137" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26-1" title="View in article">26.</a></div><div>Dosenovic, P. ∙ Pettersson, A.K. ∙ Wall, A. ...</div><div><strong>Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2316-2330</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20190446" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072985424" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31345931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20190446&amp;pmid=31345931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27" title="View in article">27.</a></div><div>Doud, M.B. ∙ Lee, J.M. ∙ Bloom, J.D.</div><div><strong>How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:1386</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-03665-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85045389473" target="_blank" aria-label="Open Scopus in new tab">Scopus (28)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29643370/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-03665-3&amp;pmid=29643370" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">28.</a></div><div>Ehrhardt, S.A. ∙ Zehner, M. ∙ Krähling, V. ...</div><div><strong>Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV</strong></div><div><em>Nat. Med.</em> 2019; <strong>25</strong>:1589-1600</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-019-0602-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85074202467" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31591605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-019-0602-4&amp;pmid=31591605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29-1" title="View in article">29.</a></div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (11218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30-1" title="View in article">30.</a></div><div>Escolano, A. ∙ Gristick, H.B. ∙ Abernathy, M.E. ...</div><div><strong>Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques</strong></div><div><em>Nature.</em> 2019; <strong>570</strong>:468-473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1250-z" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85066803291" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31142836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1250-z&amp;pmid=31142836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31-1" title="View in article">31.</a></div><div>Gaebler, C. ∙ Lorenzi, J.C.C. ∙ Oliveira, T.Y. ...</div><div><strong>Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:2253-2264</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20190896" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072992920" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31350309/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20190896&amp;pmid=31350309" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref106" title="View in article">32.</a></div><div>Gama, L. ∙ Koup, R.A.</div><div><strong>New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment</strong></div><div><em>Annu. Rev. Med.</em> 2018; <strong>69</strong>:409-419</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-med-061016-041032" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85041720660" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29029583/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-med-061016-041032&amp;pmid=29029583" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-2" title="View in article">33.</a></div><div>Gao, F. ∙ Bonsignori, M. ∙ Liao, H.X. ...</div><div><strong>Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies</strong></div><div><em>Cell.</em> 2014; <strong>158</strong>:481-491</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2014.06.022&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2014.06.022&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25065977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.06.022&amp;pmid=25065977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-3" title="View in article">34.</a></div><div>Gaudinski, M.R. ∙ Coates, E.E. ∙ Houser, K.V. ..., VRC 606 Study Team</div><div><strong>Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults</strong></div><div><em>PLoS Med.</em> 2018; <strong>15</strong>:e1002493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85041696060" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29364886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1002493&amp;pmid=29364886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-3" title="View in article">35.</a></div><div>Gaudinski, M.R. ∙ Houser, K.V. ∙ Doria-Rose, N.A. ..., VRC 605 study team</div><div><strong>Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial</strong></div><div><em>Lancet HIV.</em> 2019; <strong>6</strong>:e667-e679</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930181-X&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS2352-3018%2819%2930181-X&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85072659478" target="_blank" aria-label="Open Scopus in new tab">Scopus (3)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31473167/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS2352-3018%2819%2930181-X&amp;pmid=31473167" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">36.</a></div><div>Gautam, R. ∙ Nishimura, Y. ∙ Pegu, A. ...</div><div><strong>A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges</strong></div><div><em>Nature.</em> 2016; <strong>533</strong>:105-109</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature17677" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84966389751" target="_blank" aria-label="Open Scopus in new tab">Scopus (247)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27120156/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature17677&amp;pmid=27120156" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37-1" title="View in article">37.</a></div><div>Goddard, T.D. ∙ Huang, C.C. ∙ Ferrin, T.E.</div><div><strong>Visualizing density maps with UCSF Chimera</strong></div><div><em>J.&nbsp;Struct. Biol.</em> 2007; <strong>157</strong>:281-287</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2006.06.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33845345287" target="_blank" aria-label="Open Scopus in new tab">Scopus (449)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16963278/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2006.06.010&amp;pmid=16963278" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref120-1" title="View in article">38.</a></div><div>Gruell, H. ∙ Klein, F.</div><div><strong>Progress in HIV-1 antibody research using humanized mice</strong></div><div><em>Curr. Opin. HIV AIDS.</em> 2017; <strong>12</strong>:285-293</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/COH.0000000000000368" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85014193431" target="_blank" aria-label="Open Scopus in new tab">Scopus (5)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28422792/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FCOH.0000000000000368&amp;pmid=28422792" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">39.</a></div><div>Gruell, H. ∙ Klein, F.</div><div><strong>Antibody-mediated prevention and treatment of HIV-1 infection</strong></div><div><em>Retrovirology.</em> 2018; <strong>15</strong>:73</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12977-018-0455-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85056710424" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30445968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12977-018-0455-9&amp;pmid=30445968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">40.</a></div><div>Guindon, S. ∙ Dufayard, J.F. ∙ Lefort, V. ...</div><div><strong>New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0</strong></div><div><em>Syst. Biol.</em> 2010; <strong>59</strong>:307-321</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/sysbio/syq010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77950806408" target="_blank" aria-label="Open Scopus in new tab">Scopus (7702)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20525638/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fsysbio%2Fsyq010&amp;pmid=20525638" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">41.</a></div><div>Haddox, H.K. ∙ Dingens, A.S. ∙ Bloom, J.D.</div><div><strong>Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV’s Envelope Protein on Viral Replication in Cell Culture</strong></div><div><em>PLoS Pathog.</em> 2016; <strong>12</strong>:e1006114</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1006114" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85008164772" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27959955/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1006114&amp;pmid=27959955" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42-1" title="View in article">42.</a></div><div>Haddox, H.K. ∙ Dingens, A.S. ∙ Hilton, S.K. ...</div><div><strong>Mapping mutational effects along the evolutionary landscape of HIV envelope</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e34420</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.34420" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29590010/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.34420&amp;pmid=29590010" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">43.</a></div><div>Haynes, B.F. ∙ Fleming, J. ∙ St Clair, E.W. ...</div><div><strong>Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies</strong></div><div><em>Science.</em> 2005; <strong>308</strong>:1906-1908</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1111781" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-21344434534" target="_blank" aria-label="Open Scopus in new tab">Scopus (579)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15860590/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1111781&amp;pmid=15860590" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-4" title="View in article">44.</a></div><div>Horwitz, J.A. ∙ Halper-Stromberg, A. ∙ Mouquet, H. ...</div><div><strong>HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:16538-16543</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1315295110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84885338257" target="_blank" aria-label="Open Scopus in new tab">Scopus (167)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24043801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1315295110&amp;pmid=24043801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53-10" title="View in article">45.</a></div><div>Horwitz, J.A. ∙ Bar-On, Y. ∙ Lu, C.L. ...</div><div><strong>Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In&nbsp;Vivo</strong></div><div><em>Cell.</em> 2017; <strong>170</strong>:637-648.e10</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2017.06.048&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2017.06.048&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85026236863" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28757252/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.06.048&amp;pmid=28757252" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46-1" title="View in article">46.</a></div><div>Hraber, P. ∙ Rademeyer, C. ∙ Williamson, C. ...</div><div><strong>Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments</strong></div><div><em>J.&nbsp;Virol.</em> 2017; <strong>91</strong>:e00991-17</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00991-17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85029229191" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28747500/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00991-17&amp;pmid=28747500" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-1" title="View in article">47.</a></div><div>Huang, J. ∙ Kang, B.H. ∙ Ishida, E. ...</div><div><strong>Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth</strong></div><div><em>Immunity.</em> 2016; <strong>45</strong>:1108-1121</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2016.10.027&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84999836139" target="_blank" aria-label="Open Scopus in new tab">Scopus (116)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27851912/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.10.027&amp;pmid=27851912" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref114" title="View in article">48.</a></div><div>Huang, Y. ∙ Yu, J. ∙ Lanzi, A. ...</div><div><strong>Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:1621-1631</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.05.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.05.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84975221851" target="_blank" aria-label="Open Scopus in new tab">Scopus (91)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27315479/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.05.024&amp;pmid=27315479" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref120-1" title="View in article">49.</a></div><div>Ince, W.L. ∙ Zhang, L. ∙ Jiang, Q. ...</div><div><strong>Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model</strong></div><div><em>J.&nbsp;Virol.</em> 2010; <strong>84</strong>:2740-2752</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02180-09" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77649099626" target="_blank" aria-label="Open Scopus in new tab">Scopus (33)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20042504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02180-09&amp;pmid=20042504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">50.</a></div><div>Julg, B. ∙ Barouch, D.H.</div><div><strong>Neutralizing antibodies for HIV-1 prevention</strong></div><div><em>Curr. Opin. HIV AIDS.</em> 2019; <strong>14</strong>:318-324</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/COH.0000000000000556" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85067266618" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31082819/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FCOH.0000000000000556&amp;pmid=31082819" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-5" title="View in article">51.</a></div><div>Julg, B. ∙ Pegu, A. ∙ Abbink, P. ...</div><div><strong>Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys</strong></div><div><em>J.&nbsp;Virol.</em> 2017; <strong>91</strong>:e00498-17</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.00498-17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85026310049" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28539448/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.00498-17&amp;pmid=28539448" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref91-1" title="View in article">52.</a></div><div>Kirchherr, J.L. ∙ Lu, X. ∙ Kasongo, W. ...</div><div><strong>High throughput functional analysis of HIV-1 env genes without cloning</strong></div><div><em>J.&nbsp;Virol. Methods.</em> 2007; <strong>143</strong>:104-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jviromet.2007.02.015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-34249336735" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17416428/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jviromet.2007.02.015&amp;pmid=17416428" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-4" title="View in article">53.</a></div><div>Klein, F. ∙ Halper-Stromberg, A. ∙ Horwitz, J.A. ...</div><div><strong>HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</strong></div><div><em>Nature.</em> 2012; <strong>492</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11604" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84870562234" target="_blank" aria-label="Open Scopus in new tab">Scopus (331)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103874/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11604&amp;pmid=23103874" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54-1" title="View in article">54.</a></div><div>Kreer, C. ∙ Döring, M. ∙ Lehnen, N. ...</div><div><strong>openPrimeR for multiplex amplification of highly diverse templates</strong></div><div><em>bioRxiv.</em> 2019;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/847574" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2F847574" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">55.</a></div><div>Krissinel, E. ∙ Henrick, K.</div><div><strong>Inference of macromolecular assemblies from crystalline state</strong></div><div><em>J.&nbsp;Mol. Biol.</em> 2007; <strong>372</strong>:774-797</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jmb.2007.05.022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-34548232365" target="_blank" aria-label="Open Scopus in new tab">Scopus (5056)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17681537/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jmb.2007.05.022&amp;pmid=17681537" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref91-2" title="View in article">56.</a></div><div>Kryazhimskiy, S. ∙ Rice, D.P. ∙ Jerison, E.R. ...</div><div><strong>Microbial evolution. Global epistasis makes adaptation predictable despite sequence-level stochasticity</strong></div><div><em>Science.</em> 2014; <strong>344</strong>:1519-1522</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1250939" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84903291815" target="_blank" aria-label="Open Scopus in new tab">Scopus (149)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24970088/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1250939&amp;pmid=24970088" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57-1" title="View in article">57.</a></div><div>Kucukelbir, A. ∙ Sigworth, F.J. ∙ Tagare, H.D.</div><div><strong>Quantifying the local resolution of cryo-EM density maps</strong></div><div><em>Nat. Methods.</em> 2014; <strong>11</strong>:63-65</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2727" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84894623755" target="_blank" aria-label="Open Scopus in new tab">Scopus (678)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24213166/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2727&amp;pmid=24213166" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref122" title="View in article">58.</a></div><div>Kwong, P.D. ∙ Wyatt, R. ∙ Robinson, J. ...</div><div><strong>Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody</strong></div><div><em>Nature.</em> 1998; <strong>393</strong>:648-659</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/31405" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0032543307" target="_blank" aria-label="Open Scopus in new tab">Scopus (2341)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9641677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F31405&amp;pmid=9641677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-3" title="View in article">59.</a></div><div>Ledgerwood, J.E. ∙ Coates, E.E. ∙ Yamshchikov, G. ..., VRC 602 Study Team</div><div><strong>Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults</strong></div><div><em>Clin. Exp. Immunol.</em> 2015; <strong>182</strong>:289-301</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cei.12692" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84946480939" target="_blank" aria-label="Open Scopus in new tab">Scopus (118)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26332605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcei.12692&amp;pmid=26332605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref115" title="View in article">60.</a></div><div>Lee, J.H. ∙ Andrabi, R. ∙ Su, C.Y. ...</div><div><strong>A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure</strong></div><div><em>Immunity.</em> 2017; <strong>46</strong>:690-702</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2017.03.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85019040760" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28423342/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2017.03.017&amp;pmid=28423342" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref104" title="View in article">61.</a></div><div>Leonard, C.K. ∙ Spellman, M.W. ∙ Riddle, L. ...</div><div><strong>Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1990; <strong>265</strong>:10373-10382</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS0021-9258%2818%2986956-3&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2FS0021-9258%2818%2986956-3&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2355006/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2818%2986956-3&amp;pmid=2355006" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref94" title="View in article">62.</a></div><div>Liu, Q. ∙ Acharya, P. ∙ Dolan, M.A. ...</div><div><strong>Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2017; <strong>24</strong>:370-378</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsmb.3382" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85013157801" target="_blank" aria-label="Open Scopus in new tab">Scopus (42)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28218750/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsmb.3382&amp;pmid=28218750" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref115" title="View in article">63.</a></div><div>Liu, Q. ∙ Lai, Y.T. ∙ Zhang, P. ...</div><div><strong>Improvement of antibody functionality by structure-guided paratope engraftment</strong></div><div><em>Nat. Commun.</em> 2019; <strong>10</strong>:721</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-08658-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85061489670" target="_blank" aria-label="Open Scopus in new tab">Scopus (1)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30760721/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-08658-4&amp;pmid=30760721" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-1" title="View in article">64.</a></div><div>Lynch, R.M. ∙ Boritz, E. ∙ Coates, E.E. ..., VRC 601 Study Team</div><div><strong>Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection</strong></div><div><em>Sci. Transl. Med.</em> 2015; <strong>7</strong>:319ra206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad5752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84954445565" target="_blank" aria-label="Open Scopus in new tab">Scopus (198)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26702094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad5752&amp;pmid=26702094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65-1" title="View in article">65.</a></div><div>Lynch, R.M. ∙ Wong, P. ∙ Tran, L. ...</div><div><strong>HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2015; <strong>89</strong>:4201-4213</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.03608-14" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84925431182" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25631091/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.03608-14&amp;pmid=25631091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">66.</a></div><div>Lyumkis, D. ∙ Julien, J.P. ∙ de Val, N. ...</div><div><strong>Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer</strong></div><div><em>Science.</em> 2013; <strong>342</strong>:1484-1490</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1245627" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84890859441" target="_blank" aria-label="Open Scopus in new tab">Scopus (445)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24179160/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1245627&amp;pmid=24179160" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref122" title="View in article">67.</a></div><div>Maddon, P.J. ∙ Dalgleish, A.G. ∙ McDougal, J.S. ...</div><div><strong>The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain</strong></div><div><em>Cell.</em> 1986; <strong>47</strong>:333-348</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2F0092-8674%2886%2990590-8&amp;cf=abstract&amp;site=cell-site">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2F0092-8674%2886%2990590-8&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0023028190" target="_blank" aria-label="Open Scopus in new tab">Scopus (1429)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3094962/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0092-8674%2886%2990590-8&amp;pmid=3094962" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-3" title="View in article">68.</a></div><div>Mayer, K.H. ∙ Seaton, K.E. ∙ Huang, Y. ..., HVTN 104 Protocol Team, and the NIAID HIV Vaccine Trials Network</div><div><strong>Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial</strong></div><div><em>PLoS Med.</em> 2017; <strong>14</strong>:e1002435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85036569550" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29136037/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pmed.1002435&amp;pmid=29136037" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-1" title="View in article">69.</a></div><div>Mendoza, P. ∙ Gruell, H. ∙ Nogueira, L. ...</div><div><strong>Combination therapy with anti-HIV-1 antibodies maintains viral suppression</strong></div><div><em>Nature.</em> 2018; <strong>561</strong>:479-484</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0531-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85054033751" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0531-2&amp;pmid=30258136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">70.</a></div><div>Moldt, B. ∙ Rakasz, E.G. ∙ Schultz, N. ...</div><div><strong>Highly potent HIV-specific antibody neutralization in&nbsp;vitro translates into effective protection against mucosal SHIV challenge in&nbsp;vivo</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:18921-18925</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1214785109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84869232528" target="_blank" aria-label="Open Scopus in new tab">Scopus (297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23100539/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1214785109&amp;pmid=23100539" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref109" title="View in article">71.</a></div><div>Mouquet, H. ∙ Scharf, L. ∙ Euler, Z. ...</div><div><strong>Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:E3268-E3277</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1217207109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84869831194" target="_blank" aria-label="Open Scopus in new tab">Scopus (296)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23115339/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1217207109&amp;pmid=23115339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref85" title="View in article">72.</a></div><div>Otsuka, Y. ∙ Schmitt, K. ∙ Quinlan, B.D. ...</div><div><strong>Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies</strong></div><div><em>PLoS Pathog.</em> 2018; <strong>14</strong>:e1007238</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1007238" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85053086212" target="_blank" aria-label="Open Scopus in new tab">Scopus (4)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30125330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1007238&amp;pmid=30125330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73-1" title="View in article">73.</a></div><div>Ozawa, T. ∙ Kishi, H. ∙ Muraguchi, A.</div><div><strong>Amplification and analysis of cDNA generated from a single cell by 5′-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells</strong></div><div><em>Biotechniques.</em> 2006; <strong>40</strong>:469-470, 472, 474 passim</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2144/000112123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33646841994" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16629394/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2144%2F000112123&amp;pmid=16629394" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref109" title="View in article">74.</a></div><div>Pejchal, R. ∙ Doores, K.J. ∙ Walker, L.M. ...</div><div><strong>A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield</strong></div><div><em>Science.</em> 2011; <strong>334</strong>:1097-1103</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1213256" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-82255179322" target="_blank" aria-label="Open Scopus in new tab">Scopus (483)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21998254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1213256&amp;pmid=21998254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75-1" title="View in article">75.</a></div><div>Pietzsch, J. ∙ Scheid, J.F. ∙ Mouquet, H. ...</div><div><strong>Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2010; <strong>207</strong>:1995-2002</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20101176" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77956237048" target="_blank" aria-label="Open Scopus in new tab">Scopus (53)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20679402/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20101176&amp;pmid=20679402" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76-1" title="View in article">76.</a></div><div>Platt, E.J. ∙ Wehrly, K. ∙ Kuhmann, S.E. ...</div><div><strong>Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1</strong></div><div><em>J.&nbsp;Virol.</em> 1998; <strong>72</strong>:2855-2864</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.72.4.2855-2864.1998" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9525605/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.72.4.2855-2864.1998&amp;pmid=9525605" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77" title="View in article">77.</a></div><div>Punjani, A. ∙ Rubinstein, J.L. ∙ Fleet, D.J. ...</div><div><strong>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:290-296</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85011645437" target="_blank" aria-label="Open Scopus in new tab">Scopus (403)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28165473/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4169&amp;pmid=28165473" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-3" title="View in article">78.</a></div><div>Riddler, S.A. ∙ Zheng, L. ∙ Durand, C.M. ..., AIDS Clinical Trials Group A5342 Protocol Team</div><div><strong>Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART</strong></div><div><em>Open Forum Infect. Dis.</em> 2018; <strong>5</strong>:ofy242</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/ofid/ofy242" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85063978638" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30364428/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fofid%2Fofy242&amp;pmid=30364428" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref94" title="View in article">79.</a></div><div>Rizzuto, C.D. ∙ Wyatt, R. ∙ Hernández-Ramos, N. ...</div><div><strong>A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding</strong></div><div><em>Science.</em> 1998; <strong>280</strong>:1949-1953</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.280.5371.1949" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0032546952" target="_blank" aria-label="Open Scopus in new tab">Scopus (730)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9632396/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.280.5371.1949&amp;pmid=9632396" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-1" title="View in article">80.</a></div><div>Rudicell, R.S. ∙ Kwon, Y.D. ∙ Ko, S.Y. ..., NISC Comparative Sequencing Program</div><div><strong>Enhanced potency of a broadly neutralizing HIV-1 antibody in&nbsp;vitro improves protection against lentiviral infection in&nbsp;vivo</strong></div><div><em>J.&nbsp;Virol.</em> 2014; <strong>88</strong>:12669-12682</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02213-14" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84907971356" target="_blank" aria-label="Open Scopus in new tab">Scopus (148)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25142607/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02213-14&amp;pmid=25142607" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-1" title="View in article">81.</a></div><div>Sajadi, M.M. ∙ Dashti, A. ∙ Rikhtegaran Tehrani, Z. ...</div><div><strong>Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses</strong></div><div><em>Cell.</em> 2018; <strong>173</strong>:1783-1795.e14</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2018.03.061&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2018.03.061&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85046157216" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29731169/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.03.061&amp;pmid=29731169" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82-1" title="View in article">82.</a></div><div>Salazar-Gonzalez, J.F. ∙ Bailes, E. ∙ Pham, K.T. ...</div><div><strong>Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing</strong></div><div><em>J.&nbsp;Virol.</em> 2008; <strong>82</strong>:3952-3970</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02660-07" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-41949124934" target="_blank" aria-label="Open Scopus in new tab">Scopus (426)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18256145/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02660-07&amp;pmid=18256145" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="sref83" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref97-1" title="View in article">83.</a></div><div>Sanders, R.W. ∙ Derking, R. ∙ Cupo, A. ...</div><div><strong>A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies</strong></div><div><em>PLoS Pathog.</em> 2013; <strong>9</strong>:e1003618</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1003618" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84884678235" target="_blank" aria-label="Open Scopus in new tab">Scopus (436)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24068931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1003618&amp;pmid=24068931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib84" class="citations"><div id="sref84" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref84-1" title="View in article">84.</a></div><div>Sarzotti-Kelsoe, M. ∙ Bailer, R.T. ∙ Turk, E. ...</div><div><strong>Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2014; <strong>409</strong>:131-146</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2013.11.022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84906084946" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24291345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2013.11.022&amp;pmid=24291345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib85" class="citations"><div id="sref85" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref85" title="View in article">85.</a></div><div>Sather, D.N. ∙ Carbonetti, S. ∙ Kehayia, J. ...</div><div><strong>Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus</strong></div><div><em>J.&nbsp;Virol.</em> 2012; <strong>86</strong>:12676-12685</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.01893-12" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84869204900" target="_blank" aria-label="Open Scopus in new tab">Scopus (36)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22973035/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.01893-12&amp;pmid=22973035" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib86" class="citations"><div id="sref86" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref86" title="View in article">86.</a></div><div>Scharf, L. ∙ Scheid, J.F. ∙ Lee, J.H. ...</div><div><strong>Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike</strong></div><div><em>Cell Rep.</em> 2014; <strong>7</strong>:785-795</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.celrep.2014.04.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.celrep.2014.04.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84899909771" target="_blank" aria-label="Open Scopus in new tab">Scopus (146)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24767986/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2014.04.001&amp;pmid=24767986" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib87" class="citations"><div id="sref87" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref116-1" title="View in article">87.</a></div><div>Scheid, J.F. ∙ Mouquet, H. ∙ Feldhahn, N. ...</div><div><strong>A method for identification of HIV gp140 binding memory B cells in human blood</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2009; <strong>343</strong>:65-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2008.11.012" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-63749100579" target="_blank" aria-label="Open Scopus in new tab">Scopus (141)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19100741/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2008.11.012&amp;pmid=19100741" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib88" class="citations"><div id="sref88" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-1" title="View in article">88.</a></div><div>Scheid, J.F. ∙ Mouquet, H. ∙ Ueberheide, B. ...</div><div><strong>Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding</strong></div><div><em>Science.</em> 2011; <strong>333</strong>:1633-1637</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1207227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-80052925616" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21764753/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1207227&amp;pmid=21764753" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib89" class="citations"><div id="sref89" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89-1" title="View in article">89.</a></div><div>Scheid, J.F. ∙ Horwitz, J.A. ∙ Bar-On, Y. ...</div><div><strong>HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption</strong></div><div><em>Nature.</em> 2016; <strong>535</strong>:556-560</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature18929" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84976406858" target="_blank" aria-label="Open Scopus in new tab">Scopus (185)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27338952/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature18929&amp;pmid=27338952" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib90" class="citations"><div id="sref90" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">90.</a></div><div>Scheres, S.H. ∙ Chen, S.</div><div><strong>Prevention of overfitting in cryo-EM structure determination</strong></div><div><em>Nat. Methods.</em> 2012; <strong>9</strong>:853-854</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.2115" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84866078359" target="_blank" aria-label="Open Scopus in new tab">Scopus (510)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22842542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.2115&amp;pmid=22842542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib91" class="citations"><div id="sref91" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref91-1" title="View in article">91.</a></div><div>Schoofs, T. ∙ Klein, F. ∙ Braunschweig, M. ...</div><div><strong>HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:997-1001</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaf0972" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84966341056" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27199429/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaf0972&amp;pmid=27199429" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib92" class="citations"><div id="sref92" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92" title="View in article">92.</a></div><div>Schreiber, M. ∙ Wachsmuth, C. ∙ Müller, H. ...</div><div><strong>Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression</strong></div><div><em>J.&nbsp;Gen. Virol.</em> 1996; <strong>77</strong>:2403-2414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1099/0022-1317-77-10-2403" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8887471/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1099%2F0022-1317-77-10-2403&amp;pmid=8887471" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib93" class="citations"><div id="sref93" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref93-1" title="View in article">93.</a></div><div>Seaman, M.S. ∙ Janes, H. ∙ Hawkins, N. ...</div><div><strong>Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies</strong></div><div><em>J.&nbsp;Virol.</em> 2010; <strong>84</strong>:1439-1452</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.02108-09" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-73949127978" target="_blank" aria-label="Open Scopus in new tab">Scopus (416)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19939925/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.02108-09&amp;pmid=19939925" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib94" class="citations"><div id="sref94" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref94" title="View in article">94.</a></div><div>Shaik, M.M. ∙ Peng, H. ∙ Lu, J. ...</div><div><strong>Structural basis of coreceptor recognition by HIV-1 envelope spike</strong></div><div><em>Nature.</em> 2019; <strong>565</strong>:318-323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0804-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85060134274" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30542158/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0804-9&amp;pmid=30542158" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib95" class="citations"><div id="sref95" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref114" title="View in article">95.</a></div><div>Shingai, M. ∙ Nishimura, Y. ∙ Klein, F. ...</div><div><strong>Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia</strong></div><div><em>Nature.</em> 2013; <strong>503</strong>:277-280</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature12746" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84887627657" target="_blank" aria-label="Open Scopus in new tab">Scopus (292)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24172896/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature12746&amp;pmid=24172896" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib96" class="citations"><div id="sref96" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">96.</a></div><div>Shingai, M. ∙ Donau, O.K. ∙ Plishka, R.J. ...</div><div><strong>Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2014; <strong>211</strong>:2061-2074</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20132494" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84907212727" target="_blank" aria-label="Open Scopus in new tab">Scopus (182)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25155019/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20132494&amp;pmid=25155019" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib97" class="citations"><div id="sref97" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref97-1" title="View in article">97.</a></div><div>Sliepen, K. ∙ van Montfort, T. ∙ Ozorowski, G. ...</div><div><strong>Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer</strong></div><div><em>Biomolecules.</em> 2015; <strong>5</strong>:2919-2934</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/biom5042919" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85012065361" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26512709/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3390%2Fbiom5042919&amp;pmid=26512709" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib98" class="citations"><div id="sref98" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref106" title="View in article">98.</a></div><div>Sok, D. ∙ Burton, D.R.</div><div><strong>Recent progress in broadly neutralizing antibodies to HIV</strong></div><div><em>Nat. Immunol.</em> 2018; <strong>19</strong>:1179-1188</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41590-018-0235-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85055080189" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30333615/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41590-018-0235-7&amp;pmid=30333615" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib99" class="citations"><div id="sref99" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref109" title="View in article">99.</a></div><div>Sok, D. ∙ van Gils, M.J. ∙ Pauthner, M. ...</div><div><strong>Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2014; <strong>111</strong>:17624-17629</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1415789111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_99_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84917705974" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25422458/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1415789111&amp;pmid=25422458" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib100" class="citations"><div id="sref100" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref100" title="View in article">100.</a></div><div>Stewart-Jones, G.B. ∙ Soto, C. ∙ Lemmin, T. ...</div><div><strong>Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G</strong></div><div><em>Cell.</em> 2016; <strong>165</strong>:813-826</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.04.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2016.04.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27114034/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2016.04.010&amp;pmid=27114034" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib101" class="citations"><div id="sref101" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref101" title="View in article">101.</a></div><div>Terwilliger, T.C. ∙ Sobolev, O.V. ∙ Afonine, P.V. ...</div><div><strong>Automated map sharpening by maximization of detail and connectivity</strong></div><div><em>Acta Crystallogr. D Struct. Biol.</em> 2018; <strong>74</strong>:545-559</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S2059798318004655" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85048334770" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29872005/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS2059798318004655&amp;pmid=29872005" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib102" class="citations"><div id="sref102" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref102-1" title="View in article">102.</a></div><div>Tiller, T. ∙ Meffre, E. ∙ Yurasov, S. ...</div><div><strong>Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2008; <strong>329</strong>:112-124</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2007.09.017" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-36849031722" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17996249/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2007.09.017&amp;pmid=17996249" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib103" class="citations"><div id="sref103" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref103-1" title="View in article">103.</a></div><div>Unni, S. ∙ Huang, Y. ∙ Hanson, R.M. ...</div><div><strong>Web servers and services for electrostatics calculations with APBS and PDB2PQR</strong></div><div><em>J.&nbsp;Comput. Chem.</em> 2011; <strong>32</strong>:1488-1491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/jcc.21720" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-79952994820" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21425296/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjcc.21720&amp;pmid=21425296" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib104" class="citations"><div id="sref104" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref104" title="View in article">104.</a></div><div>van Anken, E. ∙ Sanders, R.W. ∙ Liscaljet, I.M. ...</div><div><strong>Only five of 10 strictly conserved disulfide bonds are essential for folding and eight for function of the HIV-1 envelope glycoprotein</strong></div><div><em>Mol. Biol. Cell.</em> 2008; <strong>19</strong>:4298-4309</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1091/mbc.e07-12-1282" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18653472/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1091%2Fmbc.e07-12-1282&amp;pmid=18653472" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib105" class="citations"><div id="sref105" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref105" title="View in article">105.</a></div><div>von Boehmer, L. ∙ Liu, C. ∙ Ackerman, S. ...</div><div><strong>Sequencing and cloning of antigen-specific antibodies from mouse memory B cells</strong></div><div><em>Nat. Protoc.</em> 2016; <strong>11</strong>:1908-1923</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2016.102" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_105_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84988632777" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27658009/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2016.102&amp;pmid=27658009" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib106" class="citations"><div id="sref106" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref106" title="View in article">106.</a></div><div>Walker, L.M. ∙ Burton, D.R.</div><div><strong>Passive immunotherapy of viral infections: ‘super-antibodies’ enter the fray</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:297-308</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_106_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85045850427" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29379211/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.148&amp;pmid=29379211" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib107" class="citations"><div id="sref107" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref107" title="View in article">107.</a></div><div>Walker, B.D. ∙ Yu, X.G.</div><div><strong>Unravelling the mechanisms of durable control of HIV-1</strong></div><div><em>Nat. Rev. Immunol.</em> 2013; <strong>13</strong>:487-498</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri3478" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_107_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879614980" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23797064/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri3478&amp;pmid=23797064" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib108" class="citations"><div id="sref108" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref109" title="View in article">108.</a></div><div>Walker, L.M. ∙ Phogat, S.K. ∙ Chan-Hui, P.Y. ..., Protocol G Principal Investigators</div><div><strong>Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target</strong></div><div><em>Science.</em> 2009; <strong>326</strong>:285-289</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1178746" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_108_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-70349887757" target="_blank" aria-label="Open Scopus in new tab">Scopus (1190)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19729618/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1178746&amp;pmid=19729618" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib109" class="citations"><div id="sref109" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref109" title="View in article">109.</a></div><div>Walker, L.M. ∙ Huber, M. ∙ Doores, K.J. ..., Protocol G Principal Investigators</div><div><strong>Broad neutralization coverage of HIV by multiple highly potent antibodies</strong></div><div><em>Nature.</em> 2011; <strong>477</strong>:466-470</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10373" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_109_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-80053132436" target="_blank" aria-label="Open Scopus in new tab">Scopus (951)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21849977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10373&amp;pmid=21849977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib110" class="citations"><div id="sref110" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref125-1" title="View in article">110.</a></div><div>West, Jr., A.P. ∙ Diskin, R. ∙ Nussenzweig, M.C. ...</div><div><strong>Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2012; <strong>109</strong>:E2083-E2090</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1208984109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_110_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84864363185" target="_blank" aria-label="Open Scopus in new tab">Scopus (130)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22745174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1208984109&amp;pmid=22745174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib111" class="citations"><div id="sref111" class="citation"><div class="citation-content"><div class="label"><a href="#fig3" title="View in article">111.</a></div><div>West, Jr., A.P. ∙ Scharf, L. ∙ Horwitz, J. ...</div><div><strong>Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:10598-10603</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1309215110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_111_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84879538530" target="_blank" aria-label="Open Scopus in new tab">Scopus (58)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23754383/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1309215110&amp;pmid=23754383" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib112" class="citations"><div id="sref112" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref112" title="View in article">112.</a></div><div>Williams, L.D. ∙ Ofek, G. ∙ Schätzle, S. ...</div><div><strong>Potent and broad HIV-neutralizing antibodies in memory B cells and plasma</strong></div><div><em>Sci. Immunol.</em> 2017; <strong>2</strong>:eaal2200</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/sciimmunol.aal2200" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28783671/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fsciimmunol.aal2200&amp;pmid=28783671" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib113" class="citations"><div id="sref113" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref113-1" title="View in article">113.</a></div><div>Wu, X. ∙ Yang, Z.Y. ∙ Li, Y. ...</div><div><strong>Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1</strong></div><div><em>Science.</em> 2010; <strong>329</strong>:856-861</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1187659" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_113_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77954920017" target="_blank" aria-label="Open Scopus in new tab">Scopus (1099)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20616233/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1187659&amp;pmid=20616233" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib114" class="citations"><div id="sref114" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref114" title="View in article">114.</a></div><div>Xu, L. ∙ Pegu, A. ∙ Rao, E. ...</div><div><strong>Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques</strong></div><div><em>Science.</em> 2017; <strong>358</strong>:85-90</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aan8630" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_114_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85029757883" target="_blank" aria-label="Open Scopus in new tab">Scopus (115)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28931639/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aan8630&amp;pmid=28931639" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib115" class="citations"><div id="sref115" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref115" title="View in article">115.</a></div><div>Xu, K. ∙ Acharya, P. ∙ Kong, R. ...</div><div><strong>Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:857-867</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0042-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_115_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85047980123" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29867235/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0042-6&amp;pmid=29867235" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib116" class="citations"><div id="sref116" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref116-1" title="View in article">116.</a></div><div>Yang, X. ∙ Farzan, M. ∙ Wyatt, R. ...</div><div><strong>Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins</strong></div><div><em>J.&nbsp;Virol.</em> 2000; <strong>74</strong>:5716-5725</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.74.12.5716-5725.2000" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_116_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0034087050" target="_blank" aria-label="Open Scopus in new tab">Scopus (149)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10823881/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.74.12.5716-5725.2000&amp;pmid=10823881" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib117" class="citations"><div id="sref117" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref117-1" title="View in article">117.</a></div><div>Ye, J. ∙ Ma, N. ∙ Madden, T.L. ...</div><div><strong>IgBLAST: an immunoglobulin variable domain sequence analysis tool</strong></div><div><em>Nucleic Acids Res.</em> 2013; <strong>41</strong>:W34-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkt382" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_117_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84883563447" target="_blank" aria-label="Open Scopus in new tab">Scopus (297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23671333/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkt382&amp;pmid=23671333" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib118" class="citations"><div id="sref118" class="citation"><div class="citation-content"><div class="label"><a href="#fig2" title="View in article">118.</a></div><div>Yoon, H. ∙ Macke, J. ∙ West, Jr., A.P. ...</div><div><strong>CATNAP: a tool to compile, analyze and tally neutralizing antibody panels</strong></div><div><em>Nucleic Acids Res.</em> 2015; <strong>43</strong>:W213-9</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkv404" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_118_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84979866871" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26044712/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkv404&amp;pmid=26044712" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib119" class="citations"><div id="sref119" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref119" title="View in article">119.</a></div><div>Zhang, K.</div><div><strong>Gctf: Real-time CTF determination and correction</strong></div><div><em>J.&nbsp;Struct. Biol.</em> 2016; <strong>193</strong>:1-12</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jsb.2015.11.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_119_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84955216953" target="_blank" aria-label="Open Scopus in new tab">Scopus (701)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26592709/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jsb.2015.11.003&amp;pmid=26592709" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib120" class="citations"><div id="sref120" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref120-1" title="View in article">120.</a></div><div>Zhang, Y.J. ∙ Hatziioannou, T. ∙ Zang, T. ...</div><div><strong>Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection</strong></div><div><em>J.&nbsp;Virol.</em> 2002; <strong>76</strong>:6332-6343</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/JVI.76.12.6332-6343.2002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_120_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-0036100084" target="_blank" aria-label="Open Scopus in new tab">Scopus (83)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12021366/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FJVI.76.12.6332-6343.2002&amp;pmid=12021366" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib121" class="citations"><div id="sref121" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref121" title="View in article">121.</a></div><div>Zheng, S.Q. ∙ Palovcak, E. ∙ Armache, J.P. ...</div><div><strong>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</strong></div><div><em>Nat. Methods.</em> 2017; <strong>14</strong>:331-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.4193" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_121_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85014129582" target="_blank" aria-label="Open Scopus in new tab">Scopus (955)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28250466/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.4193&amp;pmid=28250466" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib122" class="citations"><div id="sref122" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref122" title="View in article">122.</a></div><div>Zhou, T. ∙ Xu, L. ∙ Dey, B. ...</div><div><strong>Structural definition of a conserved neutralization epitope on HIV-1 gp120</strong></div><div><em>Nature.</em> 2007; <strong>445</strong>:732-737</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature05580" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_122_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-33847101745" target="_blank" aria-label="Open Scopus in new tab">Scopus (619)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17301785/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature05580&amp;pmid=17301785" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib123" class="citations"><div id="sref123" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref125-1" title="View in article">123.</a></div><div>Zhou, T. ∙ Georgiev, I. ∙ Wu, X. ...</div><div><strong>Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01</strong></div><div><em>Science.</em> 2010; <strong>329</strong>:811-817</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1192819" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_123_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-77954943648" target="_blank" aria-label="Open Scopus in new tab">Scopus (754)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20616231/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1192819&amp;pmid=20616231" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib124" class="citations"><div id="sref124" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref125-1" title="View in article">124.</a></div><div>Zhou, T. ∙ Zhu, J. ∙ Wu, X. ..., NISC Comparative Sequencing Program</div><div><strong>Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies</strong></div><div><em>Immunity.</em> 2013; <strong>39</strong>:245-258</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_124_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2013.04.012&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_124_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.immuni.2013.04.012&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_124_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84882589754" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23911655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2013.04.012&amp;pmid=23911655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib125" class="citations"><div id="sref125" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref125-1" title="View in article">125.</a></div><div>Zhou, T. ∙ Lynch, R.M. ∙ Chen, L. ..., NISC Comparative Sequencing Program</div><div><strong>Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors</strong></div><div><em>Cell.</em> 2015; <strong>161</strong>:1280-1292</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.05.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=10.1016%2Fj.cell.2015.05.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_125_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-84930418589" target="_blank" aria-label="Open Scopus in new tab">Scopus (154)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26004070/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.05.007&amp;pmid=26004070" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib126" class="citations"><div id="sref126" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref126" title="View in article">126.</a></div><div>Zivanov, J. ∙ Nakane, T. ∙ Forsberg, B.O. ...</div><div><strong>New tools for automated high-resolution cryo-EM structure determination in RELION-3</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e42166</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.42166" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_126_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.01.010&amp;key=2-s2.0-85056950318" target="_blank" aria-label="Open Scopus in new tab">Scopus (297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30412051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.42166&amp;pmid=30412051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/408e84d8-5627-4671-943e-bf890587b871/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/8779a263-3725-402a-a4d0-423201fc175a/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/a9bfc220-369e-46c5-93f2-4d7b6e69f40b/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/16de7a06-1339-4deb-a23a-d13412607a01/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/a9e70290-e70b-4af6-8c6b-771b04370e6d/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/e1b65a53-3efa-420a-a860-42896e19a666/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/b1465c96-a1f8-47b9-8bea-1ac19f44cbf8/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/93b4e14c-ad27-4576-8cc3-094050d17f04/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/830e2ea7-cd81-4456-859c-267e5823498b/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/16234f9c-5850-4094-a5d0-7a841719f868/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/d42456bd-84d2-49ae-8a04-e1c52d885cdb/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/fb630772-44b8-44d4-bfdc-e19a250c554c/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/4dc1b35a-57e1-4915-a607-38afcb6018d6/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/asset/fb6d9992-5abd-4268-bd2a-a7ceb494d86d/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel js--loaded" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3Apii%5C%3AS0092867419X00045%3Barticle%3Aarticle%3Apii%5C%3AS009286742030057X%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false">
                <li class="publication-list__box publication-list__box-axel">
                    <ul class="rlist axel-list__box">
                        
                        
            <li class="plum-x-wrapper">
                <div class="plum-x plum-x--axel">
                    <div class="plum-x__items">
                        
                    <div class="plum-x__item plum-x-citation">
                        <div class="plum-x__item-num">101</div>
                        <div class="plum-x__item-title">Citations</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-capture">
                        <div class="plum-x__item-num">181</div>
                        <div class="plum-x__item-title">Captures</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-mention">
                        <div class="plum-x__item-num">3</div>
                        <div class="plum-x__item-title">Mentions</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-socialMedia">
                        <div class="plum-x__item-num">8</div>
                        <div class="plum-x__item-title">Social Media</div>
                    </div>    
                
                    </div>
                    <div class="plum-x__details">
                        <div class="plum-x__logo">
                            <img src="/products/marlin/releasedAssets/images/plumx-logo.png" alt="Plum X logo">
                        </div>
                        <a class="plum-x__view-details" href="https://plu.mx/plum/a/?doi=10.1016/j.cell.2020.01.010&amp;theme=plum-jbs-theme&amp;hideUsage=true" target="_blank">
                            <span>View details</span>
                            <span class="sr-only">opens in a new tab</span>
                            <i class="icon-external-arrow" aria-hidden="true"></i>
                        </a>
                    </div>
                </div>  
            </li>
        
                    </ul>
                </li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (7)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/attachment/6fb2a939-510d-4154-9a17-e5f03d397e6f/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (306.35 KB)</span></a><div class="core-description">Table S1. HIV-1-Reactive Antibody Clones Isolated by Single-Cell Cloning from Individual IDC561, Related to Figure&nbsp;1</div></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/attachment/8e672388-15fa-49da-b1eb-e1a2002ee3e6/mmc2.pdf" download="mmc2.pdf"><span id="mmc2-link">PDF (516.78 KB)</span></a><div class="core-description">Table S2. Binding of Members of Isolated Antibody Clones Against HIV-1 Env by ELISA, Related to Figure&nbsp;1</div></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/attachment/167fd972-0a27-4ad1-a88e-2acfe09cf61e/mmc3.pdf" download="mmc3.pdf"><span id="mmc3-link">PDF (318.14 KB)</span></a><div class="core-description">Table S3. Neutralizing Activity against Global Pseudovirus Panel, Related to Figures 1 and 2</div></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/attachment/c8a4b5b1-2b39-4de7-b5e4-d634273ef511/mmc4.pdf" download="mmc4.pdf"><span id="mmc4-link">PDF (508.24 KB)</span></a><div class="core-description">Table S4. Sequences of V<sub>H</sub>1-46-Derived bNAbs from Individual IDC561, Related to Figures 1 and 2</div></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/attachment/d879e3a5-20b0-4bad-999b-56ce5d9e1697/mmc5.pdf" download="mmc5.pdf"><span id="mmc5-link">PDF (591.05 KB)</span></a><div class="core-description">Table S5. Neutralizing Activity Against Multiclade, Clade C, and Primary Virus Panels, Related to Figure&nbsp;2</div></div></div><div id="collapsible-supplementary" data-expandable="item"><div class="content" style="display:none;" role="region" id="collapsible-supplementary_content"><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/attachment/62acfcb3-7903-4fa9-9127-d87f10736660/mmc6.pdf" download="mmc6.pdf"><span id="mmc6-link">PDF (455.30 KB)</span></a><div class="core-description">Table S6. Cryo-EM Data Collection, Refinement, and Validation Statistics, Related to Figure&nbsp;3</div></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.01.010/attachment/a0dde207-4ab0-48e3-a344-2f3589b0b8e9/mmc7.pdf" download="mmc7.pdf"><span id="mmc7-link">PDF (1.35 MB)</span></a><div class="core-description">Table S7. Plasma SGS-Derived <i>env</i> Sequences Obtained from HIV-1<sub>YU2</sub>-Infected Humanized Mice and Antibody Sensitivity, Related to Figures 6 and 7</div></div></div></div><button class="trigger" aria-controls="collapsible-supplementary_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show more</span><span class="collapse">Show less</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related articles (40)</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S009286742030057X" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true"><div class="section-paragraph linked-article axel-related-articles"><ul class="rlist axel-related-articles__items"><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/iscience/fulltext/S2589-0042(25)01108-3" target="_blank" title="Genetic signatures in the highly virulent subtype B HIV-1 conferring resistance to broadly neutralizing antibodies">Genetic signatures in the highly virulent subtype B HIV-1 conferring resistance to broadly neutralizing antibodies</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Marichannegowda et al.</li></ul></div><div class="linked-article__details"><span><i>iScience</i></span><span id="item_date">June 6, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/structure/fulltext/S0969-2126(25)00176-5" target="_blank" title="Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody">Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Liu et al.</li></ul></div><div class="linked-article__details"><span><i>Structure</i></span><span id="item_date">May 23, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(24)01361-5" target="_blank" title="A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies">A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Cale et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">December 14, 2024</span></div></li></ul><ul class="rlist axel-related-articles__items axel-related-articles__extra-items js--hidden"><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell/fulltext/S0092-8674(24)01151-6" target="_blank" title="Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques">Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Wang et al.</li></ul></div><div class="linked-article__details"><span><i>Cell</i></span><span id="item_date">October 28, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/immunity/fulltext/S1074-7613(25)00173-6" target="_blank" title="Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer">Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Schleich et al.</li></ul></div><div class="linked-article__details"><span><i>Immunity</i></span><span id="item_date">May 7, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports-medicine/fulltext/S2666-3791(24)00423-3" target="_blank" title="Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines">Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Schwarzmüller et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports Medicine</i></span><span id="item_date">August 30, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-host-microbe/fulltext/S1931-3128(25)00022-8" target="_blank" title="Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development">Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Hesselman et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Host &amp; Microbe</i></span><span id="item_date">February 4, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell/fulltext/S0092-8674(23)01334-X" target="_blank" title="Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques">Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Saunders et al.</li></ul></div><div class="linked-article__details"><span><i>Cell</i></span><span id="item_date">January 04, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell/fulltext/S0092-8674(24)01084-5" target="_blank" title="A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification">A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Rosen et al.</li></ul></div><div class="linked-article__details"><span><i>Cell</i></span><span id="item_date">October 8, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/structure/fulltext/S0969-2126(25)00150-9" target="_blank" title="A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV">A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Sajadi et al.</li></ul></div><div class="linked-article__details"><span><i>Structure</i></span><span id="item_date">May 14, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/immunity/fulltext/S1074-7613(24)00481-3" target="_blank" title="Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses">Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Rexhepaj et al.</li></ul></div><div class="linked-article__details"><span><i>Immunity</i></span><span id="item_date">November 1, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-host-microbe/fulltext/S1931-3128(23)00257-3" target="_blank" title="Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller">Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Molinos-Albert et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Host &amp; Microbe</i></span><span id="item_date">July 10, 2023</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(24)01514-6" target="_blank" title="Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class">Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Gorman et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">January 8, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports-medicine/fulltext/S2666-3791(22)00160-4" target="_blank" title="Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody">Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Heydarchi et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports Medicine</i></span><span id="item_date">May 17, 2022</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-host-microbe/fulltext/S1931-3128(24)00126-4" target="_blank" title="Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction">Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Wiehe et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Host &amp; Microbe</i></span><span id="item_date">April 25, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(23)00543-0" target="_blank" title="Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination">Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Ju et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">May 22, 2023</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(24)01574-2" target="_blank" title="Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage">Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Mason et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">January 17, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(23)01161-0" target="_blank" title="A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody">A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Svoboda et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">September 14, 2023</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(22)01737-5" target="_blank" title="Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents">Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Cao et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">November 30, 2022</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(23)00722-2" target="_blank" title="Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design">Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Holt et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">July 11, 2023</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell/fulltext/S0092-8674(25)00402-7" target="_blank" title="Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies">Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Glanville et al.</li></ul></div><div class="linked-article__details"><span><i>Cell</i></span><span id="item_date">May 2, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell/fulltext/S0092-8674(24)00459-8" target="_blank" title="Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans">Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Williams et al.</li></ul></div><div class="linked-article__details"><span><i>Cell</i></span><span id="item_date">May 17, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-chemical-biology/fulltext/S2451-9456(22)00126-X" target="_blank" title="Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies">Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Jiang et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Chemical Biology</i></span><span id="item_date">March 29, 2022</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(23)01664-9" target="_blank" title="Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain">Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Wang et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">January 3, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(24)01553-5" target="_blank" title="Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors">Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>George et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">January 10, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/biophysj/fulltext/S0006-3495(24)01120-2" target="_blank" title="BPS2025 - Orientation-dependent electrostatic interactions between broadly neutralizing HIV-1 MPER antibodies and virus-mimetic membrane">BPS2025 - Orientation-dependent electrostatic interactions between broadly neutralizing HIV-1 MPER antibodies and virus-mimetic membrane</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Qiu et al.</li></ul></div><div class="linked-article__details"><span><i>Biophysical Journal</i></span><span id="item_date">February 13, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports-medicine/fulltext/S2666-3791(23)00368-3" target="_blank" title="HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells">HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Stab et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports Medicine</i></span><span id="item_date">October 6, 2023</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(22)00359-X" target="_blank" title="Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans">Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Huettner et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">March 29, 2022</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports-medicine/fulltext/S2666-3791(24)00269-6" target="_blank" title="Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies">Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Sheward et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports Medicine</i></span><span id="item_date">May 17, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(24)00276-6" target="_blank" title="Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolution">Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolution</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Tenggara et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">March 12, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(24)01387-1" target="_blank" title="Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV">Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Chao et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">December 6, 2024</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(25)00417-6" target="_blank" title="Structural basis of human cytomegalovirus neutralization by gB AD-5-specific potent antibodies">Structural basis of human cytomegalovirus neutralization by gB AD-5-specific potent antibodies</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Wu et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">May 17, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/iscience/fulltext/S2589-0042(23)01032-5" target="_blank" title="Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents">Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Takeshita et al.</li></ul></div><div class="linked-article__details"><span><i>iScience</i></span><span id="item_date">May 24, 2023</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/iscience/fulltext/S2589-0042(23)01672-3" target="_blank" title="Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research">Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Williamson et al.</li></ul></div><div class="linked-article__details"><span><i>iScience</i></span><span id="item_date">August 9, 2023</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(22)00163-2" target="_blank" title="Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies">Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Sahoo et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">March 01, 2022</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-host-microbe/fulltext/S1931-3128(19)30483-4" target="_blank" title="Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01">Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Pinto et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Host &amp; Microbe</i></span><span id="item_date">October 22, 2019</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell/fulltext/S0092-8674(22)00069-1" target="_blank" title="SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses">SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Walls et al.</li></ul></div><div class="linked-article__details"><span><i>Cell</i></span><span id="item_date">January 19, 2022</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/iscience/fulltext/S2589-0042(25)00795-3" target="_blank" title="A two-component cocktail of engineered DIII nanoparticles elicits broadly neutralizing antibody responses against dengue virus in mice">A two-component cocktail of engineered DIII nanoparticles elicits broadly neutralizing antibody responses against dengue virus in mice</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Mariano et al.</li></ul></div><div class="linked-article__details"><span><i>iScience</i></span><span id="item_date">April 29, 2025</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/immunity/fulltext/S1074-7613(19)30194-3" target="_blank" title="Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope">Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Schoofs et al.</li></ul></div><div class="linked-article__details"><span><i>Immunity</i></span><span id="item_date">May 21, 2019</span></div></li><li class="linked-article__item"><a class="linked-article__title link--underlined" href="/cell-reports/fulltext/S2211-1247(22)00250-9" target="_blank" title="mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice">mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice</a><div><ul class="meta__authors rlist--inline comma" title="list of authors"><li>Mu et al.</li></ul></div><div class="linked-article__details"><span><i>Cell Reports</i></span><span id="item_date">March 15, 2022</span></div></li></ul><a href="javascript:void(0)" class="toggle-extra-items"><span>Show more</span><i aria-hidden="true" class="icon-arrow_d_n"></i></a></div></div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2020.01.010","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.01.010/asset/408e84d8-5627-4671-943e-bf890587b871/main.assets/gr1.jpg" height="833" width="753" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/e4a3145f-1a67-4183-8334-b8b990a792d8/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.01.010/asset/8779a263-3725-402a-a4d0-423201fc175a/main.assets/figs1.jpg" height="790" width="659" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/7523f523-4c24-4f46-b81c-2dcc3376af06/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.01.010/asset/a9bfc220-369e-46c5-93f2-4d7b6e69f40b/main.assets/gr2.jpg" height="935" width="704" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/8b51611a-1731-403a-9db3-950a62a7206c/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.01.010/asset/16de7a06-1339-4deb-a23a-d13412607a01/main.assets/figs2.jpg" height="823" width="659" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/8c002e8b-1058-4f2c-96dd-e2e6e1e0b459/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.01.010/asset/a9e70290-e70b-4af6-8c6b-771b04370e6d/main.assets/gr3.jpg" height="848" width="659" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/be33c7da-8052-459d-aa94-8b003d7a554f/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.01.010/asset/e1b65a53-3efa-420a-a860-42896e19a666/main.assets/figs3.jpg" height="941" width="693" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/b2698f80-7b0f-4b1e-867f-9d08c5e200d9/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.01.010/asset/b1465c96-a1f8-47b9-8bea-1ac19f44cbf8/main.assets/figs4.jpg" height="903" width="751" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/4f47e248-5707-4364-91b5-fbafc1710dc5/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.01.010/asset/93b4e14c-ad27-4576-8cc3-094050d17f04/main.assets/gr4.jpg" height="639" width="754" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/1fa3f934-ae52-411f-9bd0-a4adf65e4ff2/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.01.010/asset/830e2ea7-cd81-4456-859c-267e5823498b/main.assets/figs5.jpg" height="941" width="737" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/e8f2f646-d35c-4b41-b660-7037e1dfd8f5/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.01.010/asset/16234f9c-5850-4094-a5d0-7a841719f868/main.assets/gr5.jpg" height="935" width="675" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/df55d7f4-1305-465c-89f0-91f022a04472/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.01.010/asset/d42456bd-84d2-49ae-8a04-e1c52d885cdb/main.assets/figs6.jpg" height="815" width="753" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/c71947f0-56e7-4ea5-87ec-240a062d626c/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.01.010/asset/fb630772-44b8-44d4-bfdc-e19a250c554c/main.assets/gr6.jpg" height="739" width="659" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ebe4ef24-9d27-47ab-98dd-f1f026cfbd10/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.01.010/asset/4dc1b35a-57e1-4915-a607-38afcb6018d6/main.assets/gr7.jpg" height="934" width="695" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ba8839b2-c0d1-41e8-bd95-421854aa90c7/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2020.01.010/asset/fb6d9992-5abd-4268-bd2a-a7ceb494d86d/main.assets/figs7.jpg" height="444" width="714" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ffa05378-a5df-47fc-bb81-170494fe67ca/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.01.010/asset/408e84d8-5627-4671-943e-bf890587b871/main.assets/gr1.jpg" height="833" width="753" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/e4a3145f-1a67-4183-8334-b8b990a792d8/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.01.010/asset/8779a263-3725-402a-a4d0-423201fc175a/main.assets/figs1.jpg" height="790" width="659" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/7523f523-4c24-4f46-b81c-2dcc3376af06/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.01.010/asset/a9bfc220-369e-46c5-93f2-4d7b6e69f40b/main.assets/gr2.jpg" height="935" width="704" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/8b51611a-1731-403a-9db3-950a62a7206c/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.01.010/asset/16de7a06-1339-4deb-a23a-d13412607a01/main.assets/figs2.jpg" height="823" width="659" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/8c002e8b-1058-4f2c-96dd-e2e6e1e0b459/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.01.010/asset/a9e70290-e70b-4af6-8c6b-771b04370e6d/main.assets/gr3.jpg" height="848" width="659" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/be33c7da-8052-459d-aa94-8b003d7a554f/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.01.010/asset/e1b65a53-3efa-420a-a860-42896e19a666/main.assets/figs3.jpg" height="941" width="693" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/b2698f80-7b0f-4b1e-867f-9d08c5e200d9/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.01.010/asset/b1465c96-a1f8-47b9-8bea-1ac19f44cbf8/main.assets/figs4.jpg" height="903" width="751" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/4f47e248-5707-4364-91b5-fbafc1710dc5/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.01.010/asset/93b4e14c-ad27-4576-8cc3-094050d17f04/main.assets/gr4.jpg" height="639" width="754" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/1fa3f934-ae52-411f-9bd0-a4adf65e4ff2/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.01.010/asset/830e2ea7-cd81-4456-859c-267e5823498b/main.assets/figs5.jpg" height="941" width="737" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/e8f2f646-d35c-4b41-b660-7037e1dfd8f5/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.01.010/asset/16234f9c-5850-4094-a5d0-7a841719f868/main.assets/gr5.jpg" height="935" width="675" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/df55d7f4-1305-465c-89f0-91f022a04472/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.01.010/asset/d42456bd-84d2-49ae-8a04-e1c52d885cdb/main.assets/figs6.jpg" height="815" width="753" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/c71947f0-56e7-4ea5-87ec-240a062d626c/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.01.010/asset/fb630772-44b8-44d4-bfdc-e19a250c554c/main.assets/gr6.jpg" height="739" width="659" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ebe4ef24-9d27-47ab-98dd-f1f026cfbd10/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.01.010/asset/4dc1b35a-57e1-4915-a607-38afcb6018d6/main.assets/gr7.jpg" height="934" width="695" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ba8839b2-c0d1-41e8-bd95-421854aa90c7/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2020.01.010/asset/fb6d9992-5abd-4268-bd2a-a7ceb494d86d/main.assets/figs7.jpg" height="444" width="714" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.01.010/asset/ffa05378-a5df-47fc-bb81-170494fe67ca/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30057-X';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30057-X';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749585426968","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openaccess","volumeNumber":"180","issueNumber":"3","viewState":"fulltext","format":"MIME-HTML","id":"pii:S009286742030057X","coverDate":"202002","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Restriction of HIV1 Escape by a Highly Broad and Potent Neutralizing Antibody","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94db6f8daa404edd',t:'MTc0OTU4NTQyNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94db6f8daa404edd&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2020.01.010&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>